data_2mca_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mca _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.021 -1.474 . . . . 75.5 107.021 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 61.140000000000001 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 73.209999999999994 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.140000000000001 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.200000000000003 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 71.109999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 72.239999999999995 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 72.5 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 74.400000000000006 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.519999999999996 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 75.310000000000002 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 75.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 72.200000000000003 109.012 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.447 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 73.319999999999993 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.439999999999998 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.421 ' C ' ' HG1' ' A' ' 38' ' ' THR . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 75.209999999999994 113.799 -170.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 37' ' ' ASN . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 74.439999999999998 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.409999999999997 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 75.030000000000001 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 72.120000000000005 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 74.329999999999998 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 72.310000000000002 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.420000000000002 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 74.200000000000003 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 63.409999999999997 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 71.129999999999995 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 75.129999999999995 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 73.530000000000001 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 74.530000000000001 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 74.439999999999998 108.836 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 73.030000000000001 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 75.019999999999996 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 73.430000000000007 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.420000000000002 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.409999999999997 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 75.109999999999999 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 75.310000000000002 109.952 175.089 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.369 0.877 . . . . 74.430000000000007 113.369 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 75.109999999999999 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 74.230000000000004 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 64.109999999999999 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 75.140000000000001 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 73.430000000000007 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 74.340000000000003 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 73.310000000000002 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 64.319999999999993 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 73.329999999999998 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 73.25 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.485 ' ND2' ' HG1' ' A' ' 38' ' ' THR . 28.2 t30 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.485 ' HG1' ' ND2' ' A' ' 37' ' ' ASN . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 74.430000000000007 108.135 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 64.349999999999994 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 60.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 64.209999999999994 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 74.129999999999995 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 64.519999999999996 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 71.430000000000007 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 74.420000000000002 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 73.420000000000002 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 71.439999999999998 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 75.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 75.129999999999995 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 75.239999999999995 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.420000000000002 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 63.310000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.409999999999997 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 72.540000000000006 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 64.540000000000006 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 75.349999999999994 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 64.439999999999998 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 74.25 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 75.25 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 73.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 65.140000000000001 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.239 0.519 0 CA-C-O 121.388 0.613 . . . . 75.099999999999994 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 74.109999999999999 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 73.230000000000004 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 75.150000000000006 107.349 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 75.540000000000006 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.540000000000006 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 73.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 75.409999999999997 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 71.450000000000003 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 64.400000000000006 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 74.109999999999999 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 75.430000000000007 108.591 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 64.120000000000005 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 73.439999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 75.530000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 74.340000000000003 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 74.140000000000001 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 55.219999999999999 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.219999999999999 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 75.150000000000006 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 75.329999999999998 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 73.519999999999996 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 41.439999999999998 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 73.239999999999995 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 75.140000000000001 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 72.219999999999999 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 75.450000000000003 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 75.530000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 74.549999999999997 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 72.25 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 74.150000000000006 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 62.439999999999998 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 64.519999999999996 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 75.329999999999998 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 75.430000000000007 107.941 170.768 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.0 -0.741 . . . . 73.299999999999997 109.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.230000000000004 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 71.439999999999998 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 73.349999999999994 110.353 -174.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 71.109999999999999 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 74.540000000000006 109.881 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 72.25 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 74.349999999999994 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 73.150000000000006 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 65.219999999999999 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 71.340000000000003 107.594 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.329999999999998 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 75.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 74.409999999999997 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 74.129999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 74.530000000000001 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 73.129999999999995 107.472 168.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 74.129999999999995 106.97 167.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 74.129999999999995 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 70.25 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 61.049999999999997 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 65.310000000000002 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 62.409999999999997 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 75.310000000000002 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 71.239999999999995 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 72.120000000000005 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 72.129999999999995 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 75.219999999999999 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 72.450000000000003 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 71.219999999999999 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 64.530000000000001 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 74.150000000000006 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 75.409999999999997 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 74.439999999999998 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 74.150000000000006 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 75.329999999999998 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 73.129999999999995 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 72.310000000000002 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 72.430000000000007 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.530000000000001 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 71.519999999999996 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 74.109999999999999 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 73.530000000000001 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 74.439999999999998 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.409999999999997 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 71.120000000000005 110.189 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 73.349999999999994 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 74.239999999999995 106.731 172.12 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.782 0.801 . . . . 72.310000000000002 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 70.219999999999999 109.555 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.140000000000001 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 73.430000000000007 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 74.25 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 74.120000000000005 111.173 -167.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 70.530000000000001 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 74.420000000000002 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 109.052 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 63.240000000000002 113.829 -162.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 73.349999999999994 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 70.340000000000003 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 73.25 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 65.129999999999995 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 74.439999999999998 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 73.409999999999997 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 73.349999999999994 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.319999999999993 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 73.140000000000001 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 74.239999999999995 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 45.329999999999998 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 72.430000000000007 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 74.409999999999997 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.549999999999997 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 74.349999999999994 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 62.049999999999997 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 72.010000000000005 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 72.010000000000005 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 74.030000000000001 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.414 ' HB ' HD22 ' A' ' 23' ' ' ASN . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 73.120000000000005 109.956 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 70.120000000000005 113.002 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 74.120000000000005 111.043 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 74.109999999999999 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 63.310000000000002 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 74.230000000000004 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 72.439999999999998 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 73.049999999999997 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 70.409999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 73.349999999999994 107.642 169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 74.230000000000004 107.221 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 73.329999999999998 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.430000000000007 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 54.450000000000003 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 72.239999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 73.340000000000003 110.787 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 72.219999999999999 108.055 165.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 72.319999999999993 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 72.219999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 74.150000000000006 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 74.219999999999999 109.072 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 74.129999999999995 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 109.39 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 61.409999999999997 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 72.310000000000002 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 74.430000000000007 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 71.120000000000005 108.182 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 72.230000000000004 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 74.140000000000001 106.191 162.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 74.310000000000002 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 73.099999999999994 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 74.5 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 64.109999999999999 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 75.319999999999993 109.876 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 63.420000000000002 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 74.349999999999994 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.319999999999993 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.310000000000002 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 74.519999999999996 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 61.140000000000001 108.879 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.438 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 71.209999999999994 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 73.530000000000001 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 50.119999999999997 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 54.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 63.439999999999998 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 74.450000000000003 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 75.230000000000004 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 72.409999999999997 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 64.349999999999994 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 63.329999999999998 109.485 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 73.230000000000004 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 75.319999999999993 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 55.009999999999998 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 74.400000000000006 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 75.340000000000003 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 71.230000000000004 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 75.239999999999995 108.419 174.564 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.878 -0.786 . . . . 74.439999999999998 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 65.510000000000005 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.239999999999995 108.67 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 65.349999999999994 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.239999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.340000000000003 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 72.239999999999995 113.463 -165.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 72.450000000000003 108.159 -163.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 73.420000000000002 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.420000000000002 105.37 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 72.530000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 74.239999999999995 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 73.329999999999998 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 74.519999999999996 105.862 162.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.530000000000001 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 75.329999999999998 107.986 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 75.150000000000006 107.498 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.120000000000005 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 73.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 70.409999999999997 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.510000000000005 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 70.109999999999999 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 74.209999999999994 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.239999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 73.120000000000005 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 74.530000000000001 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 72.540000000000006 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 72.540000000000006 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 71.510000000000005 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 62.25 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 62.340000000000003 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 74.510000000000005 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 74.439999999999998 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 73.340000000000003 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 74.420000000000002 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 62.530000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 74.319999999999993 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 74.120000000000005 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 70.519999999999996 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 74.230000000000004 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 72.120000000000005 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.519999999999996 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 74.25 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.209999999999994 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 72.099999999999994 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 70.239999999999995 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 74.439999999999998 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 73.230000000000004 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 74.109999999999999 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 54.020000000000003 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 74.310000000000002 109.467 -169.903 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.26 -0.645 . . . . 72.319999999999993 109.26 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 74.239999999999995 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 73.329999999999998 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 73.329999999999998 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 71.319999999999993 108.412 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 72.349999999999994 113.518 -162.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 75.109999999999999 108.841 -167.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 75.530000000000001 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 72.5 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 51.340000000000003 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 71.409999999999997 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 74.109999999999999 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 70.349999999999994 107.649 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 71.200000000000003 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 72.329999999999998 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 72.299999999999997 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 71.200000000000003 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 55.439999999999998 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 74.439999999999998 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 71.430000000000007 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 73.450000000000003 107.871 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 74.510000000000005 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 71.209999999999994 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 64.120000000000005 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.439999999999998 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 71.109999999999999 112.192 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 74.510000000000005 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 72.099999999999994 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 71.430000000000007 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 53.420000000000002 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 74.219999999999999 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 65.409999999999997 108.0 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.549999999999997 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.439999999999998 109.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 74.400000000000006 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 73.219999999999999 109.475 178.123 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.91 0.337 . . . . 64.109999999999999 111.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 72.239999999999995 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.530000000000001 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 74.450000000000003 107.383 162.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 71.530000000000001 110.479 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 72.230000000000004 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 74.540000000000006 106.826 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 71.450000000000003 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 74.319999999999993 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' ND2' ' HG1' ' A' ' 38' ' ' THR . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 74.340000000000003 108.734 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.435 ' HG1' ' ND2' ' A' ' 37' ' ' ASN . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 72.409999999999997 105.524 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 73.540000000000006 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 72.409999999999997 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 74.109999999999999 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.5 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 72.340000000000003 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 54.030000000000001 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 74.150000000000006 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 74.329999999999998 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.530000000000001 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 72.120000000000005 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 73.310000000000002 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 73.25 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 70.310000000000002 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 71.140000000000001 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 73.239999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 72.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 73.120000000000005 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 64.549999999999997 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 74.540000000000006 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 71.329999999999998 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 72.420000000000002 112.082 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 70.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 73.129999999999995 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.675 -1.232 . . . . 71.519999999999996 107.675 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 75.549999999999997 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 75.299999999999997 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.439999999999998 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 75.209999999999994 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 73.540000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 71.150000000000006 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 73.25 112.889 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 72.430000000000007 107.54 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 74.5 107.29 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 72.409999999999997 104.793 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 75.230000000000004 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 75.329999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 72.040000000000006 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 75.219999999999999 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 75.310000000000002 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 73.439999999999998 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 43.219999999999999 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 75.239999999999995 106.984 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 73.510000000000005 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 71.150000000000006 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 63.399999999999999 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 72.230000000000004 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 72.030000000000001 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG11 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 75.109999999999999 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 74.439999999999998 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 73.340000000000003 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 73.549999999999997 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 54.119999999999997 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 75.439999999999998 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 75.219999999999999 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 74.450000000000003 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 72.140000000000001 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.209999999999994 104.811 158.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 72.310000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 72.420000000000002 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 72.549999999999997 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 75.219999999999999 109.803 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 73.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 72.530000000000001 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.43 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.947 -0.39 . . . . 75.200000000000003 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 73.019999999999996 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 74.109999999999999 109.724 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 74.400000000000006 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.45 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 74.439999999999998 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 75.200000000000003 107.765 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 73.540000000000006 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 63.340000000000003 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 72.329999999999998 114.675 -163.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 73.420000000000002 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 75.129999999999995 108.858 159.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 64.200000000000003 111.416 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 75.329999999999998 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 73.209999999999994 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 75.230000000000004 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 74.239999999999995 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 51.32 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 72.030000000000001 105.213 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 75.430000000000007 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.209999999999994 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 73.120000000000005 107.95 172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 73.239999999999995 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 73.430000000000007 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 64.120000000000005 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 75.0 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 75.120000000000005 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 73.340000000000003 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 74.239999999999995 107.741 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 75.409999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 75.420000000000002 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 74.129999999999995 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 73.230000000000004 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 71.439999999999998 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 62.530000000000001 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 74.230000000000004 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 73.040000000000006 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 74.140000000000001 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 73.140000000000001 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 74.0 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 75.340000000000003 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 75.120000000000005 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 54.0 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 72.109999999999999 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 74.310000000000002 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 73.129999999999995 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.942 -0.392 . . . . 65.299999999999997 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 73.099999999999994 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 74.0 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 75.409999999999997 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 54.539999999999999 110.835 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 74.409999999999997 112.752 -165.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 74.239999999999995 104.57 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.319999999999993 106.948 159.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 63.140000000000001 106.498 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 74.019999999999996 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 53.130000000000003 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 73.400000000000006 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 110.841 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 72.109999999999999 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 74.400000000000006 106.598 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 75.140000000000001 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 73.120000000000005 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.129999999999995 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 70.019999999999996 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 71.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.299999999999997 111.775 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 64.439999999999998 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.310000000000002 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 74.099999999999994 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 74.420000000000002 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 74.010000000000005 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 73.200000000000003 105.647 173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 74.319999999999993 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 71.310000000000002 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 73.030000000000001 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 64.400000000000006 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 72.400000000000006 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 71.239999999999995 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 74.310000000000002 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.310000000000002 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.301 -1.0 . . . . 65.450000000000003 108.301 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 74.150000000000006 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 73.120000000000005 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 73.450000000000003 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 70.030000000000001 108.891 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.329999999999998 108.179 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.409999999999997 113.227 -163.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 73.019999999999996 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 73.340000000000003 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 56' ' ' LYS . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 61.039999999999999 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 72.340000000000003 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 72.319999999999993 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 65.310000000000002 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 74.299999999999997 107.672 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 53.329999999999998 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 65.340000000000003 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 71.239999999999995 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 65.040000000000006 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 53.340000000000003 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 72.439999999999998 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 30' ' ' ASP . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 62.030000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 73.329999999999998 103.68 151.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 65.409999999999997 108.492 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 70.099999999999994 111.637 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.409999999999997 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 74.299999999999997 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' CG1' ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 70.319999999999993 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 73.25 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 71.030000000000001 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 74.129999999999995 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 73.040000000000006 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 72.409999999999997 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 73.25 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 73.019999999999996 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 70.5 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.340000000000003 110.784 -163.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 73.430000000000007 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG1' ' CA ' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 71.219999999999999 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 74.349999999999994 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 63.140000000000001 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 75.400000000000006 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 73.340000000000003 112.492 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 75.439999999999998 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 72.109999999999999 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 72.299999999999997 109.517 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 74.329999999999998 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 74.400000000000006 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 73.409999999999997 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 75.109999999999999 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 74.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 63.32 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 75.209999999999994 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 64.299999999999997 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 74.530000000000001 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 63.140000000000001 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 75.310000000000002 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 70.329999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 61.140000000000001 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 71.319999999999993 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 74.209999999999994 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.230000000000004 111.61 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 73.439999999999998 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 73.040000000000006 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 74.040000000000006 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 64.219999999999999 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 73.519999999999996 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 65.420000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 73.219999999999999 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 72.519999999999996 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 75.209999999999994 104.213 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 72.530000000000001 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 74.239999999999995 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 73.299999999999997 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 53.399999999999999 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 74.230000000000004 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 74.299999999999997 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 73.540000000000006 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 72.420000000000002 109.418 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 62.43 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 75.299999999999997 112.381 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 74.430000000000007 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.439999999999998 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 74.040000000000006 108.759 161.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 74.120000000000005 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 71.109999999999999 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.452 HD22 ' HB ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 64.319999999999993 109.893 -170.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 74.109999999999999 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 74.239999999999995 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 73.200000000000003 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 74.340000000000003 110.543 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 72.400000000000006 105.478 166.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 71.329999999999998 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 72.150000000000006 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 71.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 63.049999999999997 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 74.319999999999993 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 74.010000000000005 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 75.129999999999995 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 75.439999999999998 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 75.030000000000001 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 75.109999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 73.299999999999997 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 75.310000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 73.200000000000003 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 74.010000000000005 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.452 ' HB ' HD22 ' A' ' 23' ' ' ASN . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 72.140000000000001 112.511 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 75.049999999999997 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 63.25 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 71.310000000000002 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 71.530000000000001 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 75.120000000000005 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 74.329999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 72.340000000000003 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 74.239999999999995 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 75.239999999999995 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 74.109999999999999 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 75.219999999999999 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 74.400000000000006 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 74.230000000000004 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.430000000000007 107.538 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.6 0.238 . . . . 74.040000000000006 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 62.109999999999999 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 74.010000000000005 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.230000000000004 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 73.340000000000003 114.499 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 74.239999999999995 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 74.409999999999997 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 61.509999999999998 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 73.209999999999994 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 73.5 108.32 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 72.409999999999997 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 71.030000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 64.439999999999998 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 73.299999999999997 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.411 ' C ' ' HG1' ' A' ' 38' ' ' THR . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 73.109999999999999 111.583 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 37' ' ' ASN . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 64.439999999999998 104.59 168.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 44.149999999999999 114.591 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 74.530000000000001 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 71.140000000000001 106.621 166.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 61.210000000000001 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 74.109999999999999 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 71.230000000000004 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.409999999999997 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 71.319999999999993 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 74.010000000000005 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 71.5 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 74.340000000000003 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 54.310000000000002 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 51.130000000000003 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 73.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.519999999999996 107.211 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 73.230000000000004 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.549999999999997 106.636 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 73.329999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 74.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 75.319999999999993 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.329999999999998 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 72.099999999999994 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.409999999999997 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 72.239999999999995 110.041 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 70.200000000000003 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 73.319999999999993 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.430000000000007 107.874 173.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.95 -0.389 . . . . 73.310000000000002 109.95 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 75.209999999999994 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 64.549999999999997 108.383 166.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 75.329999999999998 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 75.349999999999994 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 74.439999999999998 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 72.319999999999993 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 71.420000000000002 113.154 -162.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 74.120000000000005 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 72.239999999999995 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 74.310000000000002 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 63.350000000000001 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.219999999999999 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 74.329999999999998 107.958 -168.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.519999999999996 106.055 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 75.519999999999996 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 65.120000000000005 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 51.140000000000001 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 74.219999999999999 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 75.010000000000005 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.209999999999994 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 71.25 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 74.329999999999998 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 74.420000000000002 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 50.350000000000001 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 65.230000000000004 112.138 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 63.119999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 54.210000000000001 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 73.349999999999994 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.457 ' CA ' ' CG1' ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 64.219999999999999 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 71.140000000000001 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 55.219999999999999 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 75.310000000000002 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 72.140000000000001 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 74.319999999999993 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 75.319999999999993 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 74.450000000000003 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 62.32 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 75.519999999999996 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 75.150000000000006 110.934 -161.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' CG1' ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 73.219999999999999 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 75.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 63.439999999999998 107.364 175.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.336 0.588 . . . . 75.129999999999995 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 65.140000000000001 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 75.230000000000004 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 75.519999999999996 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 73.329999999999998 110.658 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 74.400000000000006 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.400000000000006 113.509 -163.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 75.040000000000006 110.36 -166.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 74.239999999999995 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 64.310000000000002 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.549999999999997 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 74.109999999999999 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 74.209999999999994 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 75.239999999999995 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 75.549999999999997 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 73.019999999999996 109.075 173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 73.340000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 74.340000000000003 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 75.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 73.319999999999993 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 75.120000000000005 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 71.120000000000005 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 72.310000000000002 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 70.430000000000007 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 73.420000000000002 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 74.040000000000006 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 71.129999999999995 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 74.019999999999996 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.329999999999998 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 74.209999999999994 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 75.420000000000002 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 75.129999999999995 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 73.109999999999999 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 73.340000000000003 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 71.140000000000001 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 73.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.439999999999998 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 70.25 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 73.519999999999996 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 73.030000000000001 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 61.030000000000001 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 65.030000000000001 109.752 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 74.430000000000007 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 74.120000000000005 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 70.150000000000006 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 74.329999999999998 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 73.129999999999995 107.406 175.202 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 73.120000000000005 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 74.450000000000003 108.002 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 74.150000000000006 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 63.32 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 74.319999999999993 108.717 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 71.230000000000004 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.319999999999993 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.519999999999996 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 75.120000000000005 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 75.219999999999999 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.109999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 74.450000000000003 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 74.319999999999993 106.331 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 70.540000000000006 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 74.420000000000002 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 72.430000000000007 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 62.049999999999997 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 74.140000000000001 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 64.219999999999999 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 74.310000000000002 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 72.420000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 71.530000000000001 112.294 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 72.140000000000001 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 74.420000000000002 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 74.040000000000006 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 63.020000000000003 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 62.450000000000003 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 74.530000000000001 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 75.519999999999996 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 63.520000000000003 109.055 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 75.329999999999998 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 75.439999999999998 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 74.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 72.310000000000002 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 54.240000000000002 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 121.166 0.508 . . . . 74.219999999999999 109.651 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 75.140000000000001 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 64.319999999999993 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 75.230000000000004 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 71.400000000000006 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 75.329999999999998 107.996 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 74.0 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 73.310000000000002 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 72.010000000000005 107.043 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 75.140000000000001 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 74.420000000000002 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 73.319999999999993 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 71.329999999999998 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 74.120000000000005 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.219999999999999 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 71.430000000000007 105.859 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 74.409999999999997 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 75.129999999999995 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 71.420000000000002 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 75.129999999999995 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 72.540000000000006 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.510000000000005 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.519999999999996 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 74.439999999999998 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 63.329999999999998 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.219999999999999 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 71.439999999999998 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 73.299999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.433 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 71.140000000000001 108.702 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 73.109999999999999 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 74.409999999999997 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 71.299999999999997 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 71.219999999999999 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 72.340000000000003 112.273 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 70.140000000000001 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 72.400000000000006 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 74.219999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 74.239999999999995 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 74.430000000000007 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 73.099999999999994 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 74.109999999999999 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 72.540000000000006 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.340000000000003 106.259 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 73.329999999999998 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 71.420000000000002 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 73.109999999999999 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 73.439999999999998 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 72.319999999999993 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 74.510000000000005 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 74.439999999999998 107.47 166.546 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 CA-C-O 119.572 -0.571 . . . . 74.319999999999993 111.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.87 154.11 18.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.167 0.987 . . . . 61.530000000000001 108.646 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -127.95 -14.93 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.074 0.949 . . . . 75.409999999999997 112.297 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -122.67 11.09 9.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.445 1.498 . . . . 75.0 109.86 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.93 44.14 1.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.404 1.954 . . . . 62.420000000000002 113.605 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 62.59 0.42 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.003 1.721 . . . . 75.239999999999995 109.047 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -144.43 42.49 1.38 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.656 3.183 . . . . 74.310000000000002 106.793 -157.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 149.21 35.39 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.399 1.879 . . . . 75.5 107.021 -167.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 61.140000000000001 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 73.209999999999994 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.140000000000001 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.200000000000003 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 71.109999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 72.239999999999995 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 72.5 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 74.400000000000006 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.519999999999996 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 75.310000000000002 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 75.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 72.200000000000003 109.012 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.447 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 73.319999999999993 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.439999999999998 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.421 ' C ' ' HG1' ' A' ' 38' ' ' THR . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 75.209999999999994 113.799 -170.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 37' ' ' ASN . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 74.439999999999998 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.409999999999997 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 75.030000000000001 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 72.120000000000005 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 74.329999999999998 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 72.310000000000002 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.420000000000002 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 74.200000000000003 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 63.409999999999997 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 71.129999999999995 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 75.129999999999995 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 73.530000000000001 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 74.530000000000001 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 74.439999999999998 108.836 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 73.030000000000001 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 75.019999999999996 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 73.430000000000007 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.420000000000002 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.409999999999997 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 75.109999999999999 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -85.09 168.33 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 75.310000000000002 109.952 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.36 -57.75 0.16 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.381 -1.488 . . . . 54.229999999999997 109.381 -168.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.31 15.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.711 1.256 . . . . 73.409999999999997 113.673 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 tt -74.66 82.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.34 2.256 . . . . 74.409999999999997 109.161 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 N-CA-C 103.816 -2.661 . . . . 63.100000000000001 103.816 171.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 109.526 -1.43 . . . . 65.329999999999998 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.26 56.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.214 -0.661 . . . . 72.319999999999993 109.214 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -78.15 11.35 2.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.584 1.554 . . . . 75.319999999999993 111.615 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -118.81 33.11 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.786 2.034 . . . . 61.340000000000003 107.264 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.49 -85.45 1.23 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 126.102 1.811 . . . . 53.229999999999997 109.73 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -150.95 68.33 0.94 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.656 -1.239 . . . . 71.349999999999994 107.656 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -143.04 32.71 1.37 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.194 0.998 . . . . 75.540000000000006 111.444 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.25 155.74 46.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 74.430000000000007 113.369 -164.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 75.109999999999999 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 74.230000000000004 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 64.109999999999999 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 75.140000000000001 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 73.430000000000007 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 74.340000000000003 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 73.310000000000002 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 64.319999999999993 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 73.329999999999998 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 73.25 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' ND2' ' HG1' ' A' ' 38' ' ' THR . 28.2 t30 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.485 ' HG1' ' ND2' ' A' ' 37' ' ' ASN . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 74.430000000000007 108.135 -175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 64.349999999999994 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 60.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 64.209999999999994 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 74.129999999999995 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 64.519999999999996 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 71.430000000000007 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 74.420000000000002 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 73.420000000000002 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 71.439999999999998 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 75.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 75.129999999999995 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 75.239999999999995 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.420000000000002 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 63.310000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.409999999999997 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 72.540000000000006 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 64.540000000000006 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 75.349999999999994 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 64.439999999999998 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 74.25 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 75.25 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 73.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 65.140000000000001 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -139.0 -177.05 4.71 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.82 -82.77 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.686 -2.166 . . . . 74.329999999999998 107.686 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -78.46 77.4 4.95 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.779 -0.823 . . . . 60.43 108.779 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.9 tt -126.81 110.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 125.196 1.398 . . . . 74.340000000000003 108.248 172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.389 2.275 . . . . 63.409999999999997 115.953 146.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 118.846 -0.974 . . . . 73.439999999999998 115.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.15 177.27 8.71 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.847 1.824 . . . . 73.340000000000003 107.983 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.4 -69.47 0.36 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.524 -1.288 . . . . 75.319999999999993 107.524 159.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.39 19.65 2.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 71.319999999999993 111.575 -168.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.21 -62.89 3.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.591 1.567 . . . . 73.430000000000007 114.923 -168.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -143.7 36.3 1.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.35 1.075 . . . . 73.200000000000003 111.1 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 24.39 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.843 1.423 . . . . 72.099999999999994 114.843 -158.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -132.5 163.95 27.67 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.792 1.637 . . . . 75.099999999999994 111.73 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 74.109999999999999 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 73.230000000000004 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 75.150000000000006 107.349 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 75.540000000000006 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.540000000000006 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 73.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 75.409999999999997 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 71.450000000000003 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 64.400000000000006 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 74.109999999999999 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 75.430000000000007 108.591 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 64.120000000000005 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 73.439999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 75.530000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 74.340000000000003 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 74.140000000000001 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 55.219999999999999 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.219999999999999 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 75.150000000000006 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 75.329999999999998 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 73.519999999999996 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 41.439999999999998 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 73.239999999999995 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 75.140000000000001 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 72.219999999999999 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 75.450000000000003 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 75.530000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 74.549999999999997 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 72.25 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 74.150000000000006 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 62.439999999999998 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 64.519999999999996 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 75.329999999999998 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -132.75 174.66 10.08 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 75.430000000000007 107.941 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.57 -43.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.452 -0.659 . . . . 64.439999999999998 111.452 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.39 68.76 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.233 -1.395 . . . . 73.450000000000003 107.233 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 tt -134.34 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.843 -2.281 . . . . 75.140000000000001 104.843 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.953 2.101 . . . . 64.519999999999996 108.813 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 110.58 -1.008 . . . . 74.400000000000006 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.89 179.61 1.41 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.692 0.758 . . . . 74.329999999999998 111.68 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.06 -56.67 0.77 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.323 -1.362 . . . . 73.0 107.323 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.08 9.54 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.025 0.75 . . . . 64.030000000000001 113.025 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.01 42.2 1.58 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.707 1.622 . . . . 73.010000000000005 112.749 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.26 108.22 6.71 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 104.827 -2.286 . . . . 72.030000000000001 104.827 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -128.69 31.68 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.815 1.293 . . . . 53.399999999999999 109.478 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.72 4.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 130.008 3.323 . . . . 73.299999999999997 109.0 -171.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.230000000000004 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 71.439999999999998 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 73.349999999999994 110.353 -174.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 71.109999999999999 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 74.540000000000006 109.881 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 72.25 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 74.349999999999994 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 73.150000000000006 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 65.219999999999999 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 71.340000000000003 107.594 -175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.329999999999998 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 75.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 74.409999999999997 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 74.129999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 74.530000000000001 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 73.129999999999995 107.472 168.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 74.129999999999995 106.97 167.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 74.129999999999995 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 70.25 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 61.049999999999997 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 65.310000000000002 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 62.409999999999997 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 75.310000000000002 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 71.239999999999995 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 72.120000000000005 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 72.129999999999995 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 75.219999999999999 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 72.450000000000003 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 71.219999999999999 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 64.530000000000001 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 74.150000000000006 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 75.409999999999997 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 74.439999999999998 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 74.150000000000006 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 75.329999999999998 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 73.129999999999995 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 72.310000000000002 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 72.430000000000007 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.530000000000001 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 71.519999999999996 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 74.109999999999999 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 73.530000000000001 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 74.439999999999998 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.409999999999997 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 71.120000000000005 110.189 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 73.349999999999994 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -137.05 -170.12 2.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 74.239999999999995 106.731 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.19 -78.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.265 -2.334 . . . . 71.040000000000006 107.265 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -75.53 20.53 0.16 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 71.010000000000005 114.219 -169.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.9 tt -64.65 93.14 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.358 1.863 . . . . 75.150000000000006 109.087 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 113.454 -1.703 . . . . 73.019999999999996 109.692 149.527 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.349 -1.1 . . . . 61.009999999999998 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.15 34.96 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.085 1.754 . . . . 74.129999999999995 112.105 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 75.25 -12.98 0.9 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.762 2.425 . . . . 74.420000000000002 111.695 -161.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -149.04 95.38 2.38 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.375 -2.454 . . . . 73.239999999999995 104.375 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.54 78.19 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.942 -1.663 . . . . 71.120000000000005 108.942 -161.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -135.1 24.72 3.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.038 0.535 . . . . 72.239999999999995 112.292 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.17 59.02 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 71.230000000000004 108.634 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -85.46 172.46 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.815 2.046 . . . . 72.310000000000002 110.96 169.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 70.219999999999999 109.555 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.140000000000001 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 73.430000000000007 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 74.25 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 74.120000000000005 111.173 -167.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 70.530000000000001 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 74.420000000000002 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 74.510000000000005 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 74.349999999999994 109.052 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 63.240000000000002 113.829 -162.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' N ' HD21 ' A' ' 23' ' ' ASN . 0.0 OUTLIER -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 73.349999999999994 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 70.340000000000003 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 73.25 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 65.129999999999995 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 74.439999999999998 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 73.409999999999997 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 73.349999999999994 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.319999999999993 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 73.140000000000001 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 74.239999999999995 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 45.329999999999998 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 72.430000000000007 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 74.409999999999997 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.549999999999997 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 74.349999999999994 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 62.049999999999997 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 72.010000000000005 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 72.010000000000005 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 74.030000000000001 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.414 ' HB ' HD22 ' A' ' 23' ' ' ASN . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 73.120000000000005 109.956 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 70.120000000000005 113.002 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 74.120000000000005 111.043 168.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 74.109999999999999 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 63.310000000000002 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 74.230000000000004 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 72.439999999999998 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 73.049999999999997 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 70.409999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 73.349999999999994 107.642 169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 74.230000000000004 107.221 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 73.329999999999998 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.430000000000007 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 54.450000000000003 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 72.239999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 73.340000000000003 110.787 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -86.81 -159.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 72.219999999999999 108.055 165.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.76 -22.85 0.17 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-O 119.042 -0.865 . . . . 42.520000000000003 113.573 171.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -119.4 76.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.53 -2.026 . . . . 71.239999999999995 105.53 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.8 tt -142.59 111.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 125.147 1.379 . . . . 73.109999999999999 107.559 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.904 1.282 . . . . 63.030000000000001 107.656 177.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 108.462 -1.855 . . . . 52.329999999999998 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.0 43.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.222 1.409 . . . . 74.319999999999993 107.673 172.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -92.31 0.04 57.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.814 0.845 . . . . 74.129999999999995 110.956 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -155.83 102.28 2.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 103.874 -2.639 . . . . 72.230000000000004 103.874 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.81 -119.3 1.93 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 109.993 -1.243 . . . . 75.049999999999997 109.993 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -143.3 84.37 1.81 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.372 -1.344 . . . . 74.019999999999996 107.372 168.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -152.94 24.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.033 1.123 . . . . 73.349999999999994 114.033 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -71.55 161.17 31.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 72.319999999999993 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 72.219999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 74.150000000000006 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 74.219999999999999 109.072 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 74.129999999999995 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 75.430000000000007 109.39 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 61.409999999999997 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 72.310000000000002 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 74.430000000000007 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 71.120000000000005 108.182 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 72.230000000000004 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 74.140000000000001 106.191 162.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 74.310000000000002 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 73.099999999999994 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 74.5 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 64.109999999999999 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 75.319999999999993 109.876 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 63.420000000000002 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 74.349999999999994 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.319999999999993 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.310000000000002 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 74.519999999999996 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 61.140000000000001 108.879 170.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.438 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 71.209999999999994 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 73.530000000000001 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 50.119999999999997 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 54.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 63.439999999999998 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 74.450000000000003 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 75.230000000000004 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 72.409999999999997 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 64.349999999999994 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 63.329999999999998 109.485 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 73.230000000000004 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 75.319999999999993 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 55.009999999999998 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 74.400000000000006 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 75.340000000000003 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 71.230000000000004 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -141.79 -178.2 5.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 75.239999999999995 108.419 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.84 -26.29 7.62 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 118.477 0.581 . . . . 73.540000000000006 113.702 150.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -152.56 73.31 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.511 -2.033 . . . . 75.349999999999994 105.511 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.84 123.07 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.753 -1.203 . . . . 75.209999999999994 107.753 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.868 2.867 . . . . 74.510000000000005 111.905 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.618 0 N-CA-C 109.654 -1.378 . . . . 73.420000000000002 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 157.77 19.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.358 -0.979 . . . . 73.349999999999994 108.358 163.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -72.81 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.965 -1.495 . . . . 73.530000000000001 106.965 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -150.58 40.4 0.75 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.939 1.352 . . . . 74.120000000000005 111.006 -166.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.01 12.41 68.46 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 116.937 -2.035 . . . . 54.420000000000002 114.754 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -151.88 44.43 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 121.309 2.555 . . . . 74.420000000000002 112.107 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.98 61.26 5.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 123.124 1.44 . . . . 74.319999999999993 110.16 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -133.75 176.76 8.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.431 1.892 . . . . 74.439999999999998 108.878 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 65.510000000000005 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.239999999999995 108.67 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 65.349999999999994 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.239999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.340000000000003 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 72.239999999999995 113.463 -165.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 72.450000000000003 108.159 -163.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 73.420000000000002 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.420000000000002 105.37 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 72.530000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 74.239999999999995 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 73.329999999999998 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 74.519999999999996 105.862 162.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.530000000000001 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 75.329999999999998 107.986 -167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 75.150000000000006 107.498 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.120000000000005 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 73.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 70.409999999999997 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.510000000000005 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 70.109999999999999 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 74.209999999999994 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.239999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 73.120000000000005 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 74.530000000000001 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 72.540000000000006 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 72.540000000000006 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 71.510000000000005 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 62.25 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 62.340000000000003 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 74.510000000000005 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 74.439999999999998 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 73.340000000000003 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 74.420000000000002 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 62.530000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 74.319999999999993 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 74.120000000000005 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 70.519999999999996 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 74.230000000000004 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 72.120000000000005 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.519999999999996 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 74.25 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.209999999999994 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 72.099999999999994 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 70.239999999999995 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 74.439999999999998 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 73.230000000000004 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 74.109999999999999 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 54.020000000000003 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -139.94 -170.26 2.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 74.310000000000002 109.467 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.08 -59.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.885 -1.286 . . . . 64.230000000000004 109.885 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.12 65.55 3.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.483 1.513 . . . . 72.209999999999994 109.008 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 pt -117.26 75.61 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 127.074 2.149 . . . . 74.310000000000002 105.783 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 127.91 2.484 . . . . 74.120000000000005 106.118 -168.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.824 0 N-CA-C 109.225 -1.55 . . . . 73.430000000000007 109.225 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.23 150.46 45.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.507 -1.294 . . . . 71.409999999999997 107.507 165.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.02 -82.45 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.468 -2.049 . . . . 72.5 105.468 156.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -147.34 28.38 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.54 1.162 . . . . 71.439999999999998 109.792 -165.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.73 -174.92 22.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 126.112 1.815 . . . . 73.329999999999998 109.894 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 52.7 1.4 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.771 1.228 . . . . 71.540000000000006 112.377 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -140.82 37.92 1.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.746 -1.221 . . . . 74.510000000000005 109.448 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.85 144.4 32.5 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.674 1.989 . . . . 72.319999999999993 109.26 -171.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 74.239999999999995 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 73.329999999999998 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 73.329999999999998 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 71.319999999999993 108.412 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 72.349999999999994 113.518 -162.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 75.109999999999999 108.841 -167.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 75.530000000000001 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 72.5 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 51.340000000000003 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 71.409999999999997 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 74.109999999999999 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 70.349999999999994 107.649 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 71.200000000000003 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 72.329999999999998 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 72.299999999999997 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 71.200000000000003 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 55.439999999999998 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 74.439999999999998 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 71.430000000000007 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 73.450000000000003 107.871 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 74.510000000000005 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.41 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 71.439999999999998 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 71.209999999999994 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 64.120000000000005 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.439999999999998 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 71.109999999999999 112.192 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 74.510000000000005 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 72.099999999999994 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 71.430000000000007 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 53.420000000000002 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 74.219999999999999 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 65.409999999999997 108.0 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.549999999999997 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.439999999999998 109.98 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 74.400000000000006 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -143.92 170.47 15.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 73.219999999999999 109.475 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.63 -79.94 0.29 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.442 -1.863 . . . . 63.219999999999999 108.442 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -131.49 15.32 4.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.425 1.09 . . . . 74.510000000000005 111.83 -167.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 pt -74.06 50.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.473 2.309 . . . . 71.430000000000007 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.732 2.013 . . . . 73.340000000000003 108.687 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 111.674 -0.571 . . . . 71.430000000000007 111.674 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.19 -156.59 0.73 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.664 1.585 . . . . 71.230000000000004 108.275 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -76.7 -79.81 0.1 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.543 -1.651 . . . . 71.239999999999995 106.543 165.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.55 81.88 1.29 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.938 -2.245 . . . . 71.209999999999994 104.938 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.71 -94.38 0.83 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.436 -2.666 . . . . 72.329999999999998 106.436 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.08 65.98 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.049 0.939 . . . . 71.439999999999998 110.584 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -129.72 24.84 5.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.995 0.918 . . . . 63.520000000000003 112.588 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p -100.81 170.07 8.57 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.857 -1.152 . . . . 64.109999999999999 111.91 -173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 72.239999999999995 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.530000000000001 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 74.450000000000003 107.383 162.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 71.530000000000001 110.479 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 72.230000000000004 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 74.540000000000006 106.826 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 71.450000000000003 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 74.319999999999993 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' ND2' ' HG1' ' A' ' 38' ' ' THR . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 74.340000000000003 108.734 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.435 ' HG1' ' ND2' ' A' ' 37' ' ' ASN . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 72.409999999999997 105.524 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 73.540000000000006 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 72.409999999999997 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 74.109999999999999 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.5 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 72.340000000000003 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 54.030000000000001 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 74.150000000000006 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 74.329999999999998 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.530000000000001 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 72.120000000000005 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 73.310000000000002 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 73.25 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 70.310000000000002 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 71.140000000000001 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 73.239999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 72.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 73.120000000000005 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 64.549999999999997 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 74.540000000000006 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 71.329999999999998 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 72.420000000000002 112.082 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 70.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 73.129999999999995 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -139.89 -179.6 6.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.31 -45.55 0.17 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 109.85 -1.3 . . . . 71.510000000000005 109.85 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.94 79.6 6.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.858 -1.534 . . . . 74.409999999999997 106.858 165.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tt -148.03 122.61 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.31 -2.848 . . . . 72.129999999999995 103.31 164.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.628 1.171 . . . . 70.549999999999997 109.355 175.619 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 109.527 -1.429 . . . . 74.400000000000006 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.24 23.93 9.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.071 0.949 . . . . 75.099999999999994 112.537 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 62.32 -3.38 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.879 2.072 . . . . 73.340000000000003 113.572 -158.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.88 51.45 0.8 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 123.513 1.625 . . . . 62.130000000000003 109.235 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.29 -136.77 7.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 125.889 1.709 . . . . 75.340000000000003 109.682 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -110.96 49.21 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.499 1.92 . . . . 64.510000000000005 107.581 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.44 41.99 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 120.488 -1.383 . . . . 63.329999999999998 108.507 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.65 136.38 52.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.955 1.702 . . . . 71.519999999999996 107.675 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 75.549999999999997 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 75.299999999999997 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.439999999999998 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 75.209999999999994 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 73.540000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 71.150000000000006 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 73.25 112.889 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 72.430000000000007 107.54 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 74.5 107.29 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 72.409999999999997 104.793 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 75.230000000000004 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 75.329999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 72.040000000000006 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.411 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 75.219999999999999 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 75.310000000000002 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 73.439999999999998 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 43.219999999999999 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 75.239999999999995 106.984 173.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 73.510000000000005 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 71.150000000000006 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 63.399999999999999 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 72.230000000000004 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 72.030000000000001 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG11 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 75.109999999999999 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 74.439999999999998 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 73.340000000000003 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 73.549999999999997 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 54.119999999999997 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 75.439999999999998 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 75.219999999999999 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 74.450000000000003 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 72.140000000000001 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.209999999999994 104.811 158.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 72.310000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 72.420000000000002 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 72.549999999999997 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 75.219999999999999 109.803 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 73.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG1' ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 72.530000000000001 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.43 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -107.75 -172.59 2.1 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.52 -68.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.455 -2.258 . . . . 62.549999999999997 107.455 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.3 74.83 0.24 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.154 2.182 . . . . 73.120000000000005 109.541 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -135.93 91.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.231 1.812 . . . . 75.150000000000006 107.926 168.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.227 1.011 . . . . 72.530000000000001 108.334 174.525 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 112.033 -0.427 . . . . 72.340000000000003 112.033 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 125.97 29.19 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.392 -1.336 . . . . 75.230000000000004 107.392 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -84.28 -6.71 59.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.205 0.446 . . . . 71.019999999999996 112.205 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -139.25 77.06 1.6 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.669 -1.974 . . . . 75.420000000000002 105.669 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.29 -2.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.206 1.384 . . . . 71.120000000000005 114.291 -165.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -152.45 114.59 4.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.6 -1.63 . . . . 74.299999999999997 106.6 152.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.25 24.68 12.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.096 0.95 . . . . 73.299999999999997 112.151 -166.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -135.93 171.88 13.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.737 2.015 . . . . 75.200000000000003 109.947 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 73.019999999999996 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 74.109999999999999 109.724 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 74.400000000000006 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.45 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 74.439999999999998 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 75.200000000000003 107.765 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 73.540000000000006 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 63.340000000000003 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 72.329999999999998 114.675 -163.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 73.420000000000002 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 75.129999999999995 108.858 159.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 64.200000000000003 111.416 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 75.329999999999998 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 73.209999999999994 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 75.230000000000004 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 74.239999999999995 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 51.32 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 72.030000000000001 105.213 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 75.430000000000007 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.209999999999994 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 73.120000000000005 107.95 172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 73.239999999999995 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 73.430000000000007 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 64.120000000000005 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 75.0 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 75.120000000000005 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 73.340000000000003 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 74.239999999999995 107.741 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 75.409999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 75.420000000000002 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 74.129999999999995 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 73.230000000000004 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 71.439999999999998 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 62.530000000000001 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 74.230000000000004 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 73.040000000000006 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 74.140000000000001 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 73.140000000000001 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 74.0 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 75.340000000000003 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 75.120000000000005 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 54.0 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 72.109999999999999 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 74.310000000000002 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 73.129999999999995 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -124.05 -173.92 2.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.13 -156.37 24.4 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 107.876 -2.09 . . . . 73.120000000000005 107.876 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.37 66.32 8.77 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.405 1.098 . . . . 64.030000000000001 109.475 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.1 pt -113.72 45.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.839 1.655 . . . . 64.010000000000005 110.08 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.269 1.427 . . . . 75.340000000000003 110.587 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.404 -1.878 . . . . 62.210000000000001 108.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.99 46.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 73.140000000000001 107.886 163.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.37 7.69 2.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.375 1.07 . . . . 74.239999999999995 113.27 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -149.8 100.69 2.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.321 -2.474 . . . . 74.430000000000007 104.321 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 -152.37 8.99 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.436 -0.666 . . . . 60.200000000000003 111.436 -167.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -74.27 73.97 1.82 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.581 -1.266 . . . . 75.140000000000001 107.581 167.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.2 26.02 6.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 129.068 2.947 . . . . 74.439999999999998 108.16 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -74.19 176.66 6.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.545 1.538 . . . . 65.299999999999997 109.942 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 73.099999999999994 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 74.0 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 75.409999999999997 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 54.539999999999999 110.835 -171.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 74.409999999999997 112.752 -165.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 74.239999999999995 104.57 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.319999999999993 106.948 159.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 63.140000000000001 106.498 171.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 74.019999999999996 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 53.130000000000003 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 73.400000000000006 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 74.400000000000006 110.841 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 72.109999999999999 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 74.400000000000006 106.598 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 75.140000000000001 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 73.120000000000005 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.129999999999995 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 70.019999999999996 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 71.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.299999999999997 111.775 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 64.439999999999998 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.310000000000002 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 74.099999999999994 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 74.420000000000002 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 74.010000000000005 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 73.200000000000003 105.647 173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 74.319999999999993 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 71.310000000000002 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 73.030000000000001 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 64.400000000000006 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 72.400000000000006 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 71.239999999999995 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 74.310000000000002 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.310000000000002 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -132.46 -176.46 4.09 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.87 -72.16 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 108.787 -1.725 . . . . 44.140000000000001 108.787 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.97 66.27 0.37 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.37 2.268 . . . . 63.210000000000001 110.363 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.2 pt -135.32 39.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 127.612 2.365 . . . . 74.120000000000005 108.631 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.117 -1.421 . . . . 72.030000000000001 108.18 -178.232 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.555 0 N-CA-C 108.692 -1.763 . . . . 65.420000000000002 108.692 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.14 168.38 19.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.366 -0.976 . . . . 73.010000000000005 108.366 167.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.56 -35.5 81.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.549 -0.739 . . . . 74.219999999999999 111.4 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 26.49 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 122.499 1.143 . . . . 72.010000000000005 110.685 170.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 -5.87 88.42 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.251 -1.531 . . . . 70.150000000000006 114.255 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -134.79 93.24 3.0 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.835 1.817 . . . . 74.25 107.892 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.85 26.2 4.22 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.585 0.707 . . . . 71.420000000000002 111.635 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.46 172.45 10.18 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 127.467 2.307 . . . . 65.450000000000003 108.301 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 74.150000000000006 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 73.120000000000005 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 73.450000000000003 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 70.030000000000001 108.891 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.329999999999998 108.179 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.409999999999997 113.227 -163.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 73.019999999999996 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 73.340000000000003 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 56' ' ' LYS . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 61.039999999999999 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 72.340000000000003 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 72.319999999999993 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 65.310000000000002 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 74.299999999999997 107.672 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 53.329999999999998 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 65.340000000000003 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 71.239999999999995 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 65.040000000000006 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 53.340000000000003 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 72.439999999999998 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 30' ' ' ASP . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 62.030000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 73.329999999999998 103.68 151.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 65.409999999999997 108.492 174.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 70.099999999999994 111.637 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.409999999999997 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 74.299999999999997 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' CA ' ' CG1' ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 70.319999999999993 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 73.25 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 71.030000000000001 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 74.129999999999995 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 73.040000000000006 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 72.409999999999997 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 73.25 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 73.019999999999996 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 70.5 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.340000000000003 110.784 -163.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 73.430000000000007 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.442 ' CG1' ' CA ' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 71.219999999999999 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 74.349999999999994 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -136.49 -169.66 2.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.41 -14.05 0.05 OUTLIER Glycine 0 C--O 1.226 -0.373 0 O-C-N 121.438 -0.789 . . . . 63.109999999999999 113.449 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.52 67.44 0.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.291 -1.744 . . . . 74.109999999999999 106.291 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.4 pt -140.85 68.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 126.612 1.965 . . . . 72.109999999999999 110.162 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.752 0 CA-C-N 112.65 -2.068 . . . . 72.25 113.226 166.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.304 -1.119 . . . . 72.420000000000002 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.17 5.13 2.08 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.818 1.247 . . . . 75.219999999999999 111.935 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 58.11 -169.26 0.12 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.677 0.791 . . . . 75.209999999999994 108.902 -149.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -129.34 -8.5 4.72 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.586 1.554 . . . . 63.109999999999999 111.985 -169.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.66 46.76 3.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.966 0.793 . . . . 75.349999999999994 114.974 -156.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -153.17 107.17 3.07 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.723 1.261 . . . . 74.349999999999994 110.38 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -85.63 32.78 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 128.685 2.794 . . . . 73.219999999999999 112.068 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 139.22 44.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 63.140000000000001 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 75.400000000000006 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 73.340000000000003 112.492 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 75.439999999999998 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 72.109999999999999 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 72.299999999999997 109.517 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 74.329999999999998 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 74.400000000000006 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 73.409999999999997 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 75.109999999999999 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 74.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 63.32 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 75.209999999999994 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 64.299999999999997 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 74.530000000000001 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 63.140000000000001 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 75.310000000000002 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 70.329999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 61.140000000000001 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 71.319999999999993 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 74.209999999999994 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.230000000000004 111.61 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 73.439999999999998 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 73.040000000000006 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 74.040000000000006 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 64.219999999999999 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 73.519999999999996 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 65.420000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 73.219999999999999 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 72.519999999999996 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 75.209999999999994 104.213 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 72.530000000000001 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 74.239999999999995 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 73.299999999999997 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 53.399999999999999 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 74.230000000000004 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 74.299999999999997 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 73.540000000000006 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 72.420000000000002 109.418 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 62.43 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -138.16 -178.09 5.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.78 -39.64 0.3 Allowed Glycine 0 C--O 1.226 -0.403 0 C-N-CA 124.757 1.17 . . . . 71.439999999999998 111.65 171.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -78.75 45.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.152 1.781 . . . . 62.450000000000003 110.283 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.62 105.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 126.362 1.865 . . . . 73.430000000000007 108.121 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.172 1.789 . . . . 73.420000000000002 110.086 162.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 CA-C-O 118.684 -1.065 . . . . 74.299999999999997 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 -178.29 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.992 0.896 . . . . 75.310000000000002 110.412 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -120.42 14.78 12.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.066 0.946 . . . . 75.439999999999998 109.695 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.39 23.15 1.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.851 1.26 . . . . 74.129999999999995 111.381 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.0 78.65 1.38 Allowed Glycine 0 C--N 1.34 0.79 0 O-C-N 120.762 -1.211 . . . . 53.210000000000001 110.509 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -148.65 65.28 1.06 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.301 1.04 . . . . 65.140000000000001 110.846 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.05 36.66 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.717 -0.614 . . . . 75.420000000000002 109.904 -170.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p -83.79 169.94 14.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 75.299999999999997 112.381 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 74.430000000000007 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.439999999999998 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 74.040000000000006 108.759 161.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 74.120000000000005 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 71.109999999999999 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.452 HD22 ' HB ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 64.319999999999993 109.893 -170.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 74.109999999999999 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 74.239999999999995 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 73.200000000000003 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 74.340000000000003 110.543 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 72.400000000000006 105.478 166.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 71.329999999999998 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 72.150000000000006 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 71.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 63.049999999999997 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 74.319999999999993 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 74.010000000000005 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 75.129999999999995 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 75.439999999999998 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 75.030000000000001 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 75.109999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 73.299999999999997 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 75.310000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 73.200000000000003 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 74.010000000000005 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.452 ' HB ' HD22 ' A' ' 23' ' ' ASN . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 72.140000000000001 112.511 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 75.049999999999997 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 63.25 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 71.310000000000002 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 71.530000000000001 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 75.120000000000005 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 74.329999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 72.340000000000003 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 74.239999999999995 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 75.239999999999995 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 74.109999999999999 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 75.219999999999999 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 74.400000000000006 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 74.230000000000004 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.430000000000007 107.538 178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -94.21 175.23 6.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.91 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.466 0.69 0 O-C-N 121.583 -0.698 . . . . 75.329999999999998 113.261 -168.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -135.32 63.92 1.6 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.246 -2.502 . . . . 63.229999999999997 104.246 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.49 77.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.758 1.623 . . . . 75.409999999999997 108.255 -167.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.147 2.179 . . . . 63.439999999999998 111.707 -178.201 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.246 -1.142 . . . . 65.239999999999995 110.246 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.46 27.3 2.3 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.779 2.431 . . . . 65.030000000000001 110.423 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 64.04 -2.66 0.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.472 2.309 . . . . 74.099999999999994 114.861 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.87 29.61 1.5 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.251 1.387 . . . . 74.219999999999999 111.576 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 -140.04 0.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.684 1.611 . . . . 42.130000000000003 112.092 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -128.17 42.46 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.672 0.789 . . . . 73.439999999999998 110.933 -173.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -122.35 24.69 9.25 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.488 1.115 . . . . 70.329999999999998 112.32 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -72.61 165.69 24.22 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.938 1.695 . . . . 74.040000000000006 111.563 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 62.109999999999999 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 74.010000000000005 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.230000000000004 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 73.340000000000003 114.499 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 74.239999999999995 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 74.409999999999997 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 61.509999999999998 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 73.209999999999994 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 73.5 108.32 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 72.409999999999997 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 71.030000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 64.439999999999998 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 73.299999999999997 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' C ' ' HG1' ' A' ' 38' ' ' THR . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 73.109999999999999 111.583 -176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 37' ' ' ASN . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 72.140000000000001 106.764 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 64.439999999999998 104.59 168.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 44.149999999999999 114.591 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 74.530000000000001 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 71.140000000000001 106.621 166.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 61.210000000000001 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 74.109999999999999 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 71.230000000000004 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.409999999999997 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 71.319999999999993 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 74.010000000000005 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 71.5 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 74.340000000000003 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 54.310000000000002 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 51.130000000000003 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 73.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.519999999999996 107.211 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 73.230000000000004 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.549999999999997 106.636 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 73.329999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 74.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 75.319999999999993 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.329999999999998 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 72.099999999999994 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.409999999999997 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 72.239999999999995 110.041 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 70.200000000000003 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 73.319999999999993 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -134.28 154.28 51.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.430000000000007 107.874 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.8 -93.89 0.15 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.008 -2.037 . . . . 73.430000000000007 108.008 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.49 75.63 1.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.707 1.603 . . . . 74.439999999999998 110.919 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 21.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.383 1.073 . . . . 73.409999999999997 112.749 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.707 -1.14 . . . . 72.409999999999997 109.011 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.57 -1.412 . . . . 73.420000000000002 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.43 175.13 5.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.516 -1.29 . . . . 73.219999999999999 107.516 166.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -72.93 -34.58 66.65 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.562 -0.455 . . . . 75.340000000000003 111.008 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -132.72 18.46 4.25 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 122.187 0.994 . . . . 75.450000000000003 110.068 -158.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.71 20.81 1.32 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 75.340000000000003 115.316 -164.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.92 106.62 1.84 Allowed 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 105.635 -1.987 . . . . 72.150000000000006 105.635 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.73 32.09 5.15 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.566 1.146 . . . . 55.130000000000003 111.085 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.68 135.38 38.06 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.341 1.856 . . . . 73.310000000000002 109.95 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 75.209999999999994 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 64.549999999999997 108.383 166.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 75.329999999999998 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 75.349999999999994 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 74.439999999999998 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 72.319999999999993 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 71.420000000000002 113.154 -162.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 74.120000000000005 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 72.239999999999995 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 73.540000000000006 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 74.310000000000002 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 63.350000000000001 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.219999999999999 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 74.329999999999998 107.958 -168.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.519999999999996 106.055 173.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 75.519999999999996 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 65.120000000000005 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 51.140000000000001 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 74.219999999999999 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 75.010000000000005 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.209999999999994 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 71.25 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 HG21 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 74.329999999999998 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 74.420000000000002 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 50.350000000000001 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 65.230000000000004 112.138 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 63.119999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 54.210000000000001 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 73.349999999999994 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.457 ' CA ' ' CG1' ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 64.219999999999999 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 71.140000000000001 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 55.219999999999999 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 75.310000000000002 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 72.140000000000001 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 74.319999999999993 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 75.319999999999993 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 74.450000000000003 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 62.32 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 75.519999999999996 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 75.150000000000006 110.934 -161.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' CG1' ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 73.219999999999999 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 75.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.69 -170.73 3.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 63.439999999999998 107.364 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.6 -70.03 0.33 Allowed Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 106.466 -2.654 . . . . 62.25 106.466 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -119.9 83.36 2.03 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.291 -1.374 . . . . 75.040000000000006 107.291 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.8 tt -127.54 27.28 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.42 1.888 . . . . 75.049999999999997 108.913 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.595 1.558 . . . . 73.219999999999999 110.238 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.49 0 N-CA-C 109.059 -1.617 . . . . 72.549999999999997 109.059 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 66.3 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.576 -1.268 . . . . 71.510000000000005 107.576 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.19 -53.26 36.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.05 0.94 . . . . 64.230000000000004 108.995 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -157.86 82.6 0.87 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.43 -2.433 . . . . 72.239999999999995 104.43 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.84 -169.17 25.3 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.511 -1.436 . . . . 40.240000000000002 109.511 -174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -123.25 67.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.432 -1.322 . . . . 75.129999999999995 107.432 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -147.7 53.33 1.05 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.936 2.094 . . . . 75.129999999999995 106.042 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -103.99 167.11 9.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.458 1.103 . . . . 75.129999999999995 111.456 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 65.140000000000001 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 75.230000000000004 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 75.519999999999996 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 73.329999999999998 110.658 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 74.400000000000006 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.400000000000006 113.509 -163.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 75.040000000000006 110.36 -166.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 74.239999999999995 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 64.310000000000002 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.549999999999997 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 74.109999999999999 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 74.209999999999994 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 75.239999999999995 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 75.549999999999997 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 73.019999999999996 109.075 173.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 73.340000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 74.340000000000003 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 75.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 73.319999999999993 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 75.120000000000005 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 71.120000000000005 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 72.310000000000002 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 70.430000000000007 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 73.420000000000002 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 74.040000000000006 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 71.129999999999995 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 74.019999999999996 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.329999999999998 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 74.209999999999994 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 75.420000000000002 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 75.129999999999995 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 73.109999999999999 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 73.340000000000003 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 71.140000000000001 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 73.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.439999999999998 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 70.25 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 73.519999999999996 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 73.030000000000001 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 61.030000000000001 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 65.030000000000001 109.752 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 74.430000000000007 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 74.120000000000005 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 70.150000000000006 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 74.329999999999998 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -137.72 -167.03 2.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 73.129999999999995 107.406 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.78 -76.53 0.02 OUTLIER Glycine 0 C--N 1.331 0.298 0 N-CA-C 108.322 -1.911 . . . . 71.519999999999996 108.322 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.38 61.42 0.14 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.732 2.813 . . . . 73.310000000000002 111.45 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.54 78.03 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.776 1.23 . . . . 72.150000000000006 109.487 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 128.064 2.546 . . . . 71.25 113.415 155.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.377 0 N-CA-C 110.898 -0.881 . . . . 73.040000000000006 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.46 170.33 8.32 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.335 0.654 . . . . 64.439999999999998 110.725 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -57.57 12.15 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.498 -0.927 . . . . 71.129999999999995 108.498 162.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -156.76 62.4 0.52 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.4 1.095 . . . . 74.120000000000005 110.836 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.59 58.81 5.01 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.969 0.795 . . . . 54.409999999999997 111.582 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -71.05 30.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.448 2.299 . . . . 73.439999999999998 113.914 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -155.71 42.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.028 -1.045 . . . . 74.129999999999995 111.675 -163.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 142.73 34.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 167.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 73.120000000000005 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 74.450000000000003 108.002 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 74.150000000000006 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 63.32 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 74.319999999999993 108.717 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 71.230000000000004 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.319999999999993 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.519999999999996 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 75.120000000000005 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 75.219999999999999 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.109999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 74.450000000000003 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 74.319999999999993 106.331 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 70.540000000000006 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 74.420000000000002 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 72.430000000000007 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 62.049999999999997 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 74.140000000000001 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 64.219999999999999 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 74.310000000000002 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 72.420000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 71.530000000000001 112.294 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 72.140000000000001 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 74.420000000000002 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 74.040000000000006 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 63.020000000000003 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 62.450000000000003 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 74.530000000000001 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 75.519999999999996 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 63.520000000000003 109.055 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 75.329999999999998 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 75.439999999999998 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 74.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 72.310000000000002 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 54.240000000000002 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -115.68 169.6 9.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.48 -59.53 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 109.467 -1.453 . . . . 55.509999999999998 109.467 -157.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -85.62 52.98 2.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.898 0.856 . . . . 73.209999999999994 110.494 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 pt -115.43 57.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.616 1.167 . . . . 54.020000000000003 107.923 170.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 124.177 0.991 . . . . 73.530000000000001 109.385 165.641 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.499 0 N-CA-C 109.269 -1.532 . . . . 42.340000000000003 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.04 16.28 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.721 0.808 . . . . 75.349999999999994 110.361 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.73 -5.32 19.83 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.755 0.822 . . . . 74.409999999999997 112.796 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.64 107.86 4.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.276 -3.231 . . . . 71.439999999999998 102.276 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.97 67.43 0.13 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 108.033 -2.027 . . . . 63.520000000000003 108.033 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -148.43 44.48 1.04 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.574 1.95 . . . . 74.549999999999997 107.679 -169.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -137.48 97.71 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 103.828 -2.656 . . . . 72.540000000000006 103.828 164.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.0 t -74.28 -166.79 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.726 0.81 . . . . 74.219999999999999 109.651 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 75.140000000000001 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 64.319999999999993 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 75.230000000000004 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 71.400000000000006 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 75.329999999999998 107.996 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 74.0 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 73.310000000000002 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 72.010000000000005 107.043 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 75.140000000000001 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 74.420000000000002 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 73.319999999999993 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 71.329999999999998 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 74.120000000000005 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.219999999999999 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 71.430000000000007 105.859 176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 74.409999999999997 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 75.129999999999995 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 71.420000000000002 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 75.129999999999995 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 72.540000000000006 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.510000000000005 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.519999999999996 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 74.439999999999998 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 63.329999999999998 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.219999999999999 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 71.439999999999998 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 73.299999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.433 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 71.140000000000001 108.702 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 73.109999999999999 110.886 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 74.409999999999997 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 71.299999999999997 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 71.219999999999999 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 72.340000000000003 112.273 173.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 70.140000000000001 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 72.400000000000006 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 74.219999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 74.239999999999995 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 74.430000000000007 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 73.099999999999994 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 74.109999999999999 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 72.540000000000006 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.340000000000003 106.259 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 73.329999999999998 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 71.420000000000002 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 73.109999999999999 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 73.439999999999998 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 72.319999999999993 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 74.510000000000005 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -136.95 171.84 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 74.439999999999998 107.47 166.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.61 -73.96 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 108.785 -1.726 . . . . 63.530000000000001 108.785 168.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -147.94 71.57 1.19 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 106.351 -1.722 . . . . 73.319999999999993 106.351 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.13 19.18 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.504 1.122 . . . . 72.239999999999995 110.671 175.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.874 -1.06 . . . . 72.510000000000005 109.478 171.67 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.021 -1.474 . . . . 75.5 107.021 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 44.340000000000003 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 62.32 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.019999999999996 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.109999999999999 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 42.399999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 62.299999999999997 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 62.409999999999997 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 71.109999999999999 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.5 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 73.430000000000007 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 73.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 60.140000000000001 109.012 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.441 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 60.520000000000003 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.120000000000005 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 44.530000000000001 113.799 -170.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 39' ' ' LEU . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 71.299999999999997 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.030000000000001 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 60.420000000000002 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 62.539999999999999 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 54.020000000000003 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 40.219999999999999 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.010000000000005 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 73.400000000000006 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 51.219999999999999 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 62.420000000000002 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 74.299999999999997 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CD1' HD11 ' A' ' 97' ' ' ILE . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 60.43 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 42.5 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 40.100000000000001 108.836 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 63.32 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 64.340000000000003 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 71.299999999999997 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.219999999999999 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.030000000000001 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 71.409999999999997 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 73' ' ' PHE . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 72.140000000000001 109.952 175.089 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.369 0.877 . . . . 74.430000000000007 113.369 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 74.329999999999998 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 55.549999999999997 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 45.049999999999997 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 54.109999999999999 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 63.420000000000002 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 51.439999999999998 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 71.25 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 45.310000000000002 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 71.420000000000002 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 61.130000000000003 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 40.039999999999999 108.135 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 24.41 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 53.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 34.509999999999998 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 73.209999999999994 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 44.43 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 52.109999999999999 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 65.450000000000003 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 42.43 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 62.520000000000003 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 74.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 34.299999999999997 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 73.430000000000007 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.25 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 51.420000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.140000000000001 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 71.340000000000003 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 63.409999999999997 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 54.210000000000001 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 51.340000000000003 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 62.140000000000001 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 71.239999999999995 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 64.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 62.240000000000002 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 97' ' ' ILE . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.239 0.519 0 CA-C-O 121.388 0.613 . . . . 73.540000000000006 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 64.230000000000004 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 43.219999999999999 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 60.340000000000003 107.349 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' A' ' 39' ' ' LEU . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 73.230000000000004 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.319999999999993 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 71.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 72.439999999999998 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 40.509999999999998 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 53.409999999999997 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 72.409999999999997 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 71.510000000000005 108.591 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 53.310000000000002 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 64.329999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' CB ' HD13 ' A' ' 39' ' ' LEU 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 61.43 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 44.100000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 71.120000000000005 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 53.020000000000003 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 53.299999999999997 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.120000000000005 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 74.310000000000002 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.592 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 55.149999999999999 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 63.119999999999997 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 34.399999999999999 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 63.210000000000001 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 63.240000000000002 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 64.230000000000004 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 62.149999999999999 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 63.210000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 73.140000000000001 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 64.510000000000005 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 71.549999999999997 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 61.409999999999997 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 62.350000000000001 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 72.230000000000004 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 74.319999999999993 107.941 170.768 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.0 -0.741 . . . . 64.329999999999998 109.0 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.010000000000005 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 64.120000000000005 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 71.450000000000003 110.353 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 62.229999999999997 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 63.109999999999999 109.881 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 64.239999999999995 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 65.25 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 70.25 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 61.549999999999997 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 24' ' ' ILE . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 64.230000000000004 107.594 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.049999999999997 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 72.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 70.120000000000005 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 64.239999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 71.549999999999997 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 72.109999999999999 107.472 168.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 44' ' ' SER . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 72.519999999999996 106.97 167.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CA ' HD11 ' A' ' 39' ' ' LEU . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 72.420000000000002 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 50.450000000000003 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 54.439999999999998 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 63.049999999999997 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 32.140000000000001 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 64.439999999999998 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 42.109999999999999 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 70.329999999999998 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 63.140000000000001 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 43.020000000000003 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 71.349999999999994 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 31.140000000000001 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 61.509999999999998 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 55.219999999999999 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 72.209999999999994 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 72.040000000000006 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 63.32 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 51.450000000000003 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 53.409999999999997 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 52.140000000000001 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 65.519999999999996 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.329999999999998 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 54.229999999999997 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 72.510000000000005 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 61.450000000000003 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 63.229999999999997 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.349999999999994 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 82' ' ' ARG . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 62.549999999999997 110.189 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 70.430000000000007 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 71.349999999999994 106.731 172.12 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.782 0.801 . . . . 45.43 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 61.32 109.555 164.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.129999999999995 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 65.150000000000006 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 64.310000000000002 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 72.049999999999997 111.173 -167.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 62.25 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 70.25 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 70.409999999999997 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 24' ' ' ILE . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 73.109999999999999 109.052 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 62.140000000000001 113.829 -162.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.666 HD11 HG23 ' A' ' 21' ' ' VAL . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 72.019999999999996 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 64.109999999999999 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 65.129999999999995 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 52.329999999999998 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 53.219999999999999 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 72.030000000000001 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 53.350000000000001 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.25 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 65.450000000000003 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 44.140000000000001 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 32.219999999999999 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 62.520000000000003 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 72.150000000000006 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.319999999999993 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 50.539999999999999 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 61.009999999999998 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 54.310000000000002 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 9' ' ' THR . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 64.109999999999999 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 70.340000000000003 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 70.450000000000003 109.956 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.531 ' HA ' HG12 ' A' ' 21' ' ' VAL . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 43.130000000000003 113.002 -170.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 72.430000000000007 111.043 168.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 72.230000000000004 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 54.509999999999998 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 71.450000000000003 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 70.340000000000003 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 70.040000000000006 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 53.119999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 97' ' ' ILE . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 72.439999999999998 107.642 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 13' ' ' LEU . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 72.420000000000002 107.221 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 70.129999999999995 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.230000000000004 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 52.109999999999999 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 64.129999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 65.430000000000007 110.787 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 71.209999999999994 108.055 165.781 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 64.010000000000005 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 41.149999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 63.340000000000003 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.66 ' HD2' HD11 ' A' ' 14' ' ' ILE . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 55.329999999999998 109.072 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 64.310000000000002 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.66 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 73.430000000000007 109.39 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 43.439999999999998 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 63.340000000000003 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 63.299999999999997 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 64.310000000000002 108.182 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 61.130000000000003 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 62.340000000000003 106.191 162.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 64.219999999999999 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 61.240000000000002 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 73.540000000000006 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 62.229999999999997 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 74.540000000000006 109.876 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 55.439999999999998 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 44.329999999999998 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.239999999999995 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.109999999999999 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 61.549999999999997 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.804 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 44.399999999999999 108.879 170.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.43 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 51.039999999999999 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 71.120000000000005 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 33.149999999999999 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.804 HG22 ' HB ' ' A' ' 60' ' ' THR . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 32.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 54.450000000000003 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 73.409999999999997 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 64.329999999999998 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 61.130000000000003 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 34.140000000000001 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.402 ' O ' HG22 ' A' ' 97' ' ' ILE . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 60.210000000000001 109.485 172.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 64.310000000000002 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 74.120000000000005 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 54.140000000000001 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 64.310000000000002 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 62.240000000000002 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 42.329999999999998 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 73.120000000000005 108.419 174.564 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.878 -0.786 . . . . 74.340000000000003 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 61.409999999999997 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 71.409999999999997 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.049999999999997 108.67 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 61.409999999999997 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.129999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.150000000000006 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 63.25 113.463 -165.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 44.329999999999998 108.159 -163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 70.239999999999995 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.140000000000001 105.37 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 32' ' ' LYS . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 50.350000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 70.319999999999993 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 65.510000000000005 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 73.510000000000005 105.862 162.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.319999999999993 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 71.430000000000007 107.986 -167.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 54.420000000000002 107.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.049999999999997 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 71.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 44.439999999999998 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 45.240000000000002 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 51.409999999999997 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.129999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 72.239999999999995 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 72.209999999999994 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 70.25 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 70.530000000000001 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 64.239999999999995 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 52.149999999999999 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 53.149999999999999 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 73.409999999999997 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 64.340000000000003 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 62.439999999999998 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 63.299999999999997 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 50.210000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 72.299999999999997 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 44.210000000000001 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 64.099999999999994 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 73.209999999999994 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 71.329999999999998 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.329999999999998 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 71.109999999999999 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.040000000000006 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 64.019999999999996 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 52.140000000000001 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 51.030000000000001 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 62.119999999999997 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 73.319999999999993 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 51.439999999999998 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 65.310000000000002 109.467 -169.903 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.26 -0.645 . . . . 72.319999999999993 109.26 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 73.5 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 71.230000000000004 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 65.230000000000004 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 24' ' ' ILE . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 52.25 108.412 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 63.549999999999997 113.518 -162.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 21' ' ' VAL . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 55.049999999999997 108.841 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 72.450000000000003 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.477 ' HE1' ' H ' ' A' ' 50' ' ' ASP . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 64.219999999999999 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 42.409999999999997 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 44.030000000000001 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 52.420000000000002 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 62.240000000000002 107.649 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 39' ' ' LEU . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 50.329999999999998 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 63.130000000000003 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 55.439999999999998 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' H ' ' HE1' ' A' ' 28' ' ' TRP . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 53.039999999999999 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 54.299999999999997 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 61.210000000000001 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 63.299999999999997 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 61.109999999999999 107.871 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 52.140000000000001 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 60.520000000000003 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.452 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 70.420000000000002 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 44.219999999999999 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.420000000000002 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 60' ' ' THR . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 63.299999999999997 112.192 173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 43.409999999999997 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 62.32 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 61.439999999999998 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 45.399999999999999 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 70.329999999999998 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 53.340000000000003 108.0 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.420000000000002 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.120000000000005 109.98 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 71.230000000000004 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 64.439999999999998 109.475 178.123 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.91 0.337 . . . . 50.140000000000001 111.91 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 64.510000000000005 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.450000000000003 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 73.109999999999999 107.383 162.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.458 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 87' ' ' LEU . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 64.430000000000007 110.479 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 17' ' ' THR . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 24' ' ' ILE . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 70.120000000000005 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HG23 ' A' ' 21' ' ' VAL . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 54.32 106.826 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 70.129999999999995 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 73.540000000000006 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 71.230000000000004 108.734 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 39' ' ' LEU . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 70.140000000000001 105.524 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 72.349999999999994 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 65.230000000000004 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 73.200000000000003 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.129999999999995 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 63.219999999999999 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 53.049999999999997 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 53.229999999999997 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 73.510000000000005 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.230000000000004 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 64.230000000000004 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 71.140000000000001 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 64.450000000000003 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 45.340000000000003 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 50.149999999999999 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 71.129999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 71.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 61.520000000000003 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 54.32 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 17' ' ' THR . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 70.120000000000005 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 64.150000000000006 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' VAL . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 44.149999999999999 112.082 -168.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 53.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 70.209999999999994 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.675 -1.232 . . . . 71.519999999999996 107.675 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 55.32 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 71.340000000000003 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.239999999999995 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 64.230000000000004 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 64.150000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 41.409999999999997 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' HD23 ' A' ' 39' ' ' LEU . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.512 ' CG2' HG22 ' A' ' 85' ' ' ILE . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 63.420000000000002 112.889 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 24' ' ' ILE . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 71.510000000000005 107.54 -172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HG23 ' A' ' 21' ' ' VAL . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 71.310000000000002 107.29 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 63.399999999999999 104.793 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 74.310000000000002 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 53.439999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.408 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 64.420000000000002 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 73.099999999999994 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.566 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 74.219999999999999 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 64.5 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 42.420000000000002 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 64.329999999999998 106.984 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 72.439999999999998 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 63.5 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 55.119999999999997 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 64.450000000000003 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 55.509999999999998 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.711 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 93' ' ' VAL . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.711 HG22 ' HB ' ' A' ' 60' ' ' THR . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 73.519999999999996 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 72.310000000000002 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 54.420000000000002 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 52.25 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 60.340000000000003 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 71.430000000000007 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 72.540000000000006 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 52.020000000000003 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.512 HG22 ' CG2' ' A' ' 17' ' ' THR . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.120000000000005 104.811 158.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 61.420000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 63.43 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 71.530000000000001 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 63' ' ' THR . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 62.420000000000002 109.803 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 64.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.772 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 64.420000000000002 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.310000000000002 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.947 -0.39 . . . . 75.200000000000003 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 72.129999999999995 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 71.099999999999994 109.724 177.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 71.140000000000001 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.444 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 72.0 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 72.109999999999999 107.765 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 21' ' ' VAL . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 52.100000000000001 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 60.219999999999999 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 HD21 ' A' ' 15' ' ' ASN . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 62.439999999999998 114.675 -163.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 64.209999999999994 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' A' ' 35' ' ' THR . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 55.020000000000003 108.858 159.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' HB2' HG21 ' A' ' 54' ' ' VAL . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 63.439999999999998 111.416 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 74.230000000000004 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 62.200000000000003 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 71.299999999999997 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 25' ' ' LYS . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 71.439999999999998 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 45.130000000000003 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 64.099999999999994 105.213 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 74.140000000000001 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.109999999999999 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.662 ' OD1' HG22 ' A' ' 10' ' ' THR . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 72.120000000000005 107.95 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 60.299999999999997 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 55.520000000000003 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 35.329999999999998 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 54.530000000000001 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 74.219999999999999 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 72.310000000000002 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 28' ' ' TRP . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 62.340000000000003 107.741 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 51.229999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 74.400000000000006 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 64.5 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 71.420000000000002 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 51.219999999999999 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 55.32 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 63.229999999999997 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 54.43 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 72.200000000000003 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 62.299999999999997 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 71.129999999999995 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 71.219999999999999 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 73.5 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 52.219999999999999 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 62.229999999999997 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 62.5 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 54.439999999999998 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.942 -0.392 . . . . 65.299999999999997 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 62.399999999999999 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 72.019999999999996 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 50.210000000000001 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.807 ' HB2' HD12 ' A' ' 39' ' ' LEU . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 44.420000000000002 110.835 -171.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 24' ' ' ILE . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 71.040000000000006 112.752 -165.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 p30 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 73.099999999999994 104.57 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' VAL . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.109999999999999 106.948 159.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CE ' ' HB3' ' A' ' 33' ' ' GLU . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 47' ' ' PHE . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 33' ' ' GLU . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 51.520000000000003 106.498 171.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 73.319999999999993 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 43.310000000000002 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 61.329999999999998 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG2' HG23 ' A' ' 27' ' ' THR . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 43.509999999999998 110.841 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 63.340000000000003 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG22 ' HB ' ' A' ' 24' ' ' ILE . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 71.010000000000005 106.598 -175.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 73.239999999999995 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' HD13 ' A' ' 39' ' ' LEU . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 39' ' ' LEU . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 60.229999999999997 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 26' ' ' VAL . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.0 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 64.329999999999998 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 64.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.239999999999995 111.775 169.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 52.43 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.009999999999998 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 65.030000000000001 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 62.130000000000003 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 73.239999999999995 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' A' ' 13' ' ' LEU . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 65.010000000000005 105.647 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 63.229999999999997 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 44.329999999999998 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 62.310000000000002 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 71.239999999999995 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 33.409999999999997 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 61.439999999999998 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.040000000000006 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.301 -1.0 . . . . 24.399999999999999 108.301 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 73.129999999999995 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 72.150000000000006 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 65.329999999999998 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 64.209999999999994 108.891 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.516 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.310000000000002 108.179 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.487 ' HB2' HD23 ' A' ' 39' ' ' LEU . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 87' ' ' LEU . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 24' ' ' ILE . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.140000000000001 113.227 -163.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 21' ' ' VAL . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 71.230000000000004 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 71.319999999999993 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 53.32 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 63.0 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 63.109999999999999 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 64.400000000000006 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 15' ' ' ASN . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 71.409999999999997 107.672 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 21.52 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 53.310000000000002 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 63.43 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 64.239999999999995 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 41.420000000000002 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 71.150000000000006 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 52.210000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 95' ' ' VAL . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 54.299999999999997 103.68 151.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.415 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 51.130000000000003 108.492 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 93' ' ' VAL . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 64.400000000000006 111.637 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.040000000000006 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 71.230000000000004 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 HG22 ' HB ' ' A' ' 60' ' ' THR . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 61.009999999999998 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 64.329999999999998 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 64.109999999999999 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 73.219999999999999 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 71.219999999999999 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 64.219999999999999 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 71.120000000000005 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 17' ' ' THR . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 17' ' ' THR . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 70.430000000000007 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 43.43 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 63' ' ' THR . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.239999999999995 110.784 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 65.239999999999995 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.764 HG11 ' HA3' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 64.430000000000007 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 70.230000000000004 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 52.229999999999997 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 74.200000000000003 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.481 HG23 HG22 ' A' ' 85' ' ' ILE . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 71.310000000000002 112.492 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 55.210000000000001 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 61.439999999999998 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' GLN . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 62.399999999999999 109.517 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 72.109999999999999 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 73.299999999999997 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 30.43 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 63.130000000000003 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 72.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 44.340000000000003 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 64.230000000000004 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 54.219999999999999 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 72.239999999999995 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 62.240000000000002 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 54.32 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 52.5 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 61.109999999999999 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 64.400000000000006 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.522 ' HA ' HG12 ' A' ' 21' ' ' VAL . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.040000000000006 111.61 175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 65.340000000000003 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 70.129999999999995 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 63.030000000000001 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 63.32 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 65.120000000000005 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 51.310000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 64.209999999999994 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 61.520000000000003 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 17' ' ' THR . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 61.420000000000002 104.213 168.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 60.200000000000003 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 73.019999999999996 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 42.219999999999999 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 50.329999999999998 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 54.5 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 73.140000000000001 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 71.420000000000002 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 97' ' ' ILE . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.418 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 60.310000000000002 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 61.009999999999998 112.381 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 73.010000000000005 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.120000000000005 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 73.430000000000007 108.759 161.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.537 ' HB2' HD12 ' A' ' 39' ' ' LEU . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 72.109999999999999 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 64.010000000000005 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 63' ' ' THR . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 54.020000000000003 109.893 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 61.210000000000001 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 71.219999999999999 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 72.109999999999999 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CZ2' ' HE2' ' A' ' 32' ' ' LYS . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 52.32 110.543 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 71.209999999999994 105.478 166.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 61.450000000000003 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 63.43 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 65.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' C ' HD11 ' A' ' 39' ' ' LEU . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 62.340000000000003 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 44.43 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 73.049999999999997 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 63.399999999999999 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 73.409999999999997 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 53.399999999999999 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 52.539999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 71.219999999999999 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 73.420000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 63.210000000000001 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 63.539999999999999 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.524 ' HA ' HG12 ' A' ' 21' ' ' VAL . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 60.32 112.511 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 72.319999999999993 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 23.23 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 41.229999999999997 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 51.240000000000002 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 71.409999999999997 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 55.439999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 65.120000000000005 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 55.509999999999998 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 73.400000000000006 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 63.130000000000003 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 62.409999999999997 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 61.399999999999999 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 53.109999999999999 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 97' ' ' ILE . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.340000000000003 107.538 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.6 0.238 . . . . 74.040000000000006 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 61.229999999999997 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 71.0 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.209999999999994 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 45.009999999999998 114.499 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 14' ' ' ILE . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 51.109999999999999 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 73.140000000000001 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 24.510000000000002 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 24' ' ' ILE . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 62.340000000000003 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 21' ' ' VAL . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 71.409999999999997 108.32 -174.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG2' HG22 ' A' ' 35' ' ' THR . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 71.040000000000006 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 70.140000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 43.130000000000003 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 25' ' ' LYS . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 65.340000000000003 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 71.200000000000003 111.583 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 65.540000000000006 106.764 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 63.219999999999999 104.59 168.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 39' ' ' LEU . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 30.43 114.591 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 51.229999999999997 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 39' ' ' LEU . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 61.100000000000001 106.621 166.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 54.32 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 62.200000000000003 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.200000000000003 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 65.430000000000007 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 45.200000000000003 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 70.420000000000002 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 64.209999999999994 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 51.140000000000001 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 32.310000000000002 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 62.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.150000000000006 107.211 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 71.209999999999994 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 93' ' ' VAL . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.120000000000005 106.636 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 71.439999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 73.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 44.539999999999999 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.140000000000001 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 71.109999999999999 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.319999999999993 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 69' ' ' PHE 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 64.219999999999999 110.041 164.548 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 52.039999999999999 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 63.140000000000001 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.120000000000005 107.874 173.831 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.95 -0.389 . . . . 73.310000000000002 109.95 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 72.019999999999996 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 55.240000000000002 108.383 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 12' ' ' ARG . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 61.43 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 74.420000000000002 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 53.25 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 44.039999999999999 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 65.349999999999994 113.154 -162.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 52.030000000000001 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 52.119999999999997 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 72.510000000000005 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 71.030000000000001 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 42.450000000000003 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.129999999999995 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 65.129999999999995 107.958 -168.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 39' ' ' LEU . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.219999999999999 106.055 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 55.439999999999998 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 55.119999999999997 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 50.420000000000002 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 73.310000000000002 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 55.409999999999997 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.010000000000005 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 70.120000000000005 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 71.25 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 65.25 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 42.340000000000003 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HG21 ' A' ' 93' ' ' VAL . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 62.439999999999998 112.138 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 62.229999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 51.439999999999998 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 72.439999999999998 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.599 ' CA ' HG11 ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 43.030000000000001 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 44.43 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 53.119999999999997 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 62.43 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 61.229999999999997 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 72.450000000000003 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 72.510000000000005 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 64.349999999999994 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 61.439999999999998 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 63.119999999999997 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 63' ' ' THR . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 74.230000000000004 110.934 -161.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 61.520000000000003 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 61.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 52.009999999999998 107.364 175.684 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.336 0.588 . . . . 73.430000000000007 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 62.130000000000003 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 74.530000000000001 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 61.450000000000003 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG22 ' HG3' ' A' ' 16' ' ' GLN . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.457 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 14' ' ' ILE . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 60.020000000000003 110.658 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 73.010000000000005 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.239999999999995 113.509 -163.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 74.109999999999999 110.36 -166.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 44.43 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 34' ' ' GLN . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 63.350000000000001 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.349999999999994 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 73.510000000000005 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 42.119999999999997 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 74.349999999999994 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 63.25 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.42 ' HB2' HG12 ' A' ' 26' ' ' VAL . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 64.239999999999995 109.075 173.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 62.130000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 64.109999999999999 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.457 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 73.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 63.109999999999999 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 64.519999999999996 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 54.350000000000001 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 62.350000000000001 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 54.149999999999999 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 45.439999999999998 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 73.329999999999998 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 63.119999999999997 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.427 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 43.520000000000003 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.099999999999994 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 73.030000000000001 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 52.439999999999998 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 62.109999999999999 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 63.350000000000001 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 60' ' ' THR . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 72.420000000000002 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 65.510000000000005 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 71.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.140000000000001 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 52.229999999999997 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 70.439999999999998 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 51.439999999999998 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.431 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 44.25 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 63' ' ' THR . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 54.340000000000003 109.752 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 70.209999999999994 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 63.539999999999999 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 61.350000000000001 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 50.149999999999999 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 65.129999999999995 107.406 175.202 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 71.439999999999998 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 14' ' ' ILE . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.57 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 71.319999999999993 108.002 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.76 HG22 HD12 ' A' ' 87' ' ' LEU . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 71.129999999999995 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 51.020000000000003 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 63' ' ' THR . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 65.120000000000005 108.717 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 70.120000000000005 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.310000000000002 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.430000000000007 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 74.239999999999995 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 74.329999999999998 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.039999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 25' ' ' LYS . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 64.109999999999999 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 65.549999999999997 106.331 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 39' ' ' LEU . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 64.530000000000001 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 64.319999999999993 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 71.150000000000006 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 60.439999999999998 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 42.549999999999997 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 63.329999999999998 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 73.450000000000003 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 61.240000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' HG12 ' A' ' 21' ' ' VAL . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 61.539999999999999 112.294 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 60.219999999999999 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 64.430000000000007 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 71.349999999999994 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 55.229999999999997 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 61.310000000000002 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 72.549999999999997 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 64.409999999999997 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 17' ' ' THR . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 55.109999999999999 109.055 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 74.150000000000006 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 71.340000000000003 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 72.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 22.539999999999999 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 44.149999999999999 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 6.0 t . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 121.166 0.508 . . . . 63.25 109.651 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 63.5 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 53.119999999999997 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 71.099999999999994 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 62.439999999999998 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 61.109999999999999 107.996 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 39' ' ' LEU . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 14' ' ' ILE . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 72.219999999999999 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 72.099999999999994 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 63' ' ' THR . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 72.120000000000005 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.426 ' ND2' ' HE3' ' A' ' 22' ' ' LYS . 13.7 p30 -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 35' ' ' THR . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 52.340000000000003 107.043 170.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 64.209999999999994 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 73.219999999999999 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 52.240000000000002 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 25' ' ' LYS . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 63.210000000000001 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 73.310000000000002 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.040000000000006 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 63.219999999999999 105.859 176.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 73.040000000000006 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 73.319999999999993 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 61.009999999999998 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 51.340000000000003 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 71.510000000000005 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 8' ' ' THR . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.400000000000006 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.200000000000003 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 72.530000000000001 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 54.030000000000001 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.140000000000001 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 64.5 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 55.409999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 63.100000000000001 108.702 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.654 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 73.129999999999995 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 22.34 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 63.200000000000003 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 60' ' ' THR . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 71.430000000000007 112.273 173.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 54.310000000000002 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 65.439999999999998 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 53.399999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 72.439999999999998 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 72.340000000000003 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 64.319999999999993 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 60.130000000000003 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 73.340000000000003 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 71.329999999999998 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 15' ' ' ASN . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.219999999999999 106.259 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 64.430000000000007 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 64.140000000000001 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 71.010000000000005 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 64.0 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 71.0 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 61.329999999999998 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 51.030000000000001 107.47 166.546 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 CA-C-O 119.572 -0.571 . . . . 74.319999999999993 111.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.87 154.11 18.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.167 0.987 . . . . 61.530000000000001 108.646 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -127.95 -14.93 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.074 0.949 . . . . 75.409999999999997 112.297 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -122.67 11.09 9.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.445 1.498 . . . . 74.319999999999993 109.86 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.93 44.14 1.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.404 1.954 . . . . 43.539999999999999 113.605 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 62.59 0.42 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.003 1.721 . . . . 75.239999999999995 109.047 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -144.43 42.49 1.38 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.656 3.183 . . . . 74.310000000000002 106.793 -157.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 149.21 35.39 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.399 1.879 . . . . 75.5 107.021 -167.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 44.340000000000003 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 62.32 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.019999999999996 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.109999999999999 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 42.399999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 62.299999999999997 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 62.409999999999997 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 71.109999999999999 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.5 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 73.430000000000007 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 73.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 60.140000000000001 109.012 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.441 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 60.520000000000003 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.120000000000005 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 44.530000000000001 113.799 -170.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 39' ' ' LEU . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 71.299999999999997 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.030000000000001 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 60.420000000000002 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 62.539999999999999 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 54.020000000000003 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 40.219999999999999 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.010000000000005 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 73.400000000000006 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 51.219999999999999 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 62.420000000000002 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 74.299999999999997 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CD1' HD11 ' A' ' 97' ' ' ILE . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 60.43 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 42.5 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 40.100000000000001 108.836 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 63.32 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 64.340000000000003 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 71.299999999999997 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.219999999999999 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.030000000000001 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 71.409999999999997 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 73' ' ' PHE . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -85.09 168.33 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 72.140000000000001 109.952 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.36 -57.75 0.16 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.381 -1.488 . . . . 53.119999999999997 109.381 -168.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.31 15.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.711 1.256 . . . . 73.409999999999997 113.673 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 tt -74.66 82.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.34 2.256 . . . . 72.129999999999995 109.161 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 N-CA-C 103.816 -2.661 . . . . 43.219999999999999 103.816 171.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 109.526 -1.43 . . . . 43.130000000000003 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.26 56.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.214 -0.661 . . . . 72.319999999999993 109.214 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -78.15 11.35 2.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.584 1.554 . . . . 75.319999999999993 111.615 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -118.81 33.11 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.786 2.034 . . . . 61.340000000000003 107.264 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.49 -85.45 1.23 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 126.102 1.811 . . . . 53.229999999999997 109.73 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -150.95 68.33 0.94 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.656 -1.239 . . . . 62.109999999999999 107.656 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -143.04 32.71 1.37 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.194 0.998 . . . . 75.540000000000006 111.444 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.25 155.74 46.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 74.430000000000007 113.369 -164.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 74.329999999999998 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 55.549999999999997 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 45.049999999999997 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 54.109999999999999 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 63.420000000000002 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 51.439999999999998 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 71.25 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 45.310000000000002 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 71.420000000000002 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 61.130000000000003 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 40.039999999999999 108.135 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 24.41 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 53.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 34.509999999999998 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 73.209999999999994 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 44.43 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 52.109999999999999 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 65.450000000000003 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 42.43 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 62.520000000000003 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 74.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 34.299999999999997 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 73.430000000000007 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.25 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 51.420000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.140000000000001 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 71.340000000000003 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 63.409999999999997 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 54.210000000000001 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 51.340000000000003 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 62.140000000000001 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 71.239999999999995 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 64.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 62.240000000000002 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 97' ' ' ILE . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -139.0 -177.05 4.71 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.82 -82.77 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.686 -2.166 . . . . 65.519999999999996 107.686 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -78.46 77.4 4.95 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.779 -0.823 . . . . 60.43 108.779 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.9 tt -126.81 110.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 125.196 1.398 . . . . 71.519999999999996 108.248 172.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.389 2.275 . . . . 54.420000000000002 115.953 146.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 118.846 -0.974 . . . . 73.439999999999998 115.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.15 177.27 8.71 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.847 1.824 . . . . 42.240000000000002 107.983 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.4 -69.47 0.36 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.524 -1.288 . . . . 72.510000000000005 107.524 159.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.39 19.65 2.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 71.319999999999993 111.575 -168.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.21 -62.89 3.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.591 1.567 . . . . 73.430000000000007 114.923 -168.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -143.7 36.3 1.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.35 1.075 . . . . 64.310000000000002 111.1 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 24.39 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.843 1.423 . . . . 71.340000000000003 114.843 -158.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -132.5 163.95 27.67 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.792 1.637 . . . . 73.540000000000006 111.73 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 64.230000000000004 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 43.219999999999999 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 60.340000000000003 107.349 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' A' ' 39' ' ' LEU . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 73.230000000000004 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.319999999999993 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 71.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 72.439999999999998 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 40.509999999999998 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 53.409999999999997 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 72.409999999999997 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 71.510000000000005 108.591 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 53.310000000000002 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 64.329999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' CB ' HD13 ' A' ' 39' ' ' LEU 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 61.43 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 44.100000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 71.120000000000005 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 53.020000000000003 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 53.299999999999997 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.120000000000005 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 74.310000000000002 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.592 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 55.149999999999999 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 63.119999999999997 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 34.399999999999999 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 63.210000000000001 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 63.240000000000002 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 64.230000000000004 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 62.149999999999999 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 63.210000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 73.140000000000001 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 64.510000000000005 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 71.549999999999997 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 61.409999999999997 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 62.350000000000001 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 72.230000000000004 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -132.75 174.66 10.08 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 74.319999999999993 107.941 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.57 -43.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.452 -0.659 . . . . 40.039999999999999 111.452 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.39 68.76 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.233 -1.395 . . . . 62.409999999999997 107.233 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 tt -134.34 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.843 -2.281 . . . . 72.519999999999996 104.843 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.953 2.101 . . . . 64.519999999999996 108.813 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 110.58 -1.008 . . . . 71.120000000000005 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.89 179.61 1.41 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.692 0.758 . . . . 74.329999999999998 111.68 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.06 -56.67 0.77 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.323 -1.362 . . . . 73.0 107.323 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.08 9.54 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.025 0.75 . . . . 64.030000000000001 113.025 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.01 42.2 1.58 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.707 1.622 . . . . 62.439999999999998 112.749 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.26 108.22 6.71 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 104.827 -2.286 . . . . 72.030000000000001 104.827 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -128.69 31.68 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.815 1.293 . . . . 53.399999999999999 109.478 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.72 4.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 130.008 3.323 . . . . 64.329999999999998 109.0 -171.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.010000000000005 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 64.120000000000005 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 71.450000000000003 110.353 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 62.229999999999997 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 63.109999999999999 109.881 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 64.239999999999995 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 65.25 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 70.25 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 61.549999999999997 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 24' ' ' ILE . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 64.230000000000004 107.594 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.049999999999997 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 72.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 70.120000000000005 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 64.239999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 71.549999999999997 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 72.109999999999999 107.472 168.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 44' ' ' SER . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 72.519999999999996 106.97 167.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CA ' HD11 ' A' ' 39' ' ' LEU . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 72.420000000000002 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 50.450000000000003 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 54.439999999999998 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 63.049999999999997 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 32.140000000000001 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 64.439999999999998 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 42.109999999999999 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 70.329999999999998 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 63.140000000000001 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 43.020000000000003 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 71.349999999999994 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 31.140000000000001 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 61.509999999999998 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 55.219999999999999 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 72.209999999999994 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 72.040000000000006 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 63.32 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 51.450000000000003 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 53.409999999999997 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 52.140000000000001 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 65.519999999999996 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.329999999999998 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 54.229999999999997 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 72.510000000000005 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 61.450000000000003 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 63.229999999999997 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.349999999999994 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 82' ' ' ARG . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 62.549999999999997 110.189 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 70.430000000000007 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -137.05 -170.12 2.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 71.349999999999994 106.731 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.19 -78.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.265 -2.334 . . . . 71.040000000000006 107.265 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -75.53 20.53 0.16 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 71.010000000000005 114.219 -169.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.9 tt -64.65 93.14 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.358 1.863 . . . . 74.129999999999995 109.087 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 113.454 -1.703 . . . . 73.019999999999996 109.692 149.527 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.349 -1.1 . . . . 61.009999999999998 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.15 34.96 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.085 1.754 . . . . 74.129999999999995 112.105 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 75.25 -12.98 0.9 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.762 2.425 . . . . 63.109999999999999 111.695 -161.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -149.04 95.38 2.38 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.375 -2.454 . . . . 72.329999999999998 104.375 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.54 78.19 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.942 -1.663 . . . . 71.120000000000005 108.942 -161.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -135.1 24.72 3.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.038 0.535 . . . . 72.239999999999995 112.292 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.17 59.02 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 65.420000000000002 108.634 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -85.46 172.46 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.815 2.046 . . . . 45.43 110.96 169.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 61.32 109.555 164.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.129999999999995 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 65.150000000000006 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 64.310000000000002 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 72.049999999999997 111.173 -167.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 62.25 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 70.25 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 70.409999999999997 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 24' ' ' ILE . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 73.109999999999999 109.052 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 62.140000000000001 113.829 -162.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.666 HD11 HG23 ' A' ' 21' ' ' VAL . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 72.019999999999996 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 64.109999999999999 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 65.129999999999995 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 52.329999999999998 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 53.219999999999999 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 72.030000000000001 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 53.350000000000001 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.25 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 65.450000000000003 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 44.140000000000001 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 32.219999999999999 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 62.520000000000003 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 72.150000000000006 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.319999999999993 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 50.539999999999999 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 61.009999999999998 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 54.310000000000002 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 9' ' ' THR . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 64.109999999999999 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 70.340000000000003 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 70.450000000000003 109.956 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.531 ' HA ' HG12 ' A' ' 21' ' ' VAL . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 43.130000000000003 113.002 -170.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 72.430000000000007 111.043 168.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 72.230000000000004 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 54.509999999999998 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 71.450000000000003 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 70.340000000000003 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 70.040000000000006 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 53.119999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 97' ' ' ILE . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 72.439999999999998 107.642 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 13' ' ' LEU . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 72.420000000000002 107.221 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 70.129999999999995 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.230000000000004 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 52.109999999999999 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 64.129999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 65.430000000000007 110.787 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -86.81 -159.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 71.209999999999994 108.055 165.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.76 -22.85 0.17 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-O 119.042 -0.865 . . . . 32.210000000000001 113.573 171.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -119.4 76.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.53 -2.026 . . . . 71.239999999999995 105.53 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.8 tt -142.59 111.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 125.147 1.379 . . . . 73.109999999999999 107.559 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.904 1.282 . . . . 62.149999999999999 107.656 177.632 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 108.462 -1.855 . . . . 52.329999999999998 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.0 43.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.222 1.409 . . . . 71.049999999999997 107.673 172.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -92.31 0.04 57.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.814 0.845 . . . . 74.129999999999995 110.956 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -155.83 102.28 2.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 103.874 -2.639 . . . . 52.140000000000001 103.874 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.81 -119.3 1.93 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 109.993 -1.243 . . . . 72.329999999999998 109.993 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -143.3 84.37 1.81 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.372 -1.344 . . . . 74.019999999999996 107.372 168.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -152.94 24.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.033 1.123 . . . . 73.349999999999994 114.033 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -71.55 161.17 31.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 64.010000000000005 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 41.149999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 63.340000000000003 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.66 ' HD2' HD11 ' A' ' 14' ' ' ILE . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 55.329999999999998 109.072 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 64.310000000000002 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.66 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 73.430000000000007 109.39 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 43.439999999999998 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 63.340000000000003 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 63.299999999999997 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 64.310000000000002 108.182 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 61.130000000000003 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 62.340000000000003 106.191 162.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 64.219999999999999 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 61.240000000000002 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 73.540000000000006 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 62.229999999999997 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 74.540000000000006 109.876 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 55.439999999999998 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 44.329999999999998 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.239999999999995 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.109999999999999 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 61.549999999999997 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.804 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 44.399999999999999 108.879 170.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.43 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 51.039999999999999 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 71.120000000000005 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 33.149999999999999 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.804 HG22 ' HB ' ' A' ' 60' ' ' THR . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 32.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 54.450000000000003 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 73.409999999999997 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 64.329999999999998 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 61.130000000000003 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 34.140000000000001 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.402 ' O ' HG22 ' A' ' 97' ' ' ILE . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 60.210000000000001 109.485 172.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 64.310000000000002 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 74.120000000000005 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 54.140000000000001 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 64.310000000000002 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 62.240000000000002 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 42.329999999999998 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -141.79 -178.2 5.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 73.120000000000005 108.419 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.84 -26.29 7.62 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 118.477 0.581 . . . . 42.439999999999998 113.702 150.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -152.56 73.31 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.511 -2.033 . . . . 73.409999999999997 105.511 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.84 123.07 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.753 -1.203 . . . . 75.209999999999994 107.753 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.868 2.867 . . . . 74.510000000000005 111.905 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.618 0 N-CA-C 109.654 -1.378 . . . . 73.420000000000002 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 157.77 19.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.358 -0.979 . . . . 73.349999999999994 108.358 163.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -72.81 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.965 -1.495 . . . . 73.310000000000002 106.965 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -150.58 40.4 0.75 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.939 1.352 . . . . 74.120000000000005 111.006 -166.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.01 12.41 68.46 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 116.937 -2.035 . . . . 54.420000000000002 114.754 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -151.88 44.43 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 121.309 2.555 . . . . 73.209999999999994 112.107 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.98 61.26 5.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 123.124 1.44 . . . . 74.319999999999993 110.16 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -133.75 176.76 8.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.431 1.892 . . . . 74.340000000000003 108.878 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 61.409999999999997 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 71.409999999999997 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.049999999999997 108.67 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 61.409999999999997 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.129999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.150000000000006 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 63.25 113.463 -165.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 44.329999999999998 108.159 -163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 70.239999999999995 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.140000000000001 105.37 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 32' ' ' LYS . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 50.350000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 70.319999999999993 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 65.510000000000005 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 73.510000000000005 105.862 162.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.319999999999993 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 71.430000000000007 107.986 -167.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 54.420000000000002 107.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.049999999999997 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 71.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 44.439999999999998 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 45.240000000000002 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 51.409999999999997 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.129999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 72.239999999999995 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 72.209999999999994 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 70.25 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 70.530000000000001 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 64.239999999999995 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 52.149999999999999 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 53.149999999999999 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 73.409999999999997 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 64.340000000000003 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 62.439999999999998 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 63.299999999999997 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 50.210000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 72.299999999999997 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 44.210000000000001 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 64.099999999999994 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 73.209999999999994 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 71.329999999999998 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.329999999999998 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 71.109999999999999 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.040000000000006 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 64.019999999999996 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 52.140000000000001 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 51.030000000000001 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 62.119999999999997 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 73.319999999999993 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 51.439999999999998 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -139.94 -170.26 2.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 65.310000000000002 109.467 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.08 -59.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.885 -1.286 . . . . 54.200000000000003 109.885 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.12 65.55 3.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.483 1.513 . . . . 72.209999999999994 109.008 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 pt -117.26 75.61 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 127.074 2.149 . . . . 74.239999999999995 105.783 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 127.91 2.484 . . . . 74.120000000000005 106.118 -168.669 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.824 0 N-CA-C 109.225 -1.55 . . . . 73.430000000000007 109.225 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.23 150.46 45.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 165.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.02 -82.45 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.468 -2.049 . . . . 61.299999999999997 105.468 156.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -147.34 28.38 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.54 1.162 . . . . 71.439999999999998 109.792 -165.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.73 -174.92 22.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 126.112 1.815 . . . . 72.099999999999994 109.894 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 52.7 1.4 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.771 1.228 . . . . 71.540000000000006 112.377 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -140.82 37.92 1.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.746 -1.221 . . . . 61.299999999999997 109.448 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.85 144.4 32.5 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.674 1.989 . . . . 72.319999999999993 109.26 -171.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 73.5 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 71.230000000000004 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 65.230000000000004 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 24' ' ' ILE . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 52.25 108.412 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 63.549999999999997 113.518 -162.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 21' ' ' VAL . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 55.049999999999997 108.841 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 72.450000000000003 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.477 ' HE1' ' H ' ' A' ' 50' ' ' ASP . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 64.219999999999999 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 42.409999999999997 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 44.030000000000001 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 52.420000000000002 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 62.240000000000002 107.649 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 39' ' ' LEU . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 50.329999999999998 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 63.130000000000003 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 55.439999999999998 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' H ' ' HE1' ' A' ' 28' ' ' TRP . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 53.039999999999999 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 54.299999999999997 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 61.210000000000001 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 63.299999999999997 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 61.109999999999999 107.871 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 52.140000000000001 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 60.520000000000003 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.452 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 70.420000000000002 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 44.219999999999999 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.420000000000002 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 60' ' ' THR . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 63.299999999999997 112.192 173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 43.409999999999997 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 62.32 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 61.439999999999998 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 45.399999999999999 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 70.329999999999998 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 53.340000000000003 108.0 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.420000000000002 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.120000000000005 109.98 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 71.230000000000004 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -143.92 170.47 15.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 64.439999999999998 109.475 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.63 -79.94 0.29 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.442 -1.863 . . . . 51.32 108.442 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -131.49 15.32 4.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.425 1.09 . . . . 74.510000000000005 111.83 -167.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 pt -74.06 50.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.473 2.309 . . . . 63.539999999999999 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.732 2.013 . . . . 71.5 108.687 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 111.674 -0.571 . . . . 53.130000000000003 111.674 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.19 -156.59 0.73 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.664 1.585 . . . . 63.509999999999998 108.275 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -76.7 -79.81 0.1 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.543 -1.651 . . . . 71.239999999999995 106.543 165.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.55 81.88 1.29 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.938 -2.245 . . . . 64.140000000000001 104.938 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.71 -94.38 0.83 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.436 -2.666 . . . . 72.329999999999998 106.436 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.08 65.98 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.049 0.939 . . . . 64.230000000000004 110.584 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -129.72 24.84 5.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.995 0.918 . . . . 63.520000000000003 112.588 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p -100.81 170.07 8.57 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.857 -1.152 . . . . 50.140000000000001 111.91 -173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 64.510000000000005 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.450000000000003 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 73.109999999999999 107.383 162.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.458 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 87' ' ' LEU . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 64.430000000000007 110.479 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 17' ' ' THR . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 24' ' ' ILE . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 70.120000000000005 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HG23 ' A' ' 21' ' ' VAL . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 54.32 106.826 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 70.129999999999995 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 73.540000000000006 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 71.230000000000004 108.734 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 39' ' ' LEU . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 70.140000000000001 105.524 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 72.349999999999994 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 65.230000000000004 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 73.200000000000003 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.129999999999995 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 63.219999999999999 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 53.049999999999997 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 53.229999999999997 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 73.510000000000005 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.230000000000004 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 64.230000000000004 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 71.140000000000001 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 64.450000000000003 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 45.340000000000003 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 50.149999999999999 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 71.129999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 71.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 61.520000000000003 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 54.32 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 17' ' ' THR . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 70.120000000000005 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 64.150000000000006 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' VAL . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 44.149999999999999 112.082 -168.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 53.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 70.209999999999994 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -139.89 -179.6 6.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.31 -45.55 0.17 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 109.85 -1.3 . . . . 70.109999999999999 109.85 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.94 79.6 6.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.858 -1.534 . . . . 74.409999999999997 106.858 165.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tt -148.03 122.61 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.31 -2.848 . . . . 72.129999999999995 103.31 164.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.628 1.171 . . . . 70.549999999999997 109.355 175.619 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 109.527 -1.429 . . . . 42.299999999999997 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.24 23.93 9.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.071 0.949 . . . . 64.030000000000001 112.537 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 62.32 -3.38 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.879 2.072 . . . . 73.340000000000003 113.572 -158.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.88 51.45 0.8 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 123.513 1.625 . . . . 62.130000000000003 109.235 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.29 -136.77 7.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 125.889 1.709 . . . . 64.120000000000005 109.682 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -110.96 49.21 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.499 1.92 . . . . 64.510000000000005 107.581 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.44 41.99 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 120.488 -1.383 . . . . 62.539999999999999 108.507 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.65 136.38 52.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.955 1.702 . . . . 71.519999999999996 107.675 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 55.32 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 71.340000000000003 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.239999999999995 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 64.230000000000004 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 64.150000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 41.409999999999997 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' HD23 ' A' ' 39' ' ' LEU . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.512 ' CG2' HG22 ' A' ' 85' ' ' ILE . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 63.420000000000002 112.889 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 24' ' ' ILE . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 71.510000000000005 107.54 -172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HG23 ' A' ' 21' ' ' VAL . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 71.310000000000002 107.29 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 63.399999999999999 104.793 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 74.310000000000002 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 53.439999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.408 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 64.420000000000002 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 73.099999999999994 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.566 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 74.219999999999999 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 64.5 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 42.420000000000002 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 64.329999999999998 106.984 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 72.439999999999998 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 63.5 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 55.119999999999997 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 64.450000000000003 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 55.509999999999998 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.711 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 93' ' ' VAL . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.711 HG22 ' HB ' ' A' ' 60' ' ' THR . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 73.519999999999996 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 72.310000000000002 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 54.420000000000002 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 52.25 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 60.340000000000003 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 71.430000000000007 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 72.540000000000006 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 52.020000000000003 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.512 HG22 ' CG2' ' A' ' 17' ' ' THR . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.120000000000005 104.811 158.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 61.420000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 63.43 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 71.530000000000001 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 63' ' ' THR . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 62.420000000000002 109.803 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 64.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.772 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 64.420000000000002 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.310000000000002 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -107.75 -172.59 2.1 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.52 -68.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.455 -2.258 . . . . 62.549999999999997 107.455 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.3 74.83 0.24 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.154 2.182 . . . . 73.120000000000005 109.541 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -135.93 91.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.231 1.812 . . . . 54.32 107.926 168.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.227 1.011 . . . . 64.549999999999997 108.334 174.525 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 112.033 -0.427 . . . . 72.340000000000003 112.033 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 125.97 29.19 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.392 -1.336 . . . . 75.230000000000004 107.392 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -84.28 -6.71 59.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.205 0.446 . . . . 64.0 112.205 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -139.25 77.06 1.6 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.669 -1.974 . . . . 75.420000000000002 105.669 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.29 -2.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.206 1.384 . . . . 51.530000000000001 114.291 -165.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -152.45 114.59 4.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.6 -1.63 . . . . 74.299999999999997 106.6 152.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.25 24.68 12.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.096 0.95 . . . . 73.299999999999997 112.151 -166.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -135.93 171.88 13.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.737 2.015 . . . . 75.200000000000003 109.947 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 72.129999999999995 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 71.099999999999994 109.724 177.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 71.140000000000001 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.444 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 72.0 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 72.109999999999999 107.765 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 21' ' ' VAL . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 52.100000000000001 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 60.219999999999999 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 HD21 ' A' ' 15' ' ' ASN . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 62.439999999999998 114.675 -163.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 64.209999999999994 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' A' ' 35' ' ' THR . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 55.020000000000003 108.858 159.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' HB2' HG21 ' A' ' 54' ' ' VAL . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 63.439999999999998 111.416 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 74.230000000000004 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 62.200000000000003 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 71.299999999999997 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 25' ' ' LYS . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 71.439999999999998 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 45.130000000000003 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 64.099999999999994 105.213 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 74.140000000000001 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.109999999999999 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.662 ' OD1' HG22 ' A' ' 10' ' ' THR . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 72.120000000000005 107.95 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 60.299999999999997 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 55.520000000000003 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 35.329999999999998 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 54.530000000000001 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 74.219999999999999 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 72.310000000000002 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 28' ' ' TRP . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 62.340000000000003 107.741 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 51.229999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 74.400000000000006 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 64.5 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 71.420000000000002 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 51.219999999999999 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 55.32 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 63.229999999999997 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 54.43 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 72.200000000000003 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 62.299999999999997 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 71.129999999999995 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 71.219999999999999 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 73.5 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 52.219999999999999 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 62.229999999999997 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 62.5 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 54.439999999999998 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -124.05 -173.92 2.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.13 -156.37 24.4 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 107.876 -2.09 . . . . 64.319999999999993 107.876 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.37 66.32 8.77 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.405 1.098 . . . . 64.030000000000001 109.475 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.1 pt -113.72 45.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.839 1.655 . . . . 63.0 110.08 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.269 1.427 . . . . 75.340000000000003 110.587 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.404 -1.878 . . . . 43.439999999999998 108.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.99 46.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 61.030000000000001 107.886 163.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.37 7.69 2.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.375 1.07 . . . . 74.239999999999995 113.27 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -149.8 100.69 2.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.321 -2.474 . . . . 74.430000000000007 104.321 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 -152.37 8.99 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.436 -0.666 . . . . 54.409999999999997 111.436 -167.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -74.27 73.97 1.82 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.581 -1.266 . . . . 75.140000000000001 107.581 167.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.2 26.02 6.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 129.068 2.947 . . . . 74.439999999999998 108.16 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -74.19 176.66 6.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.545 1.538 . . . . 65.299999999999997 109.942 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 62.399999999999999 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 72.019999999999996 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 50.210000000000001 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.807 ' HB2' HD12 ' A' ' 39' ' ' LEU . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 44.420000000000002 110.835 -171.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 24' ' ' ILE . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 71.040000000000006 112.752 -165.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 p30 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 73.099999999999994 104.57 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' VAL . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.109999999999999 106.948 159.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CE ' ' HB3' ' A' ' 33' ' ' GLU . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 47' ' ' PHE . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 33' ' ' GLU . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 51.520000000000003 106.498 171.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 73.319999999999993 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 43.310000000000002 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 61.329999999999998 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG2' HG23 ' A' ' 27' ' ' THR . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 43.509999999999998 110.841 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 63.340000000000003 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG22 ' HB ' ' A' ' 24' ' ' ILE . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 71.010000000000005 106.598 -175.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 73.239999999999995 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' HD13 ' A' ' 39' ' ' LEU . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 39' ' ' LEU . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 60.229999999999997 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 26' ' ' VAL . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.0 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 64.329999999999998 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 64.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.239999999999995 111.775 169.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 52.43 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.009999999999998 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 65.030000000000001 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 62.130000000000003 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 73.239999999999995 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' A' ' 13' ' ' LEU . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 65.010000000000005 105.647 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 63.229999999999997 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 44.329999999999998 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 62.310000000000002 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 71.239999999999995 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 33.409999999999997 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 61.439999999999998 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.040000000000006 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -132.46 -176.46 4.09 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.87 -72.16 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 108.787 -1.725 . . . . 44.140000000000001 108.787 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.97 66.27 0.37 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.37 2.268 . . . . 62.340000000000003 110.363 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.2 pt -135.32 39.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 127.612 2.365 . . . . 72.230000000000004 108.631 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.117 -1.421 . . . . 72.030000000000001 108.18 -178.232 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.555 0 N-CA-C 108.692 -1.763 . . . . 65.420000000000002 108.692 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.14 168.38 19.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.366 -0.976 . . . . 73.010000000000005 108.366 167.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.56 -35.5 81.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.549 -0.739 . . . . 74.219999999999999 111.4 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 26.49 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 122.499 1.143 . . . . 72.010000000000005 110.685 170.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 -5.87 88.42 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.251 -1.531 . . . . 70.150000000000006 114.255 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -134.79 93.24 3.0 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.835 1.817 . . . . 74.25 107.892 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.85 26.2 4.22 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.585 0.707 . . . . 71.420000000000002 111.635 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.46 172.45 10.18 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 127.467 2.307 . . . . 24.399999999999999 108.301 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 73.129999999999995 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 72.150000000000006 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 65.329999999999998 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 64.209999999999994 108.891 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.516 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.310000000000002 108.179 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.487 ' HB2' HD23 ' A' ' 39' ' ' LEU . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 87' ' ' LEU . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 24' ' ' ILE . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.140000000000001 113.227 -163.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 21' ' ' VAL . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 71.230000000000004 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 71.319999999999993 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 53.32 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 63.0 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 63.109999999999999 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 64.400000000000006 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 15' ' ' ASN . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 71.409999999999997 107.672 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 21.52 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 53.310000000000002 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 63.43 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 64.239999999999995 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 41.420000000000002 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 71.150000000000006 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 52.210000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 95' ' ' VAL . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 54.299999999999997 103.68 151.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 51.130000000000003 108.492 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 93' ' ' VAL . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 64.400000000000006 111.637 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.040000000000006 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 71.230000000000004 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 HG22 ' HB ' ' A' ' 60' ' ' THR . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 61.009999999999998 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 64.329999999999998 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 64.109999999999999 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 73.219999999999999 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 71.219999999999999 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 64.219999999999999 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 71.120000000000005 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 17' ' ' THR . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 17' ' ' THR . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 70.430000000000007 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 43.43 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 63' ' ' THR . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.239999999999995 110.784 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 65.239999999999995 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.764 HG11 ' HA3' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 64.430000000000007 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 70.230000000000004 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -136.49 -169.66 2.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.41 -14.05 0.05 OUTLIER Glycine 0 C--O 1.226 -0.373 0 O-C-N 121.438 -0.789 . . . . 63.109999999999999 113.449 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.52 67.44 0.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.291 -1.744 . . . . 74.109999999999999 106.291 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.4 pt -140.85 68.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 126.612 1.965 . . . . 71.049999999999997 110.162 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.752 0 CA-C-N 112.65 -2.068 . . . . 72.25 113.226 166.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.304 -1.119 . . . . 62.439999999999998 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.17 5.13 2.08 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.818 1.247 . . . . 62.43 111.935 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 58.11 -169.26 0.12 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.677 0.791 . . . . 72.329999999999998 108.902 -149.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -129.34 -8.5 4.72 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.586 1.554 . . . . 63.109999999999999 111.985 -169.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.66 46.76 3.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.966 0.793 . . . . 41.219999999999999 114.974 -156.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -153.17 107.17 3.07 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.723 1.261 . . . . 74.349999999999994 110.38 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -85.63 32.78 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 128.685 2.794 . . . . 73.219999999999999 112.068 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 139.22 44.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 52.229999999999997 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 74.200000000000003 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.481 HG23 HG22 ' A' ' 85' ' ' ILE . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 71.310000000000002 112.492 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 55.210000000000001 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 61.439999999999998 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' GLN . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 62.399999999999999 109.517 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 72.109999999999999 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 73.299999999999997 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 30.43 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 63.130000000000003 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 72.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 44.340000000000003 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 64.230000000000004 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 54.219999999999999 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 72.239999999999995 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 62.240000000000002 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 54.32 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 52.5 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 61.109999999999999 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 64.400000000000006 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.522 ' HA ' HG12 ' A' ' 21' ' ' VAL . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.040000000000006 111.61 175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 65.340000000000003 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 70.129999999999995 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 63.030000000000001 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 63.32 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 65.120000000000005 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 51.310000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 64.209999999999994 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 61.520000000000003 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 17' ' ' THR . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 61.420000000000002 104.213 168.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 60.200000000000003 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 73.019999999999996 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 42.219999999999999 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 50.329999999999998 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 54.5 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 73.140000000000001 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 71.420000000000002 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 97' ' ' ILE . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.418 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 60.310000000000002 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -138.16 -178.09 5.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.78 -39.64 0.3 Allowed Glycine 0 C--O 1.226 -0.403 0 C-N-CA 124.757 1.17 . . . . 43.340000000000003 111.65 171.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -78.75 45.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.152 1.781 . . . . 62.450000000000003 110.283 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.62 105.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 126.362 1.865 . . . . 73.430000000000007 108.121 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.172 1.789 . . . . 73.420000000000002 110.086 162.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 CA-C-O 118.684 -1.065 . . . . 74.299999999999997 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 -178.29 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.992 0.896 . . . . 75.310000000000002 110.412 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -120.42 14.78 12.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.066 0.946 . . . . 70.319999999999993 109.695 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.39 23.15 1.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.851 1.26 . . . . 74.129999999999995 111.381 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.0 78.65 1.38 Allowed Glycine 0 C--N 1.34 0.79 0 O-C-N 120.762 -1.211 . . . . 52.229999999999997 110.509 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -148.65 65.28 1.06 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.301 1.04 . . . . 65.140000000000001 110.846 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.05 36.66 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.717 -0.614 . . . . 72.329999999999998 109.904 -170.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p -83.79 169.94 14.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 61.009999999999998 112.381 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 73.010000000000005 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.120000000000005 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 73.430000000000007 108.759 161.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.537 ' HB2' HD12 ' A' ' 39' ' ' LEU . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 72.109999999999999 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 64.010000000000005 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 63' ' ' THR . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 54.020000000000003 109.893 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 61.210000000000001 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 71.219999999999999 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 72.109999999999999 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CZ2' ' HE2' ' A' ' 32' ' ' LYS . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 52.32 110.543 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 71.209999999999994 105.478 166.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 61.450000000000003 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 63.43 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 65.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' C ' HD11 ' A' ' 39' ' ' LEU . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 62.340000000000003 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 44.43 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 73.049999999999997 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 63.399999999999999 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 73.409999999999997 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 53.399999999999999 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 52.539999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 71.219999999999999 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 73.420000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 63.210000000000001 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 63.539999999999999 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.524 ' HA ' HG12 ' A' ' 21' ' ' VAL . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 60.32 112.511 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 72.319999999999993 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 23.23 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 41.229999999999997 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 51.240000000000002 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 71.409999999999997 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 55.439999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 65.120000000000005 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 55.509999999999998 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 73.400000000000006 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 63.130000000000003 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 62.409999999999997 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 61.399999999999999 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 53.109999999999999 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 97' ' ' ILE . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.340000000000003 107.538 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -94.21 175.23 6.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.91 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.466 0.69 0 O-C-N 121.583 -0.698 . . . . 75.329999999999998 113.261 -168.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -135.32 63.92 1.6 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.246 -2.502 . . . . 63.229999999999997 104.246 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.49 77.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.758 1.623 . . . . 63.409999999999997 108.255 -167.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.147 2.179 . . . . 63.439999999999998 111.707 -178.201 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.246 -1.142 . . . . 65.239999999999995 110.246 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.46 27.3 2.3 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.779 2.431 . . . . 65.030000000000001 110.423 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 64.04 -2.66 0.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.472 2.309 . . . . 74.099999999999994 114.861 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.87 29.61 1.5 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.251 1.387 . . . . 70.430000000000007 111.576 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 -140.04 0.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.684 1.611 . . . . 31.129999999999999 112.092 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -128.17 42.46 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.672 0.789 . . . . 73.030000000000001 110.933 -173.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -122.35 24.69 9.25 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.488 1.115 . . . . 63.0 112.32 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -72.61 165.69 24.22 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.938 1.695 . . . . 74.040000000000006 111.563 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 61.229999999999997 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 71.0 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.209999999999994 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 45.009999999999998 114.499 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 14' ' ' ILE . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 51.109999999999999 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 73.140000000000001 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 24.510000000000002 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 24' ' ' ILE . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 62.340000000000003 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 21' ' ' VAL . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 71.409999999999997 108.32 -174.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG2' HG22 ' A' ' 35' ' ' THR . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 71.040000000000006 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 70.140000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 43.130000000000003 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 25' ' ' LYS . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 65.340000000000003 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 71.200000000000003 111.583 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 65.540000000000006 106.764 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 63.219999999999999 104.59 168.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 39' ' ' LEU . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 30.43 114.591 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 51.229999999999997 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 39' ' ' LEU . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 61.100000000000001 106.621 166.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 54.32 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 62.200000000000003 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.200000000000003 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 65.430000000000007 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 45.200000000000003 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 70.420000000000002 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 64.209999999999994 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 51.140000000000001 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 32.310000000000002 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 62.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.150000000000006 107.211 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 71.209999999999994 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 93' ' ' VAL . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.120000000000005 106.636 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 71.439999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 73.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 44.539999999999999 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.140000000000001 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 71.109999999999999 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.319999999999993 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 69' ' ' PHE 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 64.219999999999999 110.041 164.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 52.039999999999999 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 63.140000000000001 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -134.28 154.28 51.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.120000000000005 107.874 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.8 -93.89 0.15 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.008 -2.037 . . . . 73.430000000000007 108.008 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.49 75.63 1.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.707 1.603 . . . . 74.439999999999998 110.919 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 21.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.383 1.073 . . . . 73.019999999999996 112.749 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.707 -1.14 . . . . 72.409999999999997 109.011 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.57 -1.412 . . . . 73.420000000000002 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.43 175.13 5.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.516 -1.29 . . . . 73.219999999999999 107.516 166.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -72.93 -34.58 66.65 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.562 -0.455 . . . . 75.340000000000003 111.008 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -132.72 18.46 4.25 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 122.187 0.994 . . . . 75.450000000000003 110.068 -158.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.71 20.81 1.32 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 75.340000000000003 115.316 -164.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.92 106.62 1.84 Allowed 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 105.635 -1.987 . . . . 62.340000000000003 105.635 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.73 32.09 5.15 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.566 1.146 . . . . 55.130000000000003 111.085 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.68 135.38 38.06 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.341 1.856 . . . . 73.310000000000002 109.95 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 72.019999999999996 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 55.240000000000002 108.383 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 12' ' ' ARG . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 61.43 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 74.420000000000002 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 53.25 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 44.039999999999999 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 65.349999999999994 113.154 -162.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 52.030000000000001 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 52.119999999999997 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 72.510000000000005 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 71.030000000000001 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 42.450000000000003 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.129999999999995 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 65.129999999999995 107.958 -168.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 39' ' ' LEU . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.219999999999999 106.055 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 55.439999999999998 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 55.119999999999997 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 50.420000000000002 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 73.310000000000002 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 55.409999999999997 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.010000000000005 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 70.120000000000005 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 71.25 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 65.25 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 42.340000000000003 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HG21 ' A' ' 93' ' ' VAL . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 62.439999999999998 112.138 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 62.229999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 51.439999999999998 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 72.439999999999998 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.599 ' CA ' HG11 ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 43.030000000000001 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 44.43 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 102' ' ' ILE . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 53.119999999999997 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 62.43 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 61.229999999999997 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 72.450000000000003 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 72.510000000000005 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 64.349999999999994 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 61.439999999999998 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 63.119999999999997 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 63' ' ' THR . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 74.230000000000004 110.934 -161.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 61.520000000000003 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 61.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.69 -170.73 3.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 52.009999999999998 107.364 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.6 -70.03 0.33 Allowed Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 106.466 -2.654 . . . . 31.039999999999999 106.466 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -119.9 83.36 2.03 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.291 -1.374 . . . . 64.239999999999995 107.291 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 77' ' ' VAL . 7.8 tt -127.54 27.28 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.42 1.888 . . . . 74.150000000000006 108.913 168.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.595 1.558 . . . . 51.340000000000003 110.238 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.49 0 N-CA-C 109.059 -1.617 . . . . 72.549999999999997 109.059 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 66.3 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.576 -1.268 . . . . 71.510000000000005 107.576 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.19 -53.26 36.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.05 0.94 . . . . 64.230000000000004 108.995 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -157.86 82.6 0.87 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.43 -2.433 . . . . 72.239999999999995 104.43 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.84 -169.17 25.3 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.511 -1.436 . . . . 40.240000000000002 109.511 -174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -123.25 67.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.432 -1.322 . . . . 75.129999999999995 107.432 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -147.7 53.33 1.05 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.936 2.094 . . . . 75.129999999999995 106.042 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -103.99 167.11 9.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.458 1.103 . . . . 73.430000000000007 111.456 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 62.130000000000003 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 74.530000000000001 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 61.450000000000003 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG22 ' HG3' ' A' ' 16' ' ' GLN . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.457 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 14' ' ' ILE . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 60.020000000000003 110.658 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 73.010000000000005 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.239999999999995 113.509 -163.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 p30 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 74.109999999999999 110.36 -166.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 44.43 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 34' ' ' GLN . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 63.350000000000001 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.349999999999994 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 73.510000000000005 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 42.119999999999997 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 74.349999999999994 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 63.25 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.42 ' HB2' HG12 ' A' ' 26' ' ' VAL . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 64.239999999999995 109.075 173.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 62.130000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 64.109999999999999 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.457 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 73.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 63.109999999999999 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 64.519999999999996 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 54.350000000000001 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 62.350000000000001 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 54.149999999999999 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 45.439999999999998 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 73.329999999999998 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 63.119999999999997 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.427 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 43.520000000000003 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.099999999999994 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 73.030000000000001 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 52.439999999999998 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 62.109999999999999 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 63.350000000000001 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 60' ' ' THR . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 72.420000000000002 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 65.510000000000005 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 71.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.140000000000001 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 52.229999999999997 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 70.439999999999998 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 51.439999999999998 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.431 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 44.25 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 63' ' ' THR . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 54.340000000000003 109.752 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 70.209999999999994 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 63.539999999999999 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 61.350000000000001 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 50.149999999999999 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -137.72 -167.03 2.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 65.129999999999995 107.406 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.78 -76.53 0.02 OUTLIER Glycine 0 C--N 1.331 0.298 0 N-CA-C 108.322 -1.911 . . . . 71.519999999999996 108.322 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.38 61.42 0.14 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.732 2.813 . . . . 73.310000000000002 111.45 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.54 78.03 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.776 1.23 . . . . 72.150000000000006 109.487 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 128.064 2.546 . . . . 71.25 113.415 155.82 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.377 0 N-CA-C 110.898 -0.881 . . . . 51.149999999999999 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.46 170.33 8.32 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.335 0.654 . . . . 64.439999999999998 110.725 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -57.57 12.15 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.498 -0.927 . . . . 71.129999999999995 108.498 162.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -156.76 62.4 0.52 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.4 1.095 . . . . 74.120000000000005 110.836 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.59 58.81 5.01 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.969 0.795 . . . . 54.409999999999997 111.582 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -71.05 30.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.448 2.299 . . . . 70.439999999999998 113.914 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -155.71 42.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.028 -1.045 . . . . 74.129999999999995 111.675 -163.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 142.73 34.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 167.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 71.439999999999998 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 14' ' ' ILE . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.57 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 71.319999999999993 108.002 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.76 HG22 HD12 ' A' ' 87' ' ' LEU . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 71.129999999999995 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 51.020000000000003 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 63' ' ' THR . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 65.120000000000005 108.717 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 70.120000000000005 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.310000000000002 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.430000000000007 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 74.239999999999995 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 74.329999999999998 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.039999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 25' ' ' LYS . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 64.109999999999999 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 65.549999999999997 106.331 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 39' ' ' LEU . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 64.530000000000001 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 64.319999999999993 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 71.150000000000006 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 60.439999999999998 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 42.549999999999997 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 63.329999999999998 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 73.450000000000003 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 61.240000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' HG12 ' A' ' 21' ' ' VAL . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 61.539999999999999 112.294 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 60.219999999999999 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 64.430000000000007 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 71.349999999999994 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 55.229999999999997 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 61.310000000000002 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 72.549999999999997 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 64.409999999999997 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 17' ' ' THR . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 55.109999999999999 109.055 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 74.150000000000006 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 71.340000000000003 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 72.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 22.539999999999999 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 44.149999999999999 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -115.68 169.6 9.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.48 -59.53 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 109.467 -1.453 . . . . 42.43 109.467 -157.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -85.62 52.98 2.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.898 0.856 . . . . 73.209999999999994 110.494 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 pt -115.43 57.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.616 1.167 . . . . 42.450000000000003 107.923 170.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 124.177 0.991 . . . . 73.530000000000001 109.385 165.641 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.499 0 N-CA-C 109.269 -1.532 . . . . 42.340000000000003 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.04 16.28 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.721 0.808 . . . . 51.409999999999997 110.361 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.73 -5.32 19.83 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.755 0.822 . . . . 74.409999999999997 112.796 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.64 107.86 4.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.276 -3.231 . . . . 60.439999999999998 102.276 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.97 67.43 0.13 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 108.033 -2.027 . . . . 55.32 108.033 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -148.43 44.48 1.04 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.574 1.95 . . . . 74.549999999999997 107.679 -169.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -137.48 97.71 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 103.828 -2.656 . . . . 52.43 103.828 164.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 6.0 t -74.28 -166.79 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.726 0.81 . . . . 63.25 109.651 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 63.5 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 53.119999999999997 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 71.099999999999994 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 62.439999999999998 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 61.109999999999999 107.996 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 39' ' ' LEU . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 14' ' ' ILE . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 72.219999999999999 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 72.099999999999994 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 63' ' ' THR . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 72.120000000000005 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.426 ' ND2' ' HE3' ' A' ' 22' ' ' LYS . 13.7 p30 -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 35' ' ' THR . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 52.340000000000003 107.043 170.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 64.209999999999994 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 73.219999999999999 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 52.240000000000002 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 25' ' ' LYS . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 63.210000000000001 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 73.310000000000002 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.040000000000006 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 63.219999999999999 105.859 176.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 73.040000000000006 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 73.319999999999993 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 61.009999999999998 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 51.340000000000003 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 71.510000000000005 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 8' ' ' THR . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.400000000000006 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.200000000000003 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 72.530000000000001 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 54.030000000000001 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.140000000000001 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 64.5 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 55.409999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 63.100000000000001 108.702 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.654 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 73.129999999999995 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 22.34 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 63.200000000000003 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 60' ' ' THR . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 71.430000000000007 112.273 173.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 54.310000000000002 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 65.439999999999998 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 53.399999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 72.439999999999998 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 72.340000000000003 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 64.319999999999993 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 60.130000000000003 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 73.340000000000003 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 71.329999999999998 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 15' ' ' ASN . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.219999999999999 106.259 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 64.430000000000007 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 64.140000000000001 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 71.010000000000005 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 64.0 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 71.0 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 61.329999999999998 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -136.95 171.84 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 51.030000000000001 107.47 166.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.61 -73.96 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 108.785 -1.726 . . . . 54.219999999999999 108.785 168.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -147.94 71.57 1.19 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 106.351 -1.722 . . . . 73.319999999999993 106.351 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -129.13 19.18 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.504 1.122 . . . . 72.239999999999995 110.671 175.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.874 -1.06 . . . . 72.510000000000005 109.478 171.67 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.021 -1.474 . . . . 75.5 107.021 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 44.340000000000003 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 62.32 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.019999999999996 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.109999999999999 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 42.399999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 62.299999999999997 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 62.409999999999997 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 71.109999999999999 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.5 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 73.430000000000007 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 73.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 60.140000000000001 109.012 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.441 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 60.520000000000003 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.120000000000005 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 44.530000000000001 113.799 -170.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 39' ' ' LEU . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 71.299999999999997 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.030000000000001 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 60.420000000000002 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 62.539999999999999 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 54.020000000000003 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 40.219999999999999 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.010000000000005 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 73.400000000000006 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 51.219999999999999 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 62.420000000000002 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 74.299999999999997 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CD1' HD11 ' A' ' 97' ' ' ILE . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 60.43 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 42.5 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 40.100000000000001 108.836 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 63.32 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 64.340000000000003 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 71.299999999999997 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.219999999999999 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.030000000000001 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 71.409999999999997 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 73' ' ' PHE . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 72.140000000000001 109.952 175.089 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 113.369 0.877 . . . . 74.430000000000007 113.369 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 74.329999999999998 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 55.549999999999997 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 45.049999999999997 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 54.109999999999999 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 63.420000000000002 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 51.439999999999998 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 71.25 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 45.310000000000002 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 71.420000000000002 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 61.130000000000003 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 40.039999999999999 108.135 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 24.41 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 53.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 34.509999999999998 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 73.209999999999994 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 44.43 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 52.109999999999999 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 65.450000000000003 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 42.43 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 62.520000000000003 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 74.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 34.299999999999997 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 73.430000000000007 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.25 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 51.420000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.140000000000001 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 71.340000000000003 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 63.409999999999997 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 54.210000000000001 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 51.340000000000003 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 62.140000000000001 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 71.239999999999995 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 64.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 62.240000000000002 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 97' ' ' ILE . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 . . . . . 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.239 0.519 0 CA-C-O 121.388 0.613 . . . . 73.540000000000006 111.73 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 64.230000000000004 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 43.219999999999999 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 60.340000000000003 107.349 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' A' ' 39' ' ' LEU . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 73.230000000000004 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.441 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.319999999999993 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 71.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 72.439999999999998 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 40.509999999999998 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 53.409999999999997 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 72.409999999999997 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 71.510000000000005 108.591 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 53.310000000000002 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 64.329999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.457 ' CB ' HD13 ' A' ' 39' ' ' LEU 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 61.43 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 44.100000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 71.120000000000005 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 53.020000000000003 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 53.299999999999997 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.120000000000005 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 74.310000000000002 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 23' ' ' ASN . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.592 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 55.149999999999999 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 63.119999999999997 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 34.399999999999999 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 63.210000000000001 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 63.240000000000002 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 64.230000000000004 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 62.149999999999999 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 63.210000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 73.140000000000001 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 64.510000000000005 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 71.549999999999997 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 61.409999999999997 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 62.350000000000001 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 72.230000000000004 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 74.319999999999993 107.941 170.768 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.0 -0.741 . . . . 64.329999999999998 109.0 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.010000000000005 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 64.120000000000005 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 71.450000000000003 110.353 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 62.229999999999997 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 63.109999999999999 109.881 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 64.239999999999995 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 65.25 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 70.25 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 61.549999999999997 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 24' ' ' ILE . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 64.230000000000004 107.594 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.049999999999997 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 72.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 70.120000000000005 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 64.239999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 71.549999999999997 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 72.109999999999999 107.472 168.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 44' ' ' SER . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 72.519999999999996 106.97 167.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.476 ' CA ' HD11 ' A' ' 39' ' ' LEU . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 72.420000000000002 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 50.450000000000003 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 54.439999999999998 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 63.049999999999997 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 32.140000000000001 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 64.439999999999998 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 42.109999999999999 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 70.329999999999998 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 63.140000000000001 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 43.020000000000003 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 71.349999999999994 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 31.140000000000001 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 61.509999999999998 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 55.219999999999999 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 72.209999999999994 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 72.040000000000006 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 63.32 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 51.450000000000003 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 53.409999999999997 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 52.140000000000001 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 65.519999999999996 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.329999999999998 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 54.229999999999997 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 72.510000000000005 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 61.450000000000003 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 63.229999999999997 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.349999999999994 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 82' ' ' ARG . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 62.549999999999997 110.189 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 70.430000000000007 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 . . . . . 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 71.349999999999994 106.731 172.12 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.237 0.437 0 CA-C-O 121.782 0.801 . . . . 45.43 110.96 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 61.32 109.555 164.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.129999999999995 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 65.150000000000006 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 64.310000000000002 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 72.049999999999997 111.173 -167.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 62.25 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 70.25 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 70.409999999999997 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 24' ' ' ILE . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 73.109999999999999 109.052 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 62.140000000000001 113.829 -162.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.59 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.666 HD11 HG23 ' A' ' 21' ' ' VAL . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 72.019999999999996 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 64.109999999999999 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 65.129999999999995 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 52.329999999999998 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 53.219999999999999 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 72.030000000000001 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 53.350000000000001 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.25 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 65.450000000000003 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 44.140000000000001 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 32.219999999999999 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 62.520000000000003 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 72.150000000000006 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.319999999999993 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 50.539999999999999 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 61.009999999999998 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 54.310000000000002 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 9' ' ' THR . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 64.109999999999999 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 70.340000000000003 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.59 ' HB ' HD21 ' A' ' 23' ' ' ASN . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 70.450000000000003 109.956 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.531 ' HA ' HG12 ' A' ' 21' ' ' VAL . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 43.130000000000003 113.002 -170.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 72.430000000000007 111.043 168.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 72.230000000000004 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 54.509999999999998 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 71.450000000000003 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 70.340000000000003 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 70.040000000000006 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 53.119999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 97' ' ' ILE . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 72.439999999999998 107.642 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 13' ' ' LEU . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 72.420000000000002 107.221 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 70.129999999999995 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.230000000000004 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 52.109999999999999 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 64.129999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 65.430000000000007 110.787 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 71.209999999999994 108.055 165.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 64.010000000000005 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 41.149999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 63.340000000000003 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.66 ' HD2' HD11 ' A' ' 14' ' ' ILE . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 55.329999999999998 109.072 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 64.310000000000002 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.66 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 73.430000000000007 109.39 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 43.439999999999998 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 63.340000000000003 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 63.299999999999997 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 64.310000000000002 108.182 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 61.130000000000003 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 62.340000000000003 106.191 162.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 64.219999999999999 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 61.240000000000002 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 73.540000000000006 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 62.229999999999997 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 74.540000000000006 109.876 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 55.439999999999998 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 44.329999999999998 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.239999999999995 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.109999999999999 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 61.549999999999997 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.804 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 44.399999999999999 108.879 170.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.43 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 51.039999999999999 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 71.120000000000005 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 33.149999999999999 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.804 HG22 ' HB ' ' A' ' 60' ' ' THR . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 32.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 54.450000000000003 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 73.409999999999997 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 64.329999999999998 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 61.130000000000003 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 34.140000000000001 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.402 ' O ' HG22 ' A' ' 97' ' ' ILE . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 60.210000000000001 109.485 172.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 64.310000000000002 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 74.120000000000005 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 54.140000000000001 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 64.310000000000002 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 62.240000000000002 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 42.329999999999998 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 73.120000000000005 108.419 174.564 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 108.878 -0.786 . . . . 74.340000000000003 108.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 61.409999999999997 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 71.409999999999997 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.049999999999997 108.67 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 61.409999999999997 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.129999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.150000000000006 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 63.25 113.463 -165.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 44.329999999999998 108.159 -163.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 70.239999999999995 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.140000000000001 105.37 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 32' ' ' LYS . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 50.350000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 70.319999999999993 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 65.510000000000005 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 73.510000000000005 105.862 162.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.319999999999993 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 71.430000000000007 107.986 -167.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 54.420000000000002 107.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.049999999999997 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 71.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 44.439999999999998 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 45.240000000000002 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 51.409999999999997 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.129999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 72.239999999999995 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 72.209999999999994 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 70.25 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 70.530000000000001 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 64.239999999999995 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 52.149999999999999 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 53.149999999999999 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 73.409999999999997 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 64.340000000000003 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 62.439999999999998 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 63.299999999999997 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 50.210000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 72.299999999999997 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 44.210000000000001 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 64.099999999999994 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 73.209999999999994 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 71.329999999999998 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.329999999999998 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 71.109999999999999 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.040000000000006 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 64.019999999999996 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 52.140000000000001 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 51.030000000000001 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 62.119999999999997 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 73.319999999999993 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 51.439999999999998 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 65.310000000000002 109.467 -169.903 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.26 -0.645 . . . . 72.319999999999993 109.26 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 73.5 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 71.230000000000004 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 65.230000000000004 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 24' ' ' ILE . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 52.25 108.412 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 63.549999999999997 113.518 -162.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 21' ' ' VAL . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 55.049999999999997 108.841 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 72.450000000000003 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.477 ' HE1' ' H ' ' A' ' 50' ' ' ASP . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 64.219999999999999 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 42.409999999999997 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 44.030000000000001 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 52.420000000000002 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 62.240000000000002 107.649 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 39' ' ' LEU . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 50.329999999999998 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 63.130000000000003 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 55.439999999999998 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' H ' ' HE1' ' A' ' 28' ' ' TRP . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 53.039999999999999 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 54.299999999999997 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 61.210000000000001 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 63.299999999999997 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 61.109999999999999 107.871 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 52.140000000000001 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 60.520000000000003 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.452 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 70.420000000000002 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 44.219999999999999 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.420000000000002 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 60' ' ' THR . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 63.299999999999997 112.192 173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 43.409999999999997 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 62.32 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 61.439999999999998 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 45.399999999999999 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 70.329999999999998 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 53.340000000000003 108.0 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.420000000000002 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.120000000000005 109.98 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 71.230000000000004 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 . . . . . 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 64.439999999999998 109.475 178.123 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.91 0.337 . . . . 50.140000000000001 111.91 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 64.510000000000005 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.450000000000003 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 73.109999999999999 107.383 162.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.458 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 87' ' ' LEU . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 64.430000000000007 110.479 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 17' ' ' THR . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 24' ' ' ILE . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 70.120000000000005 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HG23 ' A' ' 21' ' ' VAL . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 54.32 106.826 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 70.129999999999995 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 73.540000000000006 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 71.230000000000004 108.734 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 39' ' ' LEU . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 70.140000000000001 105.524 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 72.349999999999994 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 65.230000000000004 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 73.200000000000003 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.129999999999995 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 63.219999999999999 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 53.049999999999997 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 53.229999999999997 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 73.510000000000005 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.230000000000004 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 64.230000000000004 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 71.140000000000001 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 64.450000000000003 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 45.340000000000003 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 50.149999999999999 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 71.129999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 71.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 61.520000000000003 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 54.32 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 17' ' ' THR . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 70.120000000000005 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 64.150000000000006 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' VAL . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 44.149999999999999 112.082 -168.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 53.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 70.209999999999994 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.675 -1.232 . . . . 71.519999999999996 107.675 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 55.32 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 71.340000000000003 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.239999999999995 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 64.230000000000004 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 64.150000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 41.409999999999997 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' HD23 ' A' ' 39' ' ' LEU . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.512 ' CG2' HG22 ' A' ' 85' ' ' ILE . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 63.420000000000002 112.889 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 24' ' ' ILE . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 71.510000000000005 107.54 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HG23 ' A' ' 21' ' ' VAL . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 71.310000000000002 107.29 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 63.399999999999999 104.793 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 74.310000000000002 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 53.439999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.408 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 64.420000000000002 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 73.099999999999994 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.566 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 74.219999999999999 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 64.5 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 42.420000000000002 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 64.329999999999998 106.984 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 72.439999999999998 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 63.5 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 55.119999999999997 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 64.450000000000003 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 55.509999999999998 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.711 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 93' ' ' VAL . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.711 HG22 ' HB ' ' A' ' 60' ' ' THR . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 73.519999999999996 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 72.310000000000002 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 54.420000000000002 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 52.25 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 60.340000000000003 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 71.430000000000007 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 72.540000000000006 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 52.020000000000003 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.512 HG22 ' CG2' ' A' ' 17' ' ' THR . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.120000000000005 104.811 158.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 61.420000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 63.43 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 71.530000000000001 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 63' ' ' THR . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 62.420000000000002 109.803 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 64.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.772 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 64.420000000000002 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.310000000000002 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.947 -0.39 . . . . 75.200000000000003 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 72.129999999999995 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 71.099999999999994 109.724 177.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 71.140000000000001 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.444 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 72.0 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 72.109999999999999 107.765 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 21' ' ' VAL . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 52.100000000000001 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 60.219999999999999 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 HD21 ' A' ' 15' ' ' ASN . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 62.439999999999998 114.675 -163.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 64.209999999999994 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' A' ' 35' ' ' THR . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 55.020000000000003 108.858 159.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.411 ' HB2' HG21 ' A' ' 54' ' ' VAL . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 63.439999999999998 111.416 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 74.230000000000004 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 62.200000000000003 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 71.299999999999997 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 25' ' ' LYS . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 71.439999999999998 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 45.130000000000003 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 64.099999999999994 105.213 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 74.140000000000001 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.109999999999999 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.662 ' OD1' HG22 ' A' ' 10' ' ' THR . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 72.120000000000005 107.95 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 60.299999999999997 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 55.520000000000003 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 35.329999999999998 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 54.530000000000001 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 74.219999999999999 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 72.310000000000002 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 28' ' ' TRP . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 62.340000000000003 107.741 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 51.229999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 74.400000000000006 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 64.5 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 71.420000000000002 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 51.219999999999999 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 55.32 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 63.229999999999997 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 54.43 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 72.200000000000003 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 62.299999999999997 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 71.129999999999995 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 71.219999999999999 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 73.5 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 52.219999999999999 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 62.229999999999997 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 62.5 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 54.439999999999998 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.942 -0.392 . . . . 65.299999999999997 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 62.399999999999999 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 72.019999999999996 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 50.210000000000001 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.807 ' HB2' HD12 ' A' ' 39' ' ' LEU . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 44.420000000000002 110.835 -171.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 24' ' ' ILE . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 71.040000000000006 112.752 -165.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 73.099999999999994 104.57 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' VAL . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.109999999999999 106.948 159.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CE ' ' HB3' ' A' ' 33' ' ' GLU . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 47' ' ' PHE . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 33' ' ' GLU . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 51.520000000000003 106.498 171.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 73.319999999999993 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 43.310000000000002 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 61.329999999999998 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG2' HG23 ' A' ' 27' ' ' THR . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 43.509999999999998 110.841 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 63.340000000000003 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG22 ' HB ' ' A' ' 24' ' ' ILE . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 71.010000000000005 106.598 -175.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 73.239999999999995 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' HD13 ' A' ' 39' ' ' LEU . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 39' ' ' LEU . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 60.229999999999997 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 26' ' ' VAL . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.0 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 64.329999999999998 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 64.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.239999999999995 111.775 169.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 52.43 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.009999999999998 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 65.030000000000001 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 62.130000000000003 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 73.239999999999995 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' A' ' 13' ' ' LEU . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 65.010000000000005 105.647 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 63.229999999999997 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 44.329999999999998 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 62.310000000000002 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 71.239999999999995 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 33.409999999999997 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 61.439999999999998 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.040000000000006 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 . . . . . 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.301 -1.0 . . . . 24.399999999999999 108.301 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 73.129999999999995 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 72.150000000000006 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 65.329999999999998 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 64.209999999999994 108.891 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.516 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.310000000000002 108.179 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.487 ' HB2' HD23 ' A' ' 39' ' ' LEU . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 87' ' ' LEU . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 24' ' ' ILE . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.140000000000001 113.227 -163.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 21' ' ' VAL . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 71.230000000000004 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 71.319999999999993 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 53.32 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 63.0 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 63.109999999999999 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 64.400000000000006 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 15' ' ' ASN . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 71.409999999999997 107.672 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 21.52 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 53.310000000000002 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 63.43 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 64.239999999999995 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 41.420000000000002 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 71.150000000000006 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 52.210000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 95' ' ' VAL . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 54.299999999999997 103.68 151.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.415 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 51.130000000000003 108.492 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 93' ' ' VAL . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 64.400000000000006 111.637 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.040000000000006 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 71.230000000000004 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 HG22 ' HB ' ' A' ' 60' ' ' THR . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 61.009999999999998 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 64.329999999999998 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 64.109999999999999 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 73.219999999999999 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 71.219999999999999 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 64.219999999999999 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 71.120000000000005 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 17' ' ' THR . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 17' ' ' THR . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 70.430000000000007 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 43.43 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 63' ' ' THR . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.239999999999995 110.784 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 65.239999999999995 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.764 HG11 ' HA3' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 64.430000000000007 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 70.230000000000004 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 52.229999999999997 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 74.200000000000003 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.481 HG23 HG22 ' A' ' 85' ' ' ILE . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 71.310000000000002 112.492 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 55.210000000000001 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 61.439999999999998 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' GLN . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 62.399999999999999 109.517 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 72.109999999999999 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 73.299999999999997 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 30.43 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 63.130000000000003 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 72.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 44.340000000000003 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 64.230000000000004 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 54.219999999999999 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 72.239999999999995 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 62.240000000000002 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 54.32 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 52.5 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 61.109999999999999 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 64.400000000000006 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.522 ' HA ' HG12 ' A' ' 21' ' ' VAL . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.040000000000006 111.61 175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 65.340000000000003 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 70.129999999999995 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 63.030000000000001 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 63.32 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 65.120000000000005 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 51.310000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 64.209999999999994 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 61.520000000000003 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 17' ' ' THR . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 61.420000000000002 104.213 168.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 60.200000000000003 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 73.019999999999996 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 42.219999999999999 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 50.329999999999998 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 54.5 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 73.140000000000001 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 71.420000000000002 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 97' ' ' ILE . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.418 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 60.310000000000002 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 . . . . . 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 61.009999999999998 112.381 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 73.010000000000005 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.120000000000005 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 73.430000000000007 108.759 161.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.537 ' HB2' HD12 ' A' ' 39' ' ' LEU . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 72.109999999999999 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 64.010000000000005 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 63' ' ' THR . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.532 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 54.020000000000003 109.893 -170.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 61.210000000000001 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 71.219999999999999 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 72.109999999999999 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CZ2' ' HE2' ' A' ' 32' ' ' LYS . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 52.32 110.543 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 71.209999999999994 105.478 166.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 61.450000000000003 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 63.43 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 65.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' C ' HD11 ' A' ' 39' ' ' LEU . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 62.340000000000003 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 44.43 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 73.049999999999997 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 63.399999999999999 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 73.409999999999997 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 53.399999999999999 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 52.539999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 71.219999999999999 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 73.420000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 63.210000000000001 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 63.539999999999999 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.532 ' HB ' HD21 ' A' ' 23' ' ' ASN . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.524 ' HA ' HG12 ' A' ' 21' ' ' VAL . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 60.32 112.511 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 72.319999999999993 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 23.23 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 41.229999999999997 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 51.240000000000002 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 71.409999999999997 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 55.439999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 65.120000000000005 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 55.509999999999998 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 73.400000000000006 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 63.130000000000003 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 62.409999999999997 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 61.399999999999999 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 53.109999999999999 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 97' ' ' ILE . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.340000000000003 107.538 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.6 0.238 . . . . 74.040000000000006 111.563 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 61.229999999999997 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 71.0 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.209999999999994 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 45.009999999999998 114.499 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 14' ' ' ILE . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 51.109999999999999 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 73.140000000000001 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 24.510000000000002 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 24' ' ' ILE . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 62.340000000000003 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 21' ' ' VAL . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 71.409999999999997 108.32 -174.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG2' HG22 ' A' ' 35' ' ' THR . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 71.040000000000006 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 70.140000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 43.130000000000003 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 25' ' ' LYS . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 65.340000000000003 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 71.200000000000003 111.583 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 65.540000000000006 106.764 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 63.219999999999999 104.59 168.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 39' ' ' LEU . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 30.43 114.591 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 51.229999999999997 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 39' ' ' LEU . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 61.100000000000001 106.621 166.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 54.32 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 62.200000000000003 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.200000000000003 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 65.430000000000007 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 45.200000000000003 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 70.420000000000002 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 64.209999999999994 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 51.140000000000001 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 32.310000000000002 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 62.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.150000000000006 107.211 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 71.209999999999994 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 93' ' ' VAL . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.120000000000005 106.636 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 71.439999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 73.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 44.539999999999999 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.140000000000001 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 71.109999999999999 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.319999999999993 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 69' ' ' PHE 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 64.219999999999999 110.041 164.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 52.039999999999999 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 63.140000000000001 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.120000000000005 107.874 173.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.95 -0.389 . . . . 73.310000000000002 109.95 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 72.019999999999996 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 55.240000000000002 108.383 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 12' ' ' ARG . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 61.43 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 74.420000000000002 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 53.25 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 44.039999999999999 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 65.349999999999994 113.154 -162.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 52.030000000000001 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 52.119999999999997 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 72.510000000000005 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 71.030000000000001 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 42.450000000000003 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.129999999999995 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 65.129999999999995 107.958 -168.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 39' ' ' LEU . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.219999999999999 106.055 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 55.439999999999998 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 55.119999999999997 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 50.420000000000002 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 73.310000000000002 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 55.409999999999997 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.010000000000005 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 70.120000000000005 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 71.25 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 65.25 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 42.340000000000003 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HG21 ' A' ' 93' ' ' VAL . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 62.439999999999998 112.138 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 62.229999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 51.439999999999998 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 72.439999999999998 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.599 ' CA ' HG11 ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 43.030000000000001 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 44.43 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 53.119999999999997 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 62.43 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 61.229999999999997 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 72.450000000000003 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 72.510000000000005 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 64.349999999999994 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 61.439999999999998 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 63.119999999999997 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 63' ' ' THR . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 74.230000000000004 110.934 -161.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 61.520000000000003 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 61.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 52.009999999999998 107.364 175.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.336 0.588 . . . . 73.430000000000007 111.456 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 62.130000000000003 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 74.530000000000001 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 61.450000000000003 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.463 HG22 ' HG3' ' A' ' 16' ' ' GLN . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.457 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 14' ' ' ILE . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 60.020000000000003 110.658 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 73.010000000000005 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.239999999999995 113.509 -163.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 74.109999999999999 110.36 -166.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 44.43 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 34' ' ' GLN . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 63.350000000000001 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.349999999999994 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 73.510000000000005 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 42.119999999999997 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 74.349999999999994 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 63.25 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.42 ' HB2' HG12 ' A' ' 26' ' ' VAL . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 64.239999999999995 109.075 173.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 62.130000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 64.109999999999999 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.457 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 73.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 63.109999999999999 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 64.519999999999996 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 54.350000000000001 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 62.350000000000001 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 54.149999999999999 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 45.439999999999998 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 73.329999999999998 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 63.119999999999997 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.427 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 43.520000000000003 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.099999999999994 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 73.030000000000001 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 52.439999999999998 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 62.109999999999999 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 63.350000000000001 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 60' ' ' THR . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 72.420000000000002 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 65.510000000000005 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 71.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.140000000000001 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 52.229999999999997 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 70.439999999999998 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 51.439999999999998 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.431 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 44.25 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 63' ' ' THR . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 54.340000000000003 109.752 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 70.209999999999994 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 63.539999999999999 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 61.350000000000001 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 50.149999999999999 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 65.129999999999995 107.406 175.202 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 71.439999999999998 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 14' ' ' ILE . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.57 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 71.319999999999993 108.002 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.76 HG22 HD12 ' A' ' 87' ' ' LEU . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 71.129999999999995 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 51.020000000000003 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 63' ' ' THR . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 65.120000000000005 108.717 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 70.120000000000005 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.310000000000002 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.430000000000007 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 74.239999999999995 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 74.329999999999998 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.039999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 25' ' ' LYS . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 64.109999999999999 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 65.549999999999997 106.331 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 39' ' ' LEU . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 64.530000000000001 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 64.319999999999993 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 71.150000000000006 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 60.439999999999998 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 42.549999999999997 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 63.329999999999998 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 73.450000000000003 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 61.240000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' HG12 ' A' ' 21' ' ' VAL . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 61.539999999999999 112.294 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 60.219999999999999 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 64.430000000000007 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 71.349999999999994 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 55.229999999999997 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 61.310000000000002 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 72.549999999999997 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 64.409999999999997 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 17' ' ' THR . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 55.109999999999999 109.055 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 74.150000000000006 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 71.340000000000003 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 72.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 22.539999999999999 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 44.149999999999999 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 6.0 t . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 121.166 0.508 . . . . 63.25 109.651 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 63.5 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 53.119999999999997 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 71.099999999999994 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 62.439999999999998 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 61.109999999999999 107.996 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 39' ' ' LEU . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 14' ' ' ILE . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 72.219999999999999 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 72.099999999999994 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 63' ' ' THR . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 72.120000000000005 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 35' ' ' THR . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 52.340000000000003 107.043 170.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 64.209999999999994 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 73.219999999999999 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 52.240000000000002 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 25' ' ' LYS . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 63.210000000000001 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 73.310000000000002 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.040000000000006 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 63.219999999999999 105.859 176.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 73.040000000000006 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 73.319999999999993 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 61.009999999999998 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 51.340000000000003 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 71.510000000000005 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 8' ' ' THR . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.400000000000006 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.200000000000003 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 72.530000000000001 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 54.030000000000001 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.140000000000001 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 64.5 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 55.409999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.44 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 63.100000000000001 108.702 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.654 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 73.129999999999995 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 22.34 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 63.200000000000003 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 60' ' ' THR . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 71.430000000000007 112.273 173.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 54.310000000000002 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 65.439999999999998 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 53.399999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 72.439999999999998 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 72.340000000000003 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 64.319999999999993 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 60.130000000000003 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 73.340000000000003 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 71.329999999999998 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 15' ' ' ASN . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.219999999999999 106.259 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 64.430000000000007 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 64.140000000000001 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 71.010000000000005 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 64.0 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 71.0 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 61.329999999999998 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 51.030000000000001 107.47 166.546 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 CA-C-O 119.572 -0.571 . . . . 74.319999999999993 111.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.87 154.11 18.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.167 0.987 . . . . 61.530000000000001 108.646 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -127.95 -14.93 4.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.074 0.949 . . . . 75.409999999999997 112.297 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -122.67 11.09 9.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.445 1.498 . . . . 74.319999999999993 109.86 172.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.93 44.14 1.26 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.404 1.954 . . . . 43.539999999999999 113.605 -172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 62.59 0.42 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.003 1.721 . . . . 75.239999999999995 109.047 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -144.43 42.49 1.38 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 129.656 3.183 . . . . 74.310000000000002 106.793 -157.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.61 149.21 35.39 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.399 1.879 . . . . 75.5 107.021 -167.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -77.91 170.5 16.49 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 119.16 0.891 . . . . 44.340000000000003 110.664 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -109.61 149.77 29.2 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.32 -1.763 . . . . 71.209999999999994 108.93 159.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.27 142.96 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 105.44 -2.059 . . . . 74.209999999999994 105.44 169.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.91 109.73 6.05 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.594 -173.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.9 137.97 31.95 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.953 -1.128 . . . . 62.32 107.953 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.58 125.48 63.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.5 1.12 . . . . 72.019999999999996 108.596 170.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -87.22 64.77 8.5 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.521 1.128 . . . . 75.400000000000006 112.229 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -80.11 57.98 2.85 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.812 -1.18 . . . . 74.099999999999994 111.203 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.0 p -131.51 -170.59 2.41 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.02 1.728 . . . . 75.120000000000005 111.532 -169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.26 12.74 33.74 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 115.305 1.594 . . . . 75.329999999999998 115.305 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -136.85 -174.41 3.72 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.906 1.685 . . . . 75.109999999999999 110.925 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -108.07 155.28 20.55 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 129.085 2.954 . . . . 75.319999999999993 108.024 166.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.56 157.8 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.457 1.103 . . . . 75.319999999999993 109.384 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -143.36 16.02 1.85 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.211 1.189 . . . . 42.399999999999999 114.211 -169.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.95 55.87 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.75 -0.594 . . . . 75.230000000000004 110.484 -163.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.1 mt -88.72 114.72 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.956 -1.498 . . . . 61.310000000000002 106.956 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HE3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -80.64 136.55 36.24 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 104.538 -2.393 . . . . 62.299999999999997 104.538 156.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.28 147.7 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.48 -1.674 . . . . 62.409999999999997 106.48 164.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -124.15 145.05 49.54 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.856 -1.905 . . . . 71.109999999999999 105.856 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.5 p90 -139.94 15.08 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.792 1.178 . . . . 72.5 112.506 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -156.29 -158.68 0.82 Allowed 'General case' 0 C--N 1.322 -0.612 0 O-C-N 120.236 -1.54 . . . . 73.209999999999994 107.083 167.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.59 103.48 15.66 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.044 -2.206 . . . . 75.510000000000005 105.044 156.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.17 -8.86 42.15 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.497 1.523 . . . . 72.329999999999998 114.602 171.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 101.34 13.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.355 -1.721 . . . . 73.430000000000007 106.355 171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -141.46 160.77 39.45 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.624 1.17 . . . . 73.430000000000007 108.112 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -158.59 175.21 13.94 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.884 1.674 . . . . 60.140000000000001 109.012 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.441 ' CG2' ' HE3' ' A' ' 25' ' ' LYS . 82.6 p -121.93 155.8 34.72 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.798 1.181 . . . . 60.520000000000003 111.567 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -125.41 132.03 71.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.16 -1.052 . . . . 75.120000000000005 108.16 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -50.02 -67.56 0.25 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 128.588 2.755 . . . . 44.530000000000001 113.799 -170.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 10.5 m -157.8 156.87 32.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.722 1.609 . . . . 74.040000000000006 107.632 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 39' ' ' LEU . 9.6 tp -139.63 114.78 9.68 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.728 -1.212 . . . . 75.340000000000003 107.728 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.37 168.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.858 0 O-C-N 125.664 1.852 . . . . 73.439999999999998 112.991 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 m -54.5 115.7 2.27 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 124.776 1.23 . . . . 62.219999999999999 108.149 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.53 19.16 5.08 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.208 1.403 . . . . 71.299999999999997 114.608 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -86.74 176.6 7.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.922 1.237 . . . . 74.209999999999994 110.19 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.5 p -148.61 152.68 37.18 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.682 0.993 . . . . 73.400000000000006 113.682 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tp -147.06 144.9 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 127.233 2.213 . . . . 71.010000000000005 106.399 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.66 144.51 49.25 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.778 -1.193 . . . . 71.140000000000001 107.778 175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -146.03 155.44 42.8 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.894 -1.048 . . . . 75.030000000000001 110.029 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.56 155.61 38.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.276 1.03 . . . . 60.420000000000002 110.054 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.35 122.27 22.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.285 1.434 . . . . 71.019999999999996 107.353 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.98 14.1 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.7 2.4 . . . . 74.319999999999993 115.739 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -136.35 151.41 49.55 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 120.618 -1.301 . . . . 64.420000000000002 109.875 176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.4 -19.62 79.8 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.301 0.953 . . . . 62.539999999999999 113.631 -174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.6 p -152.62 156.69 39.75 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.965 1.706 . . . . 54.020000000000003 107.776 -175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.05 142.52 3.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.575 0.75 . . . . 64.329999999999998 111.094 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 1.2 p90 -123.52 -9.71 7.95 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 126.935 2.094 . . . . 74.519999999999996 113.794 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.4 159.4 41.7 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 120.699 1.591 . . . . 75.340000000000003 110.932 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 39.6 ttm -158.12 121.39 3.92 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.655 -1.609 . . . . 72.140000000000001 106.655 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -124.24 104.06 8.6 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.911 -1.885 . . . . 75.400000000000006 105.911 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -107.91 161.2 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.124 -1.806 . . . . 71.519999999999996 106.124 -171.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.89 114.34 1.51 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.661 -2.348 . . . . 63.329999999999998 104.661 -176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.66 178.62 23.28 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.622 -0.591 . . . . 40.219999999999999 111.622 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 m -145.78 142.16 28.63 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 121.599 -0.942 . . . . 75.129999999999995 110.269 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.6 p -73.02 174.49 7.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.328 2.251 . . . . 71.010000000000005 111.78 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -53.82 -48.82 69.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 114.445 -1.252 . . . . 73.400000000000006 110.129 164.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -83.65 34.37 0.49 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.74 0.7 . . . . 71.209999999999994 111.985 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.51 73.1 Favored Glycine 0 C--N 1.336 0.549 0 O-C-N 121.488 -0.758 . . . . 51.219999999999999 113.018 161.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 129.15 56.64 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.59 -1.263 . . . . 75.5 107.59 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -109.51 128.2 55.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.086 0.955 . . . . 73.430000000000007 110.573 -160.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -118.1 159.49 23.15 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 125.618 1.567 . . . . 75.010000000000005 109.539 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.4 p -137.25 169.61 17.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 122.503 1.144 . . . . 62.420000000000002 109.848 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.46 89.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 106.602 -2.599 . . . . 74.299999999999997 106.602 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.13 97.74 8.82 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.41 1.884 . . . . 75.109999999999999 110.741 -171.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CD1' HD11 ' A' ' 97' ' ' ILE . 52.0 m-85 -130.76 149.36 52.44 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 121.236 -0.915 . . . . 75.310000000000002 112.581 -171.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -150.4 6.94 0.57 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.34 1.856 . . . . 60.43 112.762 -171.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.49 30.06 5.9 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 127.228 2.347 . . . . 42.5 111.118 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 49.5 mt -84.78 160.69 20.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.836 -0.802 . . . . 40.100000000000001 108.836 176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.6 m -150.19 179.99 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 126.645 1.978 . . . . 63.32 107.536 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.02 178.57 51.78 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.768 -0.582 . . . . 64.310000000000002 112.732 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -108.96 34.46 3.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.318 1.047 . . . . 64.140000000000001 110.898 -171.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -166.46 159.61 14.68 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.994 2.118 . . . . 75.230000000000004 106.851 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -145.58 140.36 27.35 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.718 -0.845 . . . . 75.439999999999998 108.718 172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -116.04 177.84 4.53 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.702 1.201 . . . . 75.409999999999997 109.136 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.0 t -146.4 123.24 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.707 -1.59 . . . . 64.340000000000003 106.707 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -100.75 95.74 6.85 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 106.175 -1.787 . . . . 71.299999999999997 106.175 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -73.06 121.02 22.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 104.111 -2.551 . . . . 71.209999999999994 104.111 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -137.43 -171.13 2.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.388 1.475 . . . . 71.219999999999999 107.515 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.95 152.57 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.281 -1.007 . . . . 75.219999999999999 108.281 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 89' ' ' GLU . 42.5 t0 -153.86 -173.41 4.57 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.589 0.756 . . . . 75.219999999999999 109.421 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' H ' ' CG ' ' A' ' 88' ' ' ASP . 28.0 mt-10 67.38 -68.17 0.16 Allowed 'General case' 0 C--O 1.234 0.271 0 C-N-CA 129.85 3.26 . . . . 73.209999999999994 111.188 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -139.27 26.6 2.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.677 1.191 . . . . 75.030000000000001 110.363 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 27.81 11.67 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.145 1.778 . . . . 71.420000000000002 110.948 -161.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -83.44 149.07 26.89 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.999 -1.482 . . . . 71.409999999999997 106.999 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.3 t -79.42 115.81 22.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 121.109 0.481 . . . . 72.299999999999997 110.727 -170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -106.08 -174.75 2.61 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.416 -0.957 . . . . 75.140000000000001 108.416 170.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.23 141.14 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.144 -1.799 . . . . 71.109999999999999 106.144 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.65 172.87 11.46 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.686 1.594 . . . . 71.120000000000005 109.735 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 73' ' ' PHE . 0.7 OUTLIER -150.97 143.95 16.73 Favored Pre-proline 0 N--CA 1.451 -0.399 0 O-C-N 121.141 -0.974 . . . . 74.030000000000001 111.44 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.35 74.34 5.59 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.296 2.664 . . . . 71.219999999999999 110.629 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -85.09 168.33 14.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.529 -0.76 . . . . 72.140000000000001 109.952 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.36 -57.75 0.16 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.381 -1.488 . . . . 53.119999999999997 109.381 -168.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.31 15.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.711 1.256 . . . . 73.409999999999997 113.673 -171.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.9 tt -74.66 82.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.34 2.256 . . . . 72.129999999999995 109.161 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 N-CA-C 103.816 -2.661 . . . . 43.219999999999999 103.816 171.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 109.526 -1.43 . . . . 43.130000000000003 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.01 140.26 56.9 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.214 -0.661 . . . . 72.319999999999993 109.214 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -78.15 11.35 2.36 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.584 1.554 . . . . 75.319999999999993 111.615 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -118.81 33.11 5.79 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.786 2.034 . . . . 61.340000000000003 107.264 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.49 -85.45 1.23 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 126.102 1.811 . . . . 53.229999999999997 109.73 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -150.95 68.33 0.94 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.656 -1.239 . . . . 62.109999999999999 107.656 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -143.04 32.71 1.37 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.194 0.998 . . . . 75.540000000000006 111.444 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.25 155.74 46.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.86 1.264 . . . . 74.430000000000007 113.369 -164.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.93 135.08 34.21 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.897 1.279 . . . . 62.210000000000001 112.739 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -80.73 144.48 32.15 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.941 0.896 . . . . 71.230000000000004 108.864 163.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.34 166.01 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 104.709 -2.33 . . . . 74.329999999999998 104.709 160.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -151.93 140.26 20.45 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 119.368 -2.083 . . . . 72.329999999999998 106.588 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.6 140.99 39.77 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.718 1.207 . . . . 65.120000000000005 108.68 167.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.55 132.44 54.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.582 1.953 . . . . 55.549999999999997 106.986 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -111.21 62.43 0.61 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.897 1.279 . . . . 45.049999999999997 110.752 -169.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -81.97 63.37 6.17 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.051 1.34 . . . . 61.240000000000002 109.633 -168.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -141.48 174.69 10.32 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.181 1.393 . . . . 54.109999999999999 111.39 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -94.02 14.54 19.47 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.356 1.863 . . . . 60.409999999999997 113.71 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -134.81 170.23 16.16 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.948 0.899 . . . . 73.120000000000005 110.368 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -92.83 157.16 16.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.277 1.831 . . . . 63.420000000000002 109.431 165.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.08 156.55 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.361 1.464 . . . . 74.450000000000003 108.497 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.72 23.19 1.0 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.488 0.921 . . . . 72.439999999999998 113.488 -166.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -179.75 58.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.459 -0.941 . . . . 73.109999999999999 108.459 -166.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.0 mt -90.84 110.4 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 105.678 -1.971 . . . . 62.520000000000003 105.678 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 138.06 43.13 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.832 -1.544 . . . . 71.209999999999994 106.832 163.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.5 t -130.1 138.62 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 N-CA-C 105.889 -1.893 . . . . 51.439999999999998 105.889 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.7 m -151.97 135.91 16.45 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.52 -1.659 . . . . 71.25 106.52 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -143.56 21.84 1.83 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.852 0.861 . . . . 45.310000000000002 112.009 -169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.05 -153.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.667 1.987 . . . . 73.239999999999995 109.465 176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.8 11.84 30.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.915 1.286 . . . . 63.329999999999998 113.515 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.21 -11.68 0.02 OUTLIER Glycine 0 CA--C 1.545 1.938 0 N-CA-C 116.849 1.5 . . . . 71.420000000000002 116.849 171.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -72.08 109.1 5.65 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.753 1.621 . . . . 63.409999999999997 109.297 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -149.99 158.48 44.21 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.362 1.065 . . . . 73.209999999999994 109.466 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.78 179.53 7.94 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.528 1.531 . . . . 74.510000000000005 108.522 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -128.85 131.24 47.66 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 122.491 0.316 . . . . 61.130000000000003 111.241 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.58 135.74 26.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.541 -1.651 . . . . 75.150000000000006 106.541 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -57.99 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.826 1.329 . . . . 61.229999999999997 108.742 171.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.4 m -145.11 155.25 43.21 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.135 -1.061 . . . . 40.039999999999999 108.135 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 43' ' ' ASP . 1.8 tp -148.13 111.15 4.84 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.376 1.87 . . . . 62.240000000000002 106.203 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 172.53 19.28 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.453 1.025 . . . . 24.41 110.954 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.35 130.14 45.33 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.308 -1.113 . . . . 53.119999999999997 108.798 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 53.63 19.56 1.83 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.242 2.217 . . . . 52.409999999999997 114.146 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HG ' ' A' ' 39' ' ' LEU . 18.2 t0 -71.33 169.57 14.99 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.63 1.205 . . . . 74.25 110.129 166.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.2 p -159.72 163.59 34.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.363 -1.29 . . . . 34.509999999999998 111.228 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.0 tt -158.59 135.78 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 123.106 0.562 . . . . 75.150000000000006 109.845 172.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -105.16 105.93 16.19 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.834 2.054 . . . . 73.209999999999994 108.141 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -123.47 153.9 39.85 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.492 -1.231 . . . . 74.129999999999995 111.109 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.3 t -84.54 -178.99 7.05 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.63 1.572 . . . . 44.43 112.066 -168.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -128.21 153.8 46.52 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.602 1.561 . . . . 43.140000000000001 108.517 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.04 25.77 0.09 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.002 0.921 . . . . 52.109999999999999 112.39 166.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.92 153.78 42.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.686 1.195 . . . . 65.450000000000003 109.608 -169.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.45 -32.59 8.61 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.15 -0.932 . . . . 71.25 111.607 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 p -151.54 151.99 32.33 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.042 0.921 . . . . 73.219999999999999 109.112 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.3 t -124.38 139.06 51.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 125.782 1.633 . . . . 42.43 106.611 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.29 6.05 3.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.754 0.822 . . . . 62.520000000000003 112.819 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -150.6 149.29 29.7 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 126.951 2.1 . . . . 71.540000000000006 107.5 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.4 ttm -148.15 130.36 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.516 -0.92 . . . . 72.530000000000001 108.516 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.89 104.03 9.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.872 -1.899 . . . . 62.329999999999998 105.872 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.18 143.57 12.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.988 -1.115 . . . . 74.109999999999999 107.988 173.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.2 122.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.18 -2.156 . . . . 34.299999999999997 105.18 170.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.79 28.58 Favored Glycine 0 CA--C 1.518 0.251 0 N-CA-C 110.35 -1.1 . . . . 74.439999999999998 110.35 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 m -142.12 139.0 32.04 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.598 -0.942 . . . . 72.150000000000006 110.21 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.6 p -74.53 173.8 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.604 1.562 . . . . 73.319999999999993 111.754 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -50.09 -41.56 48.44 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.594 1.558 . . . . 73.430000000000007 111.643 168.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -78.57 -3.75 45.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.164 0.586 . . . . 75.120000000000005 111.582 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.92 80.8 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.147 -1.363 . . . . 53.25 112.309 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.88 132.02 41.16 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 120.364 2.082 . . . . 51.420000000000002 107.527 173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.954 -1.128 . . . . 73.530000000000001 107.954 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -136.74 150.28 48.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 124.555 1.142 . . . . 72.140000000000001 108.236 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 73.5 p -138.38 158.68 43.82 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.848 0.459 . . . . 71.239999999999995 110.754 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.83 -69.26 0.7 Allowed Glycine 0 C--O 1.226 -0.366 0 C-N-CA 124.19 0.9 . . . . 72.310000000000002 111.233 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 46.64 82.75 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.549 1.94 . . . . 72.510000000000005 111.928 -172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.33 153.11 34.53 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.44 1.496 . . . . 61.43 109.836 -173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 165.32 26.32 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.035 1.734 . . . . 71.340000000000003 107.665 172.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.12 58.09 13.1 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 125.244 1.402 . . . . 73.439999999999998 113.201 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 149.92 21.16 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.425 -1.324 . . . . 63.409999999999997 107.425 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.79 175.99 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.441 1.496 . . . . 54.210000000000001 109.464 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.8 52.08 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.383 -1.487 . . . . 51.340000000000003 109.383 -173.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.24 35.29 3.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.198 0.999 . . . . 53.43 110.858 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -149.61 168.01 24.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.887 1.675 . . . . 54.119999999999997 107.644 161.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.48 92.4 2.36 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.085 -1.08 . . . . 62.140000000000001 108.085 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -99.64 153.99 18.63 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 120.88 -1.138 . . . . 54.420000000000002 108.491 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.13 110.68 15.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 124.479 1.112 . . . . 75.129999999999995 108.955 -170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -93.47 93.88 8.37 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 107.273 -1.38 . . . . 75.530000000000001 107.273 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.6 120.97 20.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 104.238 -2.504 . . . . 71.239999999999995 104.238 162.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -161.13 176.27 11.48 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.826 2.45 . . . . 63.119999999999997 105.404 175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.59 173.4 6.34 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.426 0.69 . . . . 73.209999999999994 109.394 -171.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -150.41 179.08 8.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.671 -0.862 . . . . 64.349999999999994 108.671 171.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 57.27 -77.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.773 3.229 . . . . 54.520000000000003 112.899 172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.52 49.4 1.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.691 1.596 . . . . 74.349999999999994 109.532 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.8 22.17 10.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.525 1.13 . . . . 64.109999999999999 112.691 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -71.0 138.28 49.77 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.531 1.532 . . . . 74.510000000000005 108.366 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.43 105.41 6.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 118.536 0.607 . . . . 74.120000000000005 110.911 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -94.81 -171.77 2.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.124 1.37 . . . . 62.240000000000002 108.544 170.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.4 t -135.69 142.89 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 105.18 -2.156 . . . . 74.219999999999999 105.18 158.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -129.16 171.07 12.78 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.318 1.447 . . . . 73.540000000000006 108.867 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 97' ' ' ILE . 5.0 pt -152.58 143.94 16.11 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 124.553 1.141 . . . . 71.140000000000001 108.221 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.91 132.17 21.0 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.157 -1.516 . . . . 60.420000000000002 108.157 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -139.0 -177.05 4.71 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 126.514 1.925 . . . . 74.329999999999998 109.474 -173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.82 -82.77 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.686 -2.166 . . . . 65.519999999999996 107.686 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -78.46 77.4 4.95 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.779 -0.823 . . . . 60.43 108.779 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.9 tt -126.81 110.75 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 125.196 1.398 . . . . 71.519999999999996 108.248 172.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.171 0 C-N-CA 127.389 2.275 . . . . 54.420000000000002 115.953 146.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.145 0 CA-C-O 118.846 -0.974 . . . . 73.439999999999998 115.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.15 177.27 8.71 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.847 1.824 . . . . 42.240000000000002 107.983 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.4 -69.47 0.36 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.524 -1.288 . . . . 72.510000000000005 107.524 159.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.39 19.65 2.06 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.027 0.931 . . . . 71.319999999999993 111.575 -168.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.21 -62.89 3.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.591 1.567 . . . . 73.430000000000007 114.923 -168.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -143.7 36.3 1.3 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.35 1.075 . . . . 64.310000000000002 111.1 -172.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.63 24.39 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.843 1.423 . . . . 71.340000000000003 114.843 -158.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.1 p -132.5 163.95 27.67 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.792 1.637 . . . . 73.540000000000006 111.73 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 168.61 15.09 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.813 0.845 . . . . 64.230000000000004 111.623 170.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -132.66 160.53 36.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.245 -0.65 . . . . 43.219999999999999 109.245 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.25 151.66 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.3 1.84 . . . . 74.409999999999997 106.385 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.7 ttm180 -142.59 131.73 23.25 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.489 -0.93 . . . . 74.140000000000001 108.489 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.51 134.47 45.8 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.14 -1.43 . . . . 61.420000000000002 107.14 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.6 mp -129.89 126.93 63.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.19 1.396 . . . . 60.340000000000003 107.349 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.621 ' HB2' HD12 ' A' ' 39' ' ' LEU . 56.5 t30 -101.77 67.99 1.13 Allowed 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 124.102 0.961 . . . . 55.350000000000001 110.264 -171.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -83.61 48.64 1.45 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.298 1.039 . . . . 72.319999999999993 110.846 -166.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.5 p -132.58 175.69 9.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.613 1.565 . . . . 75.349999999999994 111.495 -167.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.5 26.61 3.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.354 1.461 . . . . 73.230000000000004 113.104 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -144.09 168.15 20.7 Favored 'General case' 0 C--O 1.232 0.139 0 O-C-N 120.69 -1.256 . . . . 75.140000000000001 111.924 177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -93.82 148.08 22.46 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.74 1.216 . . . . 75.530000000000001 109.92 168.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.4 m -128.73 148.0 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 123.849 0.86 . . . . 64.519999999999996 109.56 170.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -137.51 23.35 2.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.441 0.696 . . . . 75.239999999999995 112.584 -168.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.441 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -179.78 76.63 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 104.859 -2.274 . . . . 73.349999999999994 104.859 -178.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.39 120.66 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.49 -1.671 . . . . 74.329999999999998 106.49 162.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -102.01 148.51 25.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.362 1.865 . . . . 75.319999999999993 106.836 170.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.46 145.56 28.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 116.936 -1.507 . . . . 71.109999999999999 107.992 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 m -129.84 114.61 16.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.999 1.272 . . . . 75.129999999999995 109.49 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 41.7 p90 -107.8 18.82 20.88 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.506 1.522 . . . . 72.439999999999998 113.143 -171.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -164.62 -165.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.63 -1.248 . . . . 75.140000000000001 107.63 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -78.08 70.86 4.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.94 -0.763 . . . . 75.430000000000007 108.94 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.88 -26.0 8.16 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.248 1.404 . . . . 40.509999999999998 113.669 173.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -61.5 106.26 0.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.699 1.749 . . . . 75.519999999999996 110.342 -177.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 25' ' ' LYS . 5.0 pt-20 -136.48 161.93 34.49 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.063 0.945 . . . . 75.409999999999997 111.989 -176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -157.64 171.14 20.86 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.589 1.956 . . . . 74.109999999999999 109.438 171.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 t -141.6 158.8 43.38 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.856 0.862 . . . . 53.409999999999997 110.699 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.12 167.66 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 126.616 1.966 . . . . 75.439999999999998 107.857 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -64.66 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.949 0.9 . . . . 74.299999999999997 110.008 161.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.8 m -143.41 160.73 40.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.785 1.634 . . . . 72.409999999999997 107.663 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -136.17 115.42 12.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.435 1.894 . . . . 71.510000000000005 108.591 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.28 168.67 20.21 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 125.934 1.73 . . . . 53.310000000000002 112.859 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -68.93 126.98 31.5 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.971 -1.311 . . . . 64.329999999999998 108.821 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 49.27 40.83 19.06 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.793 1.637 . . . . 73.549999999999997 111.979 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.457 ' CB ' HD13 ' A' ' 39' ' ' LEU 0.283 29.9 m-20 -94.76 174.71 6.97 Favored 'General case' 0 C--O 1.239 0.511 0 O-C-N 121.829 -0.544 . . . . 72.349999999999994 111.114 167.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 p -159.3 155.24 26.53 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.112 0.565 . . . . 61.43 111.718 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -149.08 143.97 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.55 1.14 . . . . 44.100000000000001 108.952 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -109.96 149.75 29.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.733 1.213 . . . . 53.210000000000001 109.632 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -146.4 154.2 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.142 0.977 . . . . 72.329999999999998 109.701 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 p -60.11 175.16 0.43 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.851 2.061 . . . . 71.120000000000005 112.334 170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.3 p -141.77 145.91 35.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.968 -1.083 . . . . 64.140000000000001 108.207 171.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -87.21 22.24 2.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 112.749 -164.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.82 158.38 44.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.864 1.666 . . . . 53.020000000000003 109.012 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.78 -34.51 59.34 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-N 115.911 -0.586 . . . . 53.299999999999997 112.13 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.28 166.75 31.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.909 0.883 . . . . 75.5 109.676 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.87 153.76 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.59 1.156 . . . . 73.549999999999997 110.373 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.21 6.4 3.32 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.454 1.902 . . . . 74.409999999999997 112.951 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -148.06 153.96 39.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 120.932 -1.105 . . . . 75.120000000000005 109.458 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.5 tpp -155.86 121.12 4.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.426 -0.953 . . . . 74.310000000000002 108.426 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.1 100.72 9.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.119 -1.808 . . . . 60.549999999999997 106.119 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 t -87.42 141.04 14.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.84 -0.8 . . . . 75.219999999999999 108.84 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -153.73 118.78 5.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.342 -1.725 . . . . 74.340000000000003 106.342 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.08 176.56 22.03 Favored Glycine 0 C--N 1.333 0.37 0 O-C-N 121.215 -0.928 . . . . 75.420000000000002 111.244 175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.441 ' HB ' HD21 ' A' ' 23' ' ' ASN . 10.8 m -133.24 141.71 48.17 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.697 0.799 . . . . 74.230000000000004 109.991 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.592 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.4 p -87.59 172.83 9.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.327 1.851 . . . . 75.129999999999995 111.422 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 1.1 tm0? -52.39 -42.05 63.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.654 1.582 . . . . 73.209999999999994 112.065 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -69.46 -11.15 60.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.853 0.461 . . . . 55.149999999999999 111.123 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.76 18.84 64.79 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 120.978 -1.077 . . . . 73.209999999999994 111.325 -171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -81.88 133.4 35.32 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 118.718 1.259 . . . . 75.340000000000003 108.681 170.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -99.1 139.84 34.14 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.371 -1.344 . . . . 72.409999999999997 107.371 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -134.94 140.23 45.56 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.962 -1.125 . . . . 63.119999999999997 107.962 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.7 p -133.18 155.75 48.75 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.642 0.777 . . . . 73.340000000000003 112.412 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.65 -67.31 0.82 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 124.171 0.891 . . . . 34.399999999999999 112.701 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 51.76 94.08 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.866 2.467 . . . . 63.210000000000001 111.563 -169.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -128.37 145.3 51.12 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.078 0.951 . . . . 75.230000000000004 110.894 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -136.92 174.41 10.65 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.429 1.492 . . . . 63.240000000000002 108.903 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.96 23.86 70.82 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.559 0.599 . . . . 75.319999999999993 113.753 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.23 157.25 23.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.558 0.679 . . . . 75.540000000000006 109.855 -174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.15 177.76 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.086 1.755 . . . . 75.109999999999999 110.288 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.91 170.18 46.23 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.974 1.273 . . . . 73.239999999999995 110.935 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -91.64 3.62 54.62 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.085 1.354 . . . . 64.230000000000004 113.567 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -129.05 152.33 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.365 -0.834 . . . . 75.329999999999998 110.018 168.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -121.69 156.21 33.54 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.334 -1.303 . . . . 62.149999999999999 107.601 168.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -132.91 -176.46 4.12 Favored 'General case' 0 CA--C 1.513 -0.448 0 O-C-N 121.456 -0.778 . . . . 63.210000000000001 110.189 167.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.7 t -144.46 112.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 104.725 -2.324 . . . . 73.439999999999998 104.725 168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -90.37 98.27 11.68 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 105.875 -1.898 . . . . 72.340000000000003 105.875 166.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.2 mt -73.6 120.56 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 103.947 -2.612 . . . . 73.140000000000001 103.947 165.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -155.47 169.24 24.72 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.1 2.56 . . . . 75.519999999999996 105.706 173.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mt -93.55 163.72 13.45 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.224 0.61 . . . . 64.510000000000005 109.83 -172.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -157.17 -170.81 3.39 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.635 -0.666 . . . . 75.310000000000002 109.807 164.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 73.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.893 2.077 . . . . 74.439999999999998 112.577 166.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.44 40.28 1.01 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 127.905 2.482 . . . . 73.450000000000003 108.105 178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 50.51 36.91 14.6 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.8 1.64 . . . . 71.549999999999997 111.969 -168.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.5 161.62 21.18 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.354 -1.35 . . . . 61.409999999999997 107.354 167.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.46 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 116.053 -0.521 . . . . 62.350000000000001 110.357 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -98.44 -165.28 1.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.665 1.186 . . . . 74.209999999999994 108.346 171.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -139.78 138.85 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.245 -1.391 . . . . 74.530000000000001 107.245 168.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -127.1 169.35 13.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.686 1.195 . . . . 72.230000000000004 109.788 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.99 144.25 16.2 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 124.032 0.933 . . . . 74.510000000000005 109.096 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.01 110.23 3.0 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.535 1.49 . . . . 75.25 109.202 166.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -132.75 174.66 10.08 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.589 1.956 . . . . 74.319999999999993 107.941 170.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -176.57 -43.52 0.06 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 111.452 -0.659 . . . . 40.039999999999999 111.452 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -86.39 68.76 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.233 -1.395 . . . . 62.409999999999997 107.233 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 tt -134.34 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 104.843 -2.281 . . . . 72.519999999999996 104.843 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.953 2.101 . . . . 64.519999999999996 108.813 -174.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.52 0 N-CA-C 110.58 -1.008 . . . . 71.120000000000005 110.58 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.89 179.61 1.41 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.692 0.758 . . . . 74.329999999999998 111.68 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.06 -56.67 0.77 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.323 -1.362 . . . . 73.0 107.323 166.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -152.08 9.54 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.025 0.75 . . . . 64.030000000000001 113.025 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.01 42.2 1.58 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.707 1.622 . . . . 62.439999999999998 112.749 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.26 108.22 6.71 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 104.827 -2.286 . . . . 72.030000000000001 104.827 171.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -128.69 31.68 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.815 1.293 . . . . 53.399999999999999 109.478 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.37 179.72 4.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 130.008 3.323 . . . . 64.329999999999998 109.0 -171.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -97.72 -171.73 2.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 109.832 160.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 m -139.07 162.07 35.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.222 -1.77 . . . . 71.010000000000005 106.222 160.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.3 mt -131.1 138.12 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 119.993 1.27 . . . . 64.120000000000005 107.921 173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.1 OUTLIER -130.99 122.69 27.29 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.582 1.153 . . . . 71.450000000000003 110.353 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.27 129.24 55.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.867 1.267 . . . . 62.229999999999997 107.793 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mp -129.66 122.05 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.573 1.149 . . . . 63.109999999999999 109.881 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -83.46 61.79 6.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.346 1.459 . . . . 74.239999999999995 114.047 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -78.13 47.56 0.67 Allowed 'General case' 0 CA--C 1.549 0.934 0 O-C-N 120.559 -1.338 . . . . 64.439999999999998 113.006 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.8 p -126.0 179.39 5.24 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.381 2.272 . . . . 72.150000000000006 111.14 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.83 7.63 26.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.802 1.408 . . . . 64.239999999999995 114.802 172.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -123.26 -169.93 2.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 121.073 1.76 . . . . 65.25 111.962 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -123.49 151.56 42.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 129.904 3.282 . . . . 70.25 107.635 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.78 141.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.594 1.158 . . . . 61.549999999999997 108.788 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -143.62 25.54 1.65 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.994 -1.066 . . . . 74.239999999999995 113.296 -158.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.39 20.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.313 -161.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 24' ' ' ILE . 56.7 mt -64.79 124.22 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 O-C-N 120.387 -1.445 . . . . 64.230000000000004 107.594 -175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.17 128.87 49.97 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.329 -2.101 . . . . 74.049999999999997 105.329 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.73 152.89 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 106.6 -1.63 . . . . 75.150000000000006 106.6 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.05 50.56 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.877 -2.268 . . . . 72.010000000000005 104.877 172.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.2 p90 -136.97 23.53 3.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.476 1.131 . . . . 71.120000000000005 111.763 -176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.24 -177.33 2.83 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.993 -1.067 . . . . 73.010000000000005 108.864 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -82.1 65.28 7.16 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.807 -1.183 . . . . 63.229999999999997 107.807 169.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.99 -4.95 4.66 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.424 -1.209 . . . . 64.420000000000002 115.574 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 123.54 38.51 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 120.719 2.259 . . . . 75.420000000000002 110.415 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.57 175.75 9.3 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.933 1.293 . . . . 72.040000000000006 112.457 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.65 173.47 11.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.969 2.507 . . . . 70.120000000000005 109.147 157.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.7 p -130.26 139.4 50.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.553 1.069 . . . . 75.109999999999999 112.79 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.1 t -86.45 141.69 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.253 -0.904 . . . . 64.239999999999995 109.546 -174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -56.05 -58.04 9.61 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.297 1.039 . . . . 71.549999999999997 112.013 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 30.4 m -161.05 159.26 29.05 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.853 2.461 . . . . 72.109999999999999 107.472 168.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.476 HD11 ' CA ' ' A' ' 44' ' ' SER . 8.3 tp -132.43 105.21 7.13 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.085 1.754 . . . . 72.519999999999996 106.97 167.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.67 -177.56 11.19 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.958 0.789 . . . . 74.109999999999999 112.657 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.5 p -55.04 116.81 2.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.948 1.699 . . . . 62.149999999999999 112.018 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.258 0.7 OUTLIER 59.6 9.24 1.5 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.589 1.556 . . . . 74.109999999999999 114.491 -174.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 175.83 8.25 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.848 0.832 . . . . 71.150000000000006 112.331 -173.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.476 ' CA ' HD11 ' A' ' 39' ' ' LEU . 15.4 p -157.21 162.47 39.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.561 0.949 . . . . 73.25 113.561 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.83 152.79 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 126.66 1.984 . . . . 72.420000000000002 106.004 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -122.66 133.33 54.52 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.485 -1.302 . . . . 50.450000000000003 107.485 162.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -136.65 160.17 39.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.567 1.175 . . . . 54.439999999999998 111.766 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -79.1 155.73 28.61 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.691 1.996 . . . . 63.049999999999997 110.006 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.92 124.1 24.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.291 1.836 . . . . 62.030000000000001 108.074 -174.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.73 43.88 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 128.378 2.671 . . . . 72.209999999999994 111.834 170.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.27 121.59 7.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 73.409999999999997 108.646 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.78 97.77 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.517 1.056 . . . . 32.140000000000001 111.536 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 p -139.11 160.13 40.52 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.462 1.505 . . . . 64.439999999999998 108.638 175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -148.98 155.48 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.259 1.024 . . . . 74.450000000000003 110.284 173.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -134.47 7.93 3.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.192 2.197 . . . . 55.340000000000003 113.114 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 153.02 38.15 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 119.616 -1.928 . . . . 42.109999999999999 109.902 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.2 ttm -148.52 110.9 4.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.328 -0.99 . . . . 70.329999999999998 108.328 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.06 87.76 2.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.465 -1.68 . . . . 63.140000000000001 106.465 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.64 146.67 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.232 -0.655 . . . . 74.439999999999998 109.232 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.65 111.43 1.59 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 108.262 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.23 -167.3 11.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 124.809 1.195 . . . . 72.310000000000002 111.157 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 m -144.38 136.92 26.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 43.020000000000003 109.597 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 p -74.19 175.99 7.03 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 126.611 1.964 . . . . 71.349999999999994 111.239 -177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -54.07 -41.93 68.74 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 110.258 168.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.53 -9.4 58.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.81 1.244 . . . . 73.25 114.264 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.28 9.02 82.71 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.965 -1.084 . . . . 31.140000000000001 111.115 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -73.19 134.01 44.22 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 118.714 1.257 . . . . 61.509999999999998 108.411 170.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -74.57 152.61 39.27 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.591 -1.263 . . . . 55.219999999999999 107.591 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -143.08 156.27 44.78 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.752 1.221 . . . . 75.230000000000004 108.024 170.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.7 p -145.12 158.59 43.78 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.068 0.849 . . . . 63.420000000000002 111.582 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -100.96 -59.0 0.82 Allowed Glycine 0 CA--C 1.524 0.644 0 C-N-CA 123.045 0.355 . . . . 71.510000000000005 112.298 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 49.19 81.9 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.277 2.231 . . . . 72.209999999999994 113.899 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.04 146.34 49.94 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 121.436 -0.79 . . . . 72.040000000000006 111.248 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -138.11 161.9 35.6 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.2 1.0 . . . . 74.340000000000003 111.983 -175.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.07 47.48 8.07 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 127.41 2.433 . . . . 63.32 114.288 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 151.09 40.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.165 1.786 . . . . 51.450000000000003 108.942 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.41 148.91 23.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.334 -0.987 . . . . 53.409999999999997 108.334 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.43 161.73 31.45 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 127.342 2.401 . . . . 74.239999999999995 112.843 175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.4 tttt -78.34 18.93 0.49 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.257 2.223 . . . . 72.140000000000001 113.601 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -158.65 172.34 18.46 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.07 -1.644 . . . . 71.340000000000003 109.421 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -133.6 139.92 46.82 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.099 -1.074 . . . . 71.430000000000007 108.099 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . 78.1 mtt85 -125.38 164.21 20.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.246 -1.02 . . . . 73.150000000000006 108.246 167.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 46.4 t -134.78 111.77 14.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 106.535 -1.654 . . . . 73.129999999999995 106.535 -171.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -99.87 111.38 23.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 106.837 -1.542 . . . . 52.140000000000001 106.837 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mt -83.77 129.47 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 106.116 -1.809 . . . . 65.519999999999996 106.116 172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.3 167.1 23.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.664 1.186 . . . . 73.329999999999998 108.989 174.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.39 159.71 15.84 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.855 -1.535 . . . . 54.229999999999997 106.855 165.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -158.31 -175.59 5.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.674 0.67 . . . . 74.420000000000002 109.771 161.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 73.85 -63.41 0.43 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 129.653 3.181 . . . . 72.510000000000005 111.131 168.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.24 43.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.187 1.395 . . . . 73.25 108.909 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 66.44 24.15 10.44 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.525 1.93 . . . . 50.020000000000003 113.506 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -95.11 151.11 19.48 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.945 -1.502 . . . . 72.25 106.945 176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.81 115.94 14.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 O-C-N 121.98 -0.45 . . . . 61.450000000000003 111.234 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -102.87 -171.33 1.93 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.171 0.988 . . . . 63.229999999999997 108.857 166.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 33.8 t -141.22 142.17 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.573 -2.01 . . . . 73.349999999999994 105.573 171.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -126.31 165.72 18.47 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.129 1.771 . . . . 74.549999999999997 107.204 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 82' ' ' ARG . 3.7 pt -147.84 144.58 19.3 Favored Pre-proline 0 N--CA 1.445 -0.7 0 O-C-N 121.293 -0.88 . . . . 62.549999999999997 110.189 174.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -70.84 124.62 10.8 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 N-CA-C 107.167 -1.897 . . . . 70.430000000000007 107.167 166.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -137.05 -170.12 2.64 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.577 2.351 . . . . 71.349999999999994 106.731 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.19 -78.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 107.265 -2.334 . . . . 71.040000000000006 107.265 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -75.53 20.53 0.16 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 71.010000000000005 114.219 -169.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.9 tt -64.65 93.14 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 126.358 1.863 . . . . 74.129999999999995 109.087 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 113.454 -1.703 . . . . 73.019999999999996 109.692 149.527 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.65 0 N-CA-C 110.349 -1.1 . . . . 61.009999999999998 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.15 34.96 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.085 1.754 . . . . 74.129999999999995 112.105 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 75.25 -12.98 0.9 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.762 2.425 . . . . 63.109999999999999 111.695 -161.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -149.04 95.38 2.38 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 104.375 -2.454 . . . . 72.329999999999998 104.375 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -149.54 78.19 0.22 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.942 -1.663 . . . . 71.120000000000005 108.942 -161.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -135.1 24.72 3.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.038 0.535 . . . . 72.239999999999995 112.292 -169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -88.17 59.02 5.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 122.25 1.024 . . . . 65.420000000000002 108.634 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 p -85.46 172.46 10.99 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 126.815 2.046 . . . . 45.43 110.96 169.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.432 HG21 HG12 ' A' ' 54' ' ' VAL . 0.8 OUTLIER -90.94 166.56 12.97 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.016 -0.993 . . . . 61.32 109.555 164.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m -141.99 135.5 29.36 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.295 -1.372 . . . . 74.129999999999995 107.295 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 22.8 mt -119.3 144.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.274 -1.38 . . . . 65.150000000000006 107.274 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 123.62 21.69 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 108.902 -0.777 . . . . 64.310000000000002 108.902 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.0 mm? -112.65 104.81 12.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.318 1.047 . . . . 72.049999999999997 111.173 -167.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.72 130.85 53.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 124.598 1.159 . . . . 62.25 108.808 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -99.1 70.01 1.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.15 0.98 . . . . 64.319999999999993 111.75 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -87.26 56.21 3.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.871 -1.143 . . . . 72.329999999999998 110.736 -167.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.95 164.59 29.86 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.518 1.127 . . . . 70.25 111.81 -164.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.16 7.02 4.57 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.935 1.694 . . . . 73.25 114.709 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.64 174.02 10.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.703 0.801 . . . . 70.409999999999997 111.004 -174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -99.57 158.25 15.88 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.542 1.937 . . . . 74.450000000000003 109.468 163.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.666 HG23 HD11 ' A' ' 24' ' ' ILE . 4.4 m -139.97 147.36 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.258 1.423 . . . . 73.109999999999999 109.052 175.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -146.86 22.77 1.24 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.829 1.048 . . . . 62.140000000000001 113.829 -162.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.59 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -168.0 43.82 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.703 1.201 . . . . 73.120000000000005 111.351 -179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.666 HD11 HG23 ' A' ' 21' ' ' VAL . 3.0 mp -78.85 118.25 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 109.308 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.45 141.19 29.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 128.687 2.795 . . . . 70.140000000000001 108.077 164.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.88 119.3 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 116.551 -1.69 . . . . 72.019999999999996 107.623 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.85 145.04 47.03 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 121.275 1.852 . . . . 64.109999999999999 109.507 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -145.41 22.26 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 O-C-N 120.916 -1.115 . . . . 65.129999999999995 112.741 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -173.76 -174.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 126.998 2.119 . . . . 52.329999999999998 107.026 -177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -79.36 -11.52 59.93 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.141 0.882 . . . . 53.219999999999999 112.911 -174.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -159.26 21.88 0.29 Allowed Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.544 -1.142 . . . . 74.120000000000005 113.828 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -113.37 118.89 35.82 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 119.416 1.608 . . . . 72.030000000000001 107.565 170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 175.24 9.72 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.756 1.285 . . . . 73.319999999999993 110.272 163.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -141.58 178.46 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.064 1.346 . . . . 73.150000000000006 108.102 152.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -130.29 147.51 52.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.412 1.085 . . . . 73.340000000000003 108.605 176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.8 t -94.74 156.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.252 -1.388 . . . . 53.350000000000001 107.252 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.21 -85.2 0.02 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.517 0.599 . . . . 74.25 110.323 168.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.1 m -148.48 156.43 42.46 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.207 1.403 . . . . 65.450000000000003 107.571 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.53 107.5 5.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.768 1.627 . . . . 44.140000000000001 107.359 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.62 179.13 8.0 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.943 1.735 . . . . 32.219999999999999 113.34 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -65.12 125.19 24.18 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.559 -1.554 . . . . 62.520000000000003 109.163 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 57.25 20.47 5.78 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.692 1.597 . . . . 72.549999999999997 113.713 -173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.57 168.06 6.42 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.676 1.226 . . . . 72.150000000000006 110.258 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.3 p -166.33 154.93 10.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.585 -1.643 . . . . 74.340000000000003 111.523 -172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -179.48 141.98 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.401 2.281 . . . . 73.319999999999993 107.074 -164.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -120.36 142.99 48.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.676 1.99 . . . . 70.109999999999999 106.335 -177.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -138.68 136.31 35.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.773 0.797 . . . . 50.539999999999999 110.539 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.9 t -62.82 149.79 43.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.556 1.142 . . . . 72.310000000000002 109.805 174.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 103.34 5.4 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.312 -1.736 . . . . 63.439999999999998 106.312 -165.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -57.89 -17.11 14.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.39 1.876 . . . . 72.409999999999997 115.166 -164.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.28 141.82 47.2 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.915 1.286 . . . . 61.009999999999998 109.103 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.3 -19.07 78.75 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 119.626 -0.541 . . . . 54.310000000000002 112.446 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 m -146.38 164.06 33.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.946 1.298 . . . . 74.150000000000006 108.153 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG12 HG21 ' A' ' 9' ' ' THR . 1.6 p -131.15 140.95 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.437 1.095 . . . . 72.319999999999993 109.949 158.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 76' ' ' LEU . 2.7 p90 -122.22 -8.83 8.69 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.463 2.305 . . . . 73.409999999999997 112.557 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.23 147.65 31.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.262 1.392 . . . . 74.049999999999997 111.253 172.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 47.6 ttm -132.61 141.62 48.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 108.415 -0.957 . . . . 53.329999999999998 108.415 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.24 117.54 13.61 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.287 -2.486 . . . . 64.109999999999999 104.287 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.5 160.86 14.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.579 -0.737 . . . . 70.340000000000003 110.127 174.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.92 128.13 8.34 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.763 -1.569 . . . . 74.310000000000002 106.763 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.27 174.04 25.46 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 109.708 -1.357 . . . . 61.310000000000002 109.708 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.59 ' HB ' HD21 ' A' ' 23' ' ' ASN . 23.1 m -142.99 138.39 30.02 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 121.587 -0.949 . . . . 70.450000000000003 109.956 -176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.531 ' HA ' HG12 ' A' ' 21' ' ' VAL . 19.1 p -79.91 172.49 13.7 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.64 1.576 . . . . 43.130000000000003 113.002 -170.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.414 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -53.75 -36.72 62.63 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.589 1.556 . . . . 72.430000000000007 111.043 168.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.52 -3.95 54.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.345 1.058 . . . . 72.030000000000001 112.695 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.64 5.03 82.27 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.508 -1.162 . . . . 70.420000000000002 113.485 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -76.49 143.93 40.15 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 119.691 1.745 . . . . 65.109999999999999 107.216 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -100.14 148.13 24.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.502 -1.296 . . . . 72.230000000000004 107.502 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -130.73 147.36 52.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.714 -1.13 . . . . 73.049999999999997 108.35 170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.68 152.2 48.01 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.748 0.819 . . . . 54.509999999999998 109.681 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.67 -73.28 1.28 Allowed Glycine 0 CA--C 1.524 0.641 0 CA-C-O 121.888 0.716 . . . . 71.450000000000003 112.508 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 44.77 89.29 0.01 OUTLIER 'General case' 0 C--O 1.235 0.297 0 C-N-CA 130.048 3.339 . . . . 71.319999999999993 113.405 -169.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -124.9 140.55 52.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 126.118 1.767 . . . . 72.319999999999993 109.83 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -135.66 161.83 34.43 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.466 1.506 . . . . 70.340000000000003 108.558 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 66.07 52.09 39.71 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 124.062 0.839 . . . . 74.120000000000005 112.269 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 55' ' ' TYR . 0.4 OUTLIER -88.15 142.5 27.71 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.956 -1.128 . . . . 73.129999999999995 107.956 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.6 160.97 24.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.86 1.264 . . . . 74.319999999999993 110.624 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.34 163.89 31.71 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 110.433 -1.067 . . . . 70.040000000000006 110.433 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 ttpt -106.75 20.84 18.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.199 1.4 . . . . 74.010000000000005 111.406 -171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -139.64 166.85 23.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 126.371 1.869 . . . . 74.019999999999996 107.946 163.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.6 m -152.03 151.15 30.77 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.139 -1.8 . . . . 53.119999999999997 106.139 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.569 ' O ' HG22 ' A' ' 97' ' ' ILE . 3.7 mtt-85 -132.43 165.81 23.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 107.642 -1.244 . . . . 72.439999999999998 107.642 169.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 13' ' ' LEU . 48.0 t -128.64 122.42 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.221 -1.399 . . . . 72.420000000000002 107.221 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -106.0 95.65 5.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.637 -1.616 . . . . 73.129999999999995 106.637 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 30.7 mt -72.24 129.82 35.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.294 -2.113 . . . . 74.239999999999995 105.294 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -146.28 179.97 7.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.14 2.576 . . . . 74.329999999999998 108.46 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.1 mt -104.71 178.03 4.68 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.815 1.246 . . . . 73.439999999999998 110.653 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.99 -177.23 3.28 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.46 1.504 . . . . 70.129999999999995 111.607 175.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -58.31 -37.62 75.43 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.558 1.143 . . . . 73.109999999999999 112.848 -167.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -102.82 38.27 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.863 0.865 . . . . 65.230000000000004 109.986 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.89 29.36 18.93 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.746 1.219 . . . . 70.140000000000001 111.874 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -81.65 172.72 13.09 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.25 1.82 . . . . 73.129999999999995 108.497 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.7 t -118.95 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 120.199 1.363 . . . . 52.109999999999999 110.267 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -118.53 -164.66 1.05 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.757 1.623 . . . . 64.129999999999995 108.023 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 t -142.93 135.73 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 106.315 -1.735 . . . . 71.420000000000002 106.315 170.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -125.34 172.07 9.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.217 1.407 . . . . 73.109999999999999 109.826 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -154.28 144.32 15.57 Favored Pre-proline 0 N--CA 1.452 -0.364 0 C-N-CA 124.421 1.088 . . . . 65.430000000000007 110.787 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 86.75 1.22 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.43 2.087 . . . . 74.150000000000006 109.787 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -86.81 -159.79 0.53 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.055 -1.091 . . . . 71.209999999999994 108.055 165.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 163.76 -22.85 0.17 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-O 119.042 -0.865 . . . . 32.210000000000001 113.573 171.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -119.4 76.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.53 -2.026 . . . . 71.239999999999995 105.53 171.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.8 tt -142.59 111.33 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 125.147 1.379 . . . . 73.109999999999999 107.559 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 C--O 1.249 1.048 0 C-N-CA 124.904 1.282 . . . . 62.149999999999999 107.656 177.632 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 108.462 -1.855 . . . . 52.329999999999998 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.27 152.0 43.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.222 1.409 . . . . 71.049999999999997 107.673 172.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.8 tp60 -92.31 0.04 57.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.814 0.845 . . . . 74.129999999999995 110.956 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -155.83 102.28 2.18 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 103.874 -2.639 . . . . 52.140000000000001 103.874 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.81 -119.3 1.93 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 109.993 -1.243 . . . . 72.329999999999998 109.993 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -143.3 84.37 1.81 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.372 -1.344 . . . . 74.019999999999996 107.372 168.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -152.94 24.51 0.56 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.033 1.123 . . . . 73.349999999999994 114.033 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -71.55 161.17 31.43 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.653 1.215 . . . . 75.319999999999993 111.711 177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -82.51 -176.46 6.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.035 1.734 . . . . 64.010000000000005 110.791 164.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.5 m -127.79 155.89 43.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.559 -1.2 . . . . 41.149999999999999 109.01 164.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.0 mt -126.45 145.88 33.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.424 -2.065 . . . . 63.340000000000003 105.424 163.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.66 ' HD2' HD11 ' A' ' 14' ' ' ILE . 4.2 ttm-85 -142.93 118.83 10.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.072 -0.714 . . . . 55.329999999999998 109.072 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -94.84 133.75 38.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 118.172 -0.918 . . . . 64.310000000000002 108.912 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.66 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.7 mp -125.88 125.6 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.899 1.28 . . . . 73.430000000000007 109.39 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -96.41 53.92 1.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.798 1.239 . . . . 74.439999999999998 113.241 -168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -69.97 2.04 3.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.047 1.339 . . . . 43.439999999999998 114.155 -166.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.81 -173.42 0.62 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.193 2.197 . . . . 63.340000000000003 112.892 168.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.5 3.66 53.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.109 2.164 . . . . 75.340000000000003 116.011 -178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 -172.94 2.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.649 1.113 . . . . 75.200000000000003 112.217 -169.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -109.08 150.81 27.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.227 1.811 . . . . 63.299999999999997 107.965 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 m -139.1 137.15 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.182 -1.044 . . . . 64.310000000000002 108.182 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 17.83 2.63 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 123.344 1.545 . . . . 73.5 112.183 -160.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -169.01 42.47 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.886 1.274 . . . . 61.130000000000003 109.946 -162.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.492 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.05 109.36 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 106.492 -1.67 . . . . 70.439999999999998 106.492 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.1 OUTLIER -76.43 134.24 39.64 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.191 -1.781 . . . . 62.340000000000003 106.191 162.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 47' ' ' PHE . 9.5 p -131.99 144.45 37.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.207 -1.405 . . . . 74.549999999999997 107.207 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.417 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 18.2 m -136.18 139.85 43.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.447 -1.686 . . . . 72.519999999999996 106.447 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -139.33 14.23 2.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.212 1.405 . . . . 71.049999999999997 111.376 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.76 -169.92 3.35 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 120.541 -1.35 . . . . 64.219999999999999 107.425 169.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -77.83 76.36 4.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.155 -1.424 . . . . 74.109999999999999 107.155 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.11 2.67 59.18 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.298 -1.279 . . . . 61.039999999999999 114.922 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -78.84 113.46 16.94 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.652 2.226 . . . . 74.430000000000007 106.329 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.52 161.91 40.15 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.96 1.304 . . . . 71.040000000000006 109.8 -171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -152.54 174.84 13.43 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.627 1.571 . . . . 71.430000000000007 108.624 164.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -123.48 144.26 49.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 119.028 0.831 . . . . 73.319999999999993 110.333 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.01 169.77 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.265 -1.013 . . . . 61.240000000000002 108.265 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -70.84 -85.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.901 0.773 . . . . 72.319999999999993 109.585 164.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.9 m -151.9 158.11 42.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.589 1.556 . . . . 73.540000000000006 108.159 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.1 tp -142.63 113.0 7.22 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.391 1.877 . . . . 75.409999999999997 107.263 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.27 179.91 51.33 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 124.75 1.167 . . . . 73.439999999999998 110.813 174.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 m -56.44 130.07 43.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.018 0.909 . . . . 74.230000000000004 109.263 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.55 1.6 0.59 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.898 1.679 . . . . 73.319999999999993 114.972 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.06 172.1 6.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 120.347 1.431 . . . . 75.230000000000004 111.127 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.6 p -156.77 161.41 39.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.053 -0.976 . . . . 74.430000000000007 112.908 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 tp -151.22 146.63 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 C-N-CA 127.197 2.199 . . . . 62.229999999999997 105.413 -174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.05 148.88 50.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 123.937 0.895 . . . . 73.530000000000001 108.795 169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 2.9 p90 -147.31 144.97 29.18 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 113.718 -1.583 . . . . 74.540000000000006 109.876 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.34 123.03 22.18 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.648 1.179 . . . . 75.540000000000006 108.529 171.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.06 134.57 35.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.153 1.781 . . . . 62.149999999999999 108.716 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.91 32.23 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.47 1.108 . . . . 73.329999999999998 113.894 -165.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -144.15 142.6 30.66 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.793 -1.558 . . . . 55.439999999999998 106.793 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.49 -9.71 74.07 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 118.752 0.705 . . . . 75.109999999999999 113.635 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 p -150.58 162.43 40.66 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.022 1.329 . . . . 64.310000000000002 109.398 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.72 159.42 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 127.612 2.365 . . . . 44.329999999999998 109.518 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.38 5.19 1.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.52 1.928 . . . . 75.239999999999995 112.447 172.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.46 153.32 50.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 125.085 1.354 . . . . 64.120000000000005 108.868 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.8 ttm -149.38 122.79 9.06 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.787 -1.19 . . . . 72.239999999999995 107.787 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -124.78 76.55 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 122.855 1.312 . . . . 74.109999999999999 107.862 -167.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.75 150.92 4.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.027 1.331 . . . . 61.549999999999997 110.44 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.804 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -156.63 138.64 14.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.777 0.831 . . . . 44.399999999999999 108.879 170.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.86 -173.43 29.45 Favored Glycine 0 CA--C 1.524 0.618 0 O-C-N 121.355 -0.841 . . . . 63.100000000000001 112.323 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.43 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 1.4 m -134.66 139.2 45.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.512 1.525 . . . . 51.039999999999999 108.674 -174.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HG2' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -76.4 -178.14 4.46 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 121.707 2.049 . . . . 73.129999999999995 110.556 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -55.62 5.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.397 1.879 . . . . 64.129999999999995 108.971 163.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.7 -2.04 24.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.935 1.694 . . . . 71.120000000000005 113.405 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.85 5.48 64.38 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.324 -1.265 . . . . 33.149999999999999 113.3 171.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' HG2' HG23 ' A' ' 63' ' ' THR . 2.6 pt-20 -83.22 150.68 26.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.825 1.813 . . . . 74.519999999999996 109.28 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -107.8 136.85 46.84 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.673 0.789 . . . . 74.319999999999993 110.413 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -130.79 157.56 42.53 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.77 2.028 . . . . 74.230000000000004 109.741 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.804 HG22 ' HB ' ' A' ' 60' ' ' THR . 16.2 p -150.69 155.91 40.26 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.221 1.408 . . . . 61.240000000000002 111.007 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.63 -73.45 1.2 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 123.808 0.718 . . . . 32.43 113.939 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 55.57 82.02 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.092 2.157 . . . . 72.230000000000004 113.369 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -116.16 157.12 25.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.928 1.691 . . . . 54.450000000000003 110.017 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -154.06 171.69 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.815 0.34 . . . . 72.340000000000003 111.817 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.64 30.48 78.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.739 -1.034 . . . . 74.230000000000004 113.451 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.7 mt -70.51 166.67 20.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.721 1.208 . . . . 73.409999999999997 110.552 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.9 m -148.76 162.57 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 126.195 1.798 . . . . 64.329999999999998 109.869 177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.73 152.84 8.79 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 126.174 1.845 . . . . 74.340000000000003 111.758 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -84.47 20.69 1.63 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.495 0.924 . . . . 61.130000000000003 113.495 -165.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -131.18 163.83 26.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.128 2.171 . . . . 63.229999999999997 109.532 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.11 93.34 2.31 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.869 0.868 . . . . 34.140000000000001 108.923 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.402 ' O ' HG22 ' A' ' 97' ' ' ILE . 71.3 mtt180 -84.86 159.74 20.31 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.073 -1.017 . . . . 60.210000000000001 109.485 172.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.3 t -141.45 104.66 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 105.506 -2.035 . . . . 64.310000000000002 105.506 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -93.34 96.43 9.95 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.122 -1.066 . . . . 74.120000000000005 108.122 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.5 mt -73.4 116.89 16.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.824 -1.917 . . . . 74.120000000000005 105.824 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -142.92 -179.72 6.52 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.076 1.75 . . . . 72.299999999999997 108.493 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.8 153.08 37.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.336 1.054 . . . . 54.140000000000001 110.007 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -155.69 -175.43 5.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.122 0.569 . . . . 64.310000000000002 111.134 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 58.55 -69.88 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 131.565 3.946 . . . . 71.519999999999996 112.723 -172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -130.72 -2.99 4.17 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.757 2.023 . . . . 75.5 111.972 -171.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.59 56.22 0.06 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.729 2.411 . . . . 62.240000000000002 110.154 -159.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.28 164.47 11.77 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.8 -1.926 . . . . 62.229999999999997 105.8 156.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -84.42 117.27 29.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.315 -0.402 . . . . 72.530000000000001 110.828 -167.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -108.95 174.34 5.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 122.755 1.264 . . . . 75.340000000000003 111.161 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 t -137.0 100.73 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 103.945 -2.613 . . . . 73.120000000000005 103.945 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -101.83 162.62 12.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.266 -0.879 . . . . 73.340000000000003 109.992 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.2 pt -151.4 144.15 16.75 Favored Pre-proline 0 C--O 1.234 0.268 0 O-C-N 121.944 -0.472 . . . . 75.230000000000004 111.182 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.39 120.53 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.981 2.454 . . . . 42.329999999999998 109.883 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -141.79 -178.2 5.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.916 2.086 . . . . 73.120000000000005 108.419 174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.84 -26.29 7.62 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 118.477 0.581 . . . . 42.439999999999998 113.702 150.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -152.56 73.31 1.02 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.511 -2.033 . . . . 73.409999999999997 105.511 170.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.2 pt -139.84 123.07 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.753 -1.203 . . . . 75.209999999999994 107.753 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.868 2.867 . . . . 74.510000000000005 111.905 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.618 0 N-CA-C 109.654 -1.378 . . . . 73.420000000000002 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 157.77 19.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.358 -0.979 . . . . 73.349999999999994 108.358 163.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -76.55 -72.81 0.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.965 -1.495 . . . . 73.310000000000002 106.965 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -150.58 40.4 0.75 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.939 1.352 . . . . 74.120000000000005 111.006 -166.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.01 12.41 68.46 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 116.937 -2.035 . . . . 54.420000000000002 114.754 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -151.88 44.43 0.74 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 121.309 2.555 . . . . 73.209999999999994 112.107 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -81.98 61.26 5.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 123.124 1.44 . . . . 74.319999999999993 110.16 -173.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 p -133.75 176.76 8.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.431 1.892 . . . . 74.340000000000003 108.878 169.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.04 174.91 5.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.924 1.289 . . . . 74.310000000000002 109.987 172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -148.79 103.34 3.37 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.769 -1.567 . . . . 61.409999999999997 106.769 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.8 mt -94.11 152.96 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 106.062 -1.829 . . . . 61.409999999999997 106.062 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 ttm180 -136.66 129.26 30.42 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.086 -1.079 . . . . 74.049999999999997 108.086 171.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -102.11 132.89 47.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 106.763 -1.569 . . . . 71.409999999999997 106.763 172.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.541 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.9 mp -125.85 127.98 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.67 -0.863 . . . . 64.049999999999997 108.67 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -95.4 67.24 2.91 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.482 1.113 . . . . 61.409999999999997 111.805 -175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.99 46.4 0.9 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.152 -0.967 . . . . 73.129999999999995 110.86 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 p -133.95 -179.75 5.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.633 1.573 . . . . 73.150000000000006 111.868 -165.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 17.5 19.86 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.662 1.585 . . . . 74.430000000000007 113.62 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.54 176.17 8.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.787 1.176 . . . . 72.439999999999998 110.281 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -98.98 156.91 16.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.086 1.354 . . . . 71.129999999999995 108.671 170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.57 143.92 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 124.876 1.27 . . . . 75.510000000000005 107.812 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.3 OUTLIER -136.36 16.85 3.17 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.878 -1.139 . . . . 63.25 113.463 -165.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -170.78 58.81 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.159 -1.052 . . . . 44.329999999999998 108.159 -163.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.5 mm -86.93 111.62 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 O-C-N 120.148 -1.595 . . . . 70.239999999999995 107.571 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' OG1' ' A' ' 27' ' ' THR . 0.0 OUTLIER -77.7 127.57 32.66 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 105.685 -1.969 . . . . 74.340000000000003 105.685 162.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.72 154.62 32.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.885 -1.154 . . . . 73.239999999999995 107.885 164.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 25' ' ' LYS . 5.8 m -139.86 136.96 34.51 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 128.554 2.742 . . . . 74.140000000000001 105.37 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CE2' ' HG3' ' A' ' 32' ' ' LYS . 42.4 p90 -136.43 17.01 3.15 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 123.047 1.403 . . . . 74.219999999999999 111.659 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.27 -162.04 1.08 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.808 -1.552 . . . . 50.350000000000001 106.808 167.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.87 54.6 1.58 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.622 1.556 . . . . 70.319999999999993 112.711 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.18 8.82 24.97 Favored Glycine 0 CA--C 1.526 0.774 0 O-C-N 120.883 -1.136 . . . . 65.510000000000005 113.141 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' HG3' ' CE2' ' A' ' 28' ' ' TRP . 7.5 tppt? -77.03 109.98 11.3 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.862 -1.903 . . . . 73.510000000000005 105.862 162.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.67 160.89 42.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.001 1.321 . . . . 71.530000000000001 111.639 -165.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.78 170.14 23.04 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.778 1.631 . . . . 73.319999999999993 110.037 174.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.9 p -119.71 146.34 45.71 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.898 0.479 . . . . 64.519999999999996 110.408 172.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 m -84.6 167.82 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 123.573 0.749 . . . . 75.519999999999996 110.482 172.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.84 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.738 1.215 . . . . 75.129999999999995 109.089 166.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.7 m -154.72 158.38 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.535 -1.353 . . . . 71.430000000000007 107.986 -167.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.3 tp -142.01 107.78 5.12 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.397 1.879 . . . . 54.420000000000002 107.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.65 -177.7 24.06 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.959 1.742 . . . . 71.230000000000004 111.657 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.0 128.08 34.71 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.061 -1.258 . . . . 72.409999999999997 109.759 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 50.57 26.63 2.51 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.694 1.198 . . . . 73.049999999999997 112.01 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -72.18 173.68 8.23 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.266 1.031 . . . . 61.32 109.604 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.2 p -152.59 162.63 40.97 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.396 -1.275 . . . . 73.219999999999999 110.545 165.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.0 tt -145.37 140.02 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 105.295 -2.113 . . . . 71.150000000000006 105.295 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -122.9 140.91 52.47 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 107.086 -1.45 . . . . 62.310000000000002 107.086 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.39 132.56 23.12 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.344 -1.298 . . . . 44.439999999999998 110.179 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.1 t -61.67 144.69 54.15 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.79 136.12 44.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.383 -0.969 . . . . 73.329999999999998 108.383 -162.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.35 63.85 6.72 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.206 1.003 . . . . 45.240000000000002 110.785 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.85 125.15 5.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.749 -1.204 . . . . 51.409999999999997 107.749 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.02 -22.06 78.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 120.004 -0.331 . . . . 62.210000000000001 112.898 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 146.78 45.26 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.954 -1.869 . . . . 74.129999999999995 105.954 169.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.8 t -130.54 152.39 37.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.283 -1.747 . . . . 72.239999999999995 106.283 166.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -155.96 1.02 0.15 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.332 1.053 . . . . 74.209999999999994 111.865 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.84 150.24 46.99 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.595 1.558 . . . . 70.540000000000006 107.843 171.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.4 ttm -142.98 127.02 17.37 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.456 -1.312 . . . . 72.209999999999994 107.456 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.78 122.34 47.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.086 -1.82 . . . . 70.25 106.086 168.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -113.6 144.26 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.556 1.543 . . . . 73.349999999999994 107.829 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 t -157.01 119.54 3.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.733 -1.581 . . . . 70.530000000000001 106.733 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.04 175.48 21.86 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.584 -1.406 . . . . 64.239999999999995 109.584 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.5 m -136.82 138.25 40.63 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.418 1.087 . . . . 52.149999999999999 109.612 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.8 p -77.9 171.83 14.39 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.88 2.072 . . . . 70.540000000000006 111.78 -174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -55.46 -44.83 76.78 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.406 1.082 . . . . 73.120000000000005 109.985 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -59.59 -16.29 24.56 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.569 1.547 . . . . 53.149999999999999 112.797 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.16 26.54 59.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 118.379 -1.234 . . . . 73.409999999999997 111.464 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.04 156.75 20.96 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 119.024 1.412 . . . . 64.340000000000003 108.946 163.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -122.11 133.78 54.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.579 0.752 . . . . 62.439999999999998 110.831 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -126.32 165.31 19.24 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.987 1.715 . . . . 73.310000000000002 109.209 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.2 p -143.2 163.31 33.27 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.309 1.044 . . . . 71.319999999999993 111.651 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.08 93.84 0.15 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 107.739 -2.144 . . . . 63.299999999999997 107.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 -109.13 107.3 17.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.446 1.123 . . . . 50.210000000000001 108.115 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -126.77 158.46 36.49 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.583 1.953 . . . . 72.299999999999997 111.422 -162.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -141.91 159.29 42.52 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 124.651 1.18 . . . . 74.510000000000005 109.849 -173.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.24 61.59 3.1 Favored Glycine 0 C--O 1.226 -0.394 0 C-N-CA 126.415 1.96 . . . . 44.039999999999999 112.423 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.26 163.3 25.87 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.977 0.911 . . . . 44.210000000000001 108.656 175.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.06 164.91 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 109.662 -0.496 . . . . 70.329999999999998 109.662 171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.66 -84.94 0.09 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.307 0.948 . . . . 64.099999999999994 115.305 -164.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.73 12.73 32.45 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.745 1.017 . . . . 73.209999999999994 113.745 -159.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -143.94 151.19 39.46 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.488 1.915 . . . . 71.329999999999998 109.114 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.45 150.57 37.88 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.927 0.891 . . . . 74.129999999999995 110.243 172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -128.86 168.38 16.01 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.417 -0.957 . . . . 73.329999999999998 108.417 157.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.73 116.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.979 -1.86 . . . . 73.209999999999994 105.979 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.16 101.9 14.42 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.172 -1.418 . . . . 72.120000000000005 107.172 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.07 118.82 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.595 -2.743 . . . . 71.109999999999999 103.595 157.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.77 178.77 9.88 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 126.403 1.881 . . . . 74.230000000000004 107.878 175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.3 mt -112.3 162.98 14.92 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.658 -0.868 . . . . 65.040000000000006 108.658 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -161.02 -163.61 1.06 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.144 1.378 . . . . 65.420000000000002 107.515 168.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 68.16 -69.78 0.14 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 127.708 2.403 . . . . 71.209999999999994 113.526 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -143.64 27.53 1.51 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.795 2.038 . . . . 64.019999999999996 108.987 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 58.73 30.35 19.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.627 1.571 . . . . 52.140000000000001 111.183 -157.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -73.17 143.74 47.13 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.771 -1.196 . . . . 73.140000000000001 107.771 177.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.71 133.56 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.758 -0.83 . . . . 51.030000000000001 108.758 170.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -152.66 -173.09 4.44 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.248 1.419 . . . . 62.119999999999997 110.303 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.37 144.76 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.915 -1.143 . . . . 72.140000000000001 107.915 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -133.68 167.69 20.05 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.13 2.172 . . . . 73.319999999999993 108.169 -175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.67 145.37 22.88 Favored Pre-proline 0 C--O 1.233 0.203 0 O-C-N 121.226 -0.921 . . . . 74.420000000000002 110.659 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.48 116.9 4.63 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.051 3.168 . . . . 51.439999999999998 109.07 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -139.94 -170.26 2.91 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.372 1.469 . . . . 65.310000000000002 109.467 -169.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.08 -59.9 0.07 OUTLIER Glycine 0 C--N 1.334 0.422 0 N-CA-C 109.885 -1.286 . . . . 54.200000000000003 109.885 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.12 65.55 3.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.483 1.513 . . . . 72.209999999999994 109.008 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 pt -117.26 75.61 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 127.074 2.149 . . . . 74.239999999999995 105.783 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.251 1.151 0 C-N-CA 127.91 2.484 . . . . 74.120000000000005 106.118 -168.669 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.824 0 N-CA-C 109.225 -1.55 . . . . 73.430000000000007 109.225 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.23 150.46 45.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 165.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -110.02 -82.45 0.57 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.468 -2.049 . . . . 61.299999999999997 105.468 156.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -147.34 28.38 0.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.54 1.162 . . . . 71.439999999999998 109.792 -165.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.73 -174.92 22.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 126.112 1.815 . . . . 72.099999999999994 109.894 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.41 52.7 1.4 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.771 1.228 . . . . 71.540000000000006 112.377 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -140.82 37.92 1.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.746 -1.221 . . . . 61.299999999999997 109.448 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.85 144.4 32.5 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.674 1.989 . . . . 72.319999999999993 109.26 -171.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -78.67 160.56 27.45 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.846 1.258 . . . . 71.5 112.395 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.97 155.77 27.44 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.587 -1.188 . . . . 70.5 108.81 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -120.15 159.49 21.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.263 -1.754 . . . . 73.230000000000004 106.263 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -138.49 145.09 40.38 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.042 -1.036 . . . . 73.5 108.45 162.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 139.69 45.18 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.675 0.79 . . . . 74.209999999999994 109.431 167.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.58 105.51 6.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.752 1.221 . . . . 71.230000000000004 108.619 -175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -75.69 79.08 2.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 118.294 -0.86 . . . . 72.319999999999993 113.026 177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -90.45 56.96 3.5 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.451 1.932 . . . . 72.140000000000001 111.195 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.3 p -132.89 -178.49 4.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.884 0.85 . . . . 70.120000000000005 111.963 -172.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 10.36 32.76 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.191 1.396 . . . . 74.150000000000006 113.978 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -129.96 173.43 10.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.654 1.116 . . . . 65.230000000000004 110.37 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -93.77 156.37 16.71 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.498 1.519 . . . . 73.209999999999994 108.018 165.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG23 HD11 ' A' ' 24' ' ' ILE . 12.6 m -131.8 145.33 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.412 -0.958 . . . . 52.25 108.412 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.7 OUTLIER -140.28 18.18 2.41 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.119 -0.988 . . . . 63.549999999999997 113.518 -162.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -174.87 48.24 0.01 OUTLIER 'General case' 0 C--O 1.236 0.37 0 O-C-N 122.039 -0.413 . . . . 72.540000000000006 111.344 -159.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 21' ' ' VAL . 3.3 mp -100.51 109.47 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.7 -1.25 . . . . 55.049999999999997 108.841 -167.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tptt -68.89 143.15 54.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 118.864 -0.589 . . . . 72.450000000000003 109.71 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.51 124.83 30.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.615 0 CA-C-O 117.297 -1.335 . . . . 74.099999999999994 110.633 171.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -130.97 129.01 41.57 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.31 1.844 . . . . 72.439999999999998 107.064 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.477 ' HE1' ' H ' ' A' ' 50' ' ' ASP . 47.7 p90 -131.35 15.67 5.02 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.088 1.313 . . . . 74.340000000000003 110.956 -173.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -159.57 -178.09 6.86 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 121.192 -0.943 . . . . 74.409999999999997 108.79 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -78.88 82.58 5.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.008 -1.849 . . . . 64.219999999999999 106.008 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.36 -14.42 43.28 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.261 1.41 . . . . 42.409999999999997 114.733 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -89.38 125.28 35.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.734 2.267 . . . . 75.439999999999998 109.06 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.38 172.63 13.61 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.077 0.951 . . . . 74.239999999999995 109.941 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.94 -179.97 7.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.024 2.53 . . . . 44.030000000000001 109.098 163.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.66 148.75 50.42 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.909 1.231 . . . . 75.510000000000005 110.047 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 74.9 t -94.53 130.26 43.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.322 -0.992 . . . . 52.420000000000002 108.322 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -54.09 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.339 0.121 0 C-N-CA 127.327 2.251 . . . . 74.510000000000005 110.23 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 98.0 m -151.23 143.8 24.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.649 -1.241 . . . . 62.240000000000002 107.649 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 39' ' ' LEU . 11.7 tp -133.44 103.84 6.13 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.99 -1.856 . . . . 74.329999999999998 105.99 -176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.35 171.26 8.42 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 122.377 0.987 . . . . 74.25 112.464 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.3 t -57.6 117.91 4.68 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.04 -1.096 . . . . 71.219999999999999 108.04 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.329 4.8 m-70 66.7 20.64 10.68 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.832 1.653 . . . . 72.340000000000003 114.755 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -87.07 171.56 10.62 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.164 -0.96 . . . . 71.150000000000006 111.625 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.9 p -149.43 158.49 44.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.144 0.978 . . . . 73.319999999999993 112.086 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.6 tt -143.59 143.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 N-CA-C 107.768 -1.197 . . . . 50.329999999999998 107.768 171.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.15 133.4 56.07 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.682 1.593 . . . . 74.329999999999998 108.0 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -141.45 154.32 45.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.417 0.687 . . . . 63.130000000000003 109.826 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -74.13 153.44 39.56 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.157 -0.683 . . . . 74.099999999999994 109.157 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.75 -158.07 0.47 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 106.635 -1.617 . . . . 55.439999999999998 106.635 173.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' H ' ' HE1' ' A' ' 28' ' ' TRP . 22.5 t0 -145.64 57.8 1.24 Allowed 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.93 -1.137 . . . . 54.140000000000001 107.93 171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -173.24 138.72 0.74 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.47 -0.937 . . . . 53.039999999999999 108.47 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.97 -26.39 55.24 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 114.169 0.428 . . . . 54.299999999999997 114.169 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 p -161.12 165.48 29.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.78 1.232 . . . . 63.329999999999998 110.064 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.26 147.15 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.855 2.062 . . . . 61.210000000000001 111.051 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.08 7.76 4.69 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.177 1.791 . . . . 75.409999999999997 112.811 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.54 158.6 43.69 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.379 -1.451 . . . . 74.099999999999994 111.059 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.8 ttm -155.24 125.64 6.81 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.234 0.925 . . . . 75.430000000000007 109.543 176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -128.45 99.47 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.274 -1.38 . . . . 73.120000000000005 107.274 -173.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.1 t -96.53 148.94 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 107.529 -1.286 . . . . 63.299999999999997 107.529 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.6 t -160.27 99.37 1.32 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.871 -1.159 . . . . 61.109999999999999 107.871 175.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.17 -178.94 16.59 Favored Glycine 0 N--CA 1.467 0.725 0 O-C-N 120.932 -1.105 . . . . 52.140000000000001 111.682 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -133.42 140.89 47.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.812 0.845 . . . . 60.520000000000003 111.356 -177.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.452 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 14.2 p -74.52 170.63 15.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 119.104 0.865 . . . . 62.420000000000002 111.796 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.12 -54.69 5.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.736 1.614 . . . . 70.420000000000002 109.555 163.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.8 m -75.53 -8.78 57.63 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.554 0.946 . . . . 75.150000000000006 113.554 -173.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.13 5.28 28.78 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.202 -0.777 . . . . 44.219999999999999 113.195 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -78.24 116.21 18.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.547 1.165 . . . . 72.439999999999998 108.897 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -85.69 127.44 34.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 124.879 1.272 . . . . 75.530000000000001 107.649 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.64 150.86 42.11 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 125.856 1.662 . . . . 73.420000000000002 108.206 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 60' ' ' THR . 57.4 p -141.76 154.38 45.22 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 123.419 0.688 . . . . 63.299999999999997 112.192 173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.37 -84.17 1.77 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.426 -0.806 . . . . 43.409999999999997 112.318 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 65.98 75.97 0.33 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.262 1.825 . . . . 75.200000000000003 111.713 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -114.26 160.58 18.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.984 2.113 . . . . 75.219999999999999 111.044 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -145.36 170.72 15.79 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.062 2.145 . . . . 74.120000000000005 108.465 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.51 78.19 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.607 1.098 . . . . 62.32 114.084 167.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.18 163.1 24.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.232 0.516 . . . . 61.439999999999998 109.946 -173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 m -146.01 170.36 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.704 2.002 . . . . 75.209999999999994 110.46 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.21 170.51 42.64 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.03 1.3 . . . . 45.399999999999999 110.915 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -101.06 29.31 4.71 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.922 -1.34 . . . . 70.329999999999998 110.723 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -165.71 168.76 15.86 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 127.275 2.23 . . . . 74.099999999999994 107.804 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.96 31.18 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.997 2.519 . . . . 64.530000000000001 105.369 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.54 ' O ' HG22 ' A' ' 97' ' ' ILE . 1.4 ptp180 -167.44 174.91 7.56 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.0 -1.111 . . . . 53.340000000000003 108.0 173.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.61 122.5 63.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.226 -1.398 . . . . 74.519999999999996 107.226 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -91.02 115.51 28.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.607 -1.257 . . . . 70.510000000000005 107.607 167.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.48 122.64 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 N-CA-C 106.339 -1.726 . . . . 70.230000000000004 106.339 171.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.11 -175.56 4.94 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.988 1.715 . . . . 74.319999999999993 108.073 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.6 mt -114.51 162.58 16.52 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.169 1.387 . . . . 63.409999999999997 107.943 172.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -152.19 -175.44 5.25 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.525 1.53 . . . . 60.32 107.513 167.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 66.83 -85.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.139 2.576 . . . . 64.140000000000001 108.991 169.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 35.78 1.62 Allowed 'General case' 0 C--O 1.238 0.462 0 C-N-CA 127.452 2.301 . . . . 75.409999999999997 109.54 -167.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.43 32.11 14.62 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.553 2.341 . . . . 73.329999999999998 110.423 -164.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.53 149.8 33.0 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.088 -1.449 . . . . 75.439999999999998 107.088 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -96.63 100.73 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-O 121.631 0.729 . . . . 75.420000000000002 110.515 -166.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -83.89 175.0 9.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 123.629 1.681 . . . . 73.310000000000002 110.977 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.94 136.47 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 113.649 -1.614 . . . . 73.329999999999998 107.098 162.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -139.3 167.81 21.24 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.465 1.106 . . . . 73.400000000000006 109.013 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 82' ' ' ARG . 5.5 pt -152.32 145.2 17.28 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 124.373 1.069 . . . . 74.120000000000005 109.98 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -64.91 123.38 11.54 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.269 1.98 . . . . 71.230000000000004 108.639 168.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -143.92 170.47 15.85 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.886 1.674 . . . . 64.439999999999998 109.475 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.63 -79.94 0.29 Allowed Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 108.442 -1.863 . . . . 51.32 108.442 161.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.0 mp0 -131.49 15.32 4.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.425 1.09 . . . . 74.510000000000005 111.83 -167.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 pt -74.06 50.32 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 127.473 2.309 . . . . 63.539999999999999 110.84 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.138 0 C-N-CA 126.732 2.013 . . . . 71.5 108.687 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 111.674 -0.571 . . . . 53.130000000000003 111.674 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.19 -156.59 0.73 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.664 1.585 . . . . 63.509999999999998 108.275 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -76.7 -79.81 0.1 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.543 -1.651 . . . . 71.239999999999995 106.543 165.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.55 81.88 1.29 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 104.938 -2.245 . . . . 64.140000000000001 104.938 168.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -127.71 -94.38 0.83 Allowed Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 106.436 -2.666 . . . . 72.329999999999998 106.436 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -78.08 65.98 3.6 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.049 0.939 . . . . 64.230000000000004 110.584 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -129.72 24.84 5.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.995 0.918 . . . . 63.520000000000003 112.588 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.9 p -100.81 170.07 8.57 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 120.857 -1.152 . . . . 50.140000000000001 111.91 -173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 p -100.4 173.58 6.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.141 0.976 . . . . 72.430000000000007 111.937 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -127.68 146.68 50.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.765 -0.457 . . . . 64.510000000000005 109.765 170.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.98 150.58 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.805 -1.554 . . . . 73.450000000000003 106.805 172.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.0 ttm180 -135.02 137.46 43.0 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 107.383 -1.34 . . . . 73.109999999999999 107.383 162.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.2 136.52 41.88 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.178 -0.675 . . . . 74.530000000000001 109.178 165.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.458 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.0 mp -128.49 111.91 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.805 1.642 . . . . 73.549999999999997 109.125 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -80.76 80.51 7.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 118.138 -0.934 . . . . 70.329999999999998 111.104 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -94.53 47.04 1.16 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 121.669 2.032 . . . . 72.219999999999999 110.86 -174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.68 HG22 HD12 ' A' ' 87' ' ' LEU . 30.6 p -114.53 -164.32 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.096 1.758 . . . . 64.430000000000007 110.479 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 0.02 45.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.05 1.5 . . . . 65.540000000000006 115.05 170.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 17' ' ' THR . 3.0 p90 -121.98 172.28 8.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.444 1.475 . . . . 70.140000000000001 111.98 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -92.85 152.59 19.33 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.513 1.525 . . . . 71.430000000000007 109.998 167.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.551 HG23 HD11 ' A' ' 24' ' ' ILE . 15.2 m -132.62 149.13 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 71.510000000000005 110.235 170.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -139.82 18.27 2.49 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.65 1.18 . . . . 73.439999999999998 113.341 -164.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -173.08 49.18 0.02 OUTLIER 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.534 -0.729 . . . . 70.120000000000005 111.443 -163.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.551 HD11 HG23 ' A' ' 21' ' ' VAL . 2.5 mp -92.26 114.05 28.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.826 -1.546 . . . . 54.32 106.826 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 139.22 41.15 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.525 -1.287 . . . . 71.129999999999995 107.525 166.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -133.17 111.13 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.304 -1.739 . . . . 70.319999999999993 106.304 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -122.65 130.36 52.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.17 1.388 . . . . 70.129999999999995 107.631 -174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -130.17 19.93 5.37 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 123.622 1.677 . . . . 73.540000000000006 112.605 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.71 179.09 7.39 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 125.82 1.648 . . . . 74.310000000000002 108.902 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -71.37 97.74 1.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.759 -2.312 . . . . 73.209999999999994 104.759 159.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.18 -55.41 0.58 Allowed Glycine 0 CA--C 1.52 0.377 0 C-N-CA 126.806 2.146 . . . . 74.099999999999994 111.339 165.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -68.02 123.18 19.92 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.283 1.033 . . . . 73.209999999999994 110.647 -163.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.85 178.92 6.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.288 1.435 . . . . 64.420000000000002 111.047 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.17 -174.95 5.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.005 2.522 . . . . 72.319999999999993 107.079 158.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.9 p -132.85 140.98 48.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.095 0.862 . . . . 73.230000000000004 111.538 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.59 137.75 20.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 104.761 -2.311 . . . . 74.430000000000007 104.761 171.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -62.79 -80.53 0.03 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.734 -0.839 . . . . 71.230000000000004 108.734 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.4 m -142.85 122.18 13.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.456 -1.313 . . . . 65.340000000000003 107.456 -177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 39' ' ' LEU . 10.0 tp -105.83 105.25 15.19 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.524 -2.028 . . . . 70.140000000000001 105.524 176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.22 171.2 2.18 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 123.004 1.335 . . . . 73.549999999999997 112.61 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.2 t -60.83 112.9 2.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.713 1.205 . . . . 72.349999999999994 107.767 172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.317 2.8 m170 67.81 24.59 8.16 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.619 1.568 . . . . 74.430000000000007 113.038 -175.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.73 174.25 7.45 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 121.34 -0.85 . . . . 64.439999999999998 111.534 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 p -159.1 153.67 24.33 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.748 1.219 . . . . 72.25 111.235 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.6 tt -148.21 146.23 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.306 1.442 . . . . 65.230000000000004 107.994 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.06 144.27 49.01 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.827 1.251 . . . . 74.219999999999999 109.836 175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -150.1 154.62 38.4 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.132 0.968 . . . . 74.530000000000001 111.049 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 144.64 48.1 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.756 1.223 . . . . 73.200000000000003 111.077 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 p -128.29 149.09 50.64 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.037 2.135 . . . . 65.129999999999995 107.621 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -133.68 53.44 2.01 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.857 0.837 . . . . 64.510000000000005 110.36 -147.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -143.79 19.97 1.82 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.073 -1.017 . . . . 74.129999999999995 113.383 -165.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.88 -36.27 1.45 Allowed Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.743 1.163 . . . . 70.519999999999996 114.779 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.4 p -177.23 166.47 2.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.316 2.647 . . . . 63.219999999999999 107.227 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -134.91 152.86 33.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.93 -0.767 . . . . 53.049999999999997 108.93 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -138.91 -10.06 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 127.11 2.164 . . . . 53.229999999999997 112.293 172.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -140.71 154.72 46.47 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.185 0.902 . . . . 73.510000000000005 111.097 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.3 ttm -148.37 133.6 18.4 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 105.649 -1.982 . . . . 70.120000000000005 105.649 -171.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.73 107.65 6.67 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.925 1.69 . . . . 72.230000000000004 106.543 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.84 146.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 107.176 -1.416 . . . . 71.25 107.176 168.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.16 136.85 35.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.286 -1.746 . . . . 73.150000000000006 106.286 148.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 178.96 29.16 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 109.728 -1.349 . . . . 74.239999999999995 109.728 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -145.78 136.23 24.08 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.675 1.19 . . . . 74.230000000000004 109.016 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.1 p -75.18 170.26 16.4 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.063 1.745 . . . . 74.140000000000001 110.848 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.62 -47.52 49.63 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.394 1.477 . . . . 64.230000000000004 110.253 165.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -67.26 -8.53 32.56 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 127.09 2.156 . . . . 72.120000000000005 113.896 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.19 6.61 74.59 Favored Glycine 0 C--O 1.223 -0.537 0 CA-C-O 118.488 -1.173 . . . . 74.549999999999997 111.977 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.59 140.73 44.57 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 119.66 1.73 . . . . 74.430000000000007 108.829 176.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -110.57 123.48 50.03 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.853 -0.795 . . . . 70.530000000000001 108.853 -171.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -117.39 156.67 27.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.523 1.129 . . . . 72.409999999999997 108.357 -176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.1 p -135.78 161.15 36.39 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.674 1.19 . . . . 64.340000000000003 108.665 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.9 83.24 0.18 Allowed Glycine 0 C--O 1.226 -0.398 0 N-CA-C 108.037 -2.025 . . . . 71.140000000000001 108.037 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -102.12 125.52 48.84 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.081 -1.081 . . . . 73.109999999999999 108.081 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -137.24 151.3 48.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 126.658 1.983 . . . . 71.140000000000001 108.955 -172.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -139.01 0.57 1.97 Allowed 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 115.846 1.795 . . . . 73.450000000000003 115.846 -163.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.37 93.43 0.16 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.242 -3.543 . . . . 64.450000000000003 104.242 -174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.2 158.21 38.72 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.801 0.841 . . . . 73.450000000000003 109.234 176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.02 173.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.546 1.539 . . . . 45.340000000000003 108.895 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.54 168.53 7.6 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-O 122.304 0.947 . . . . 50.149999999999999 114.178 170.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.85 6.26 48.33 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.547 0.739 . . . . 72.219999999999999 111.87 -174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -137.96 145.2 41.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.579 1.952 . . . . 70.420000000000002 107.103 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.86 143.77 33.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.923 0.889 . . . . 61.310000000000002 108.866 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -133.25 165.81 23.94 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.374 1.47 . . . . 71.129999999999995 108.114 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.2 t -139.85 114.2 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.672 -1.973 . . . . 71.420000000000002 105.672 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -101.66 91.34 4.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.713 -1.588 . . . . 72.510000000000005 106.713 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.5 mt -75.18 126.13 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.848 -1.908 . . . . 61.520000000000003 105.848 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -152.33 167.88 27.22 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.217 1.007 . . . . 54.32 109.967 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.68 HD12 HG22 ' A' ' 17' ' ' THR . 7.2 mp -85.54 154.33 21.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-O 123.135 1.445 . . . . 74.519999999999996 110.565 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -71.2 173.29 7.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.716 -2.038 . . . . 73.239999999999995 109.458 161.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -51.97 -37.95 54.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.217 1.407 . . . . 70.120000000000005 111.642 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -96.85 11.52 35.47 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.402 1.881 . . . . 74.510000000000005 111.994 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.92 58.94 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.299 0.954 . . . . 64.150000000000006 108.911 -169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 93' ' ' VAL . 45.4 t0 -104.34 -177.85 3.49 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.752 2.021 . . . . 73.209999999999994 105.556 155.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' H ' ' CG ' ' A' ' 92' ' ' ASP . 12.9 t -121.76 111.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 CA-C-N 118.19 0.45 . . . . 44.149999999999999 112.082 -168.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -116.98 -175.05 2.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.663 0.785 . . . . 73.129999999999995 108.912 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.97 139.03 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.554 -1.276 . . . . 53.140000000000001 107.554 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -127.08 171.81 11.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.591 1.957 . . . . 70.319999999999993 109.094 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 pt -151.02 147.76 21.36 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.332 0.653 . . . . 70.209999999999994 111.028 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.77 110.95 2.25 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 123.538 2.825 . . . . 74.25 107.65 165.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -139.89 -179.6 6.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.646 1.978 . . . . 74.109999999999999 106.743 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.31 -45.55 0.17 Allowed Glycine 0 C--N 1.33 0.225 0 N-CA-C 109.85 -1.3 . . . . 70.109999999999999 109.85 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.94 79.6 6.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.858 -1.534 . . . . 74.409999999999997 106.858 165.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tt -148.03 122.61 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 N-CA-C 103.31 -2.848 . . . . 72.129999999999995 103.31 164.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.628 1.171 . . . . 70.549999999999997 109.355 175.619 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 109.527 -1.429 . . . . 42.299999999999997 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.24 23.93 9.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.071 0.949 . . . . 64.030000000000001 112.537 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 62.32 -3.38 0.27 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.879 2.072 . . . . 73.340000000000003 113.572 -158.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.88 51.45 0.8 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 123.513 1.625 . . . . 62.130000000000003 109.235 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.29 -136.77 7.41 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 125.889 1.709 . . . . 64.120000000000005 109.682 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -110.96 49.21 0.88 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.499 1.92 . . . . 64.510000000000005 107.581 -177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -139.44 41.99 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 120.488 -1.383 . . . . 62.539999999999999 108.507 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.65 136.38 52.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.955 1.702 . . . . 71.519999999999996 107.675 174.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 151.55 46.98 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.703 2.001 . . . . 55.32 111.547 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 152.18 22.39 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.812 -0.81 . . . . 71.340000000000003 108.812 165.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -122.62 154.2 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 105.678 -1.971 . . . . 73.239999999999995 105.678 165.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.35 126.67 19.95 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 108.841 -0.8 . . . . 64.230000000000004 108.841 171.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.11 142.35 29.92 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.616 -0.883 . . . . 64.150000000000006 108.616 175.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.9 mp -133.53 138.58 50.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.562 1.545 . . . . 41.409999999999997 107.726 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' HD23 ' A' ' 39' ' ' LEU . 53.5 t30 -110.27 70.69 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.364 0.665 . . . . 74.310000000000002 111.7 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -87.59 61.71 6.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.238 -0.913 . . . . 75.519999999999996 109.276 -171.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.512 ' CG2' HG22 ' A' ' 85' ' ' ILE . 64.5 p -141.8 176.81 8.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.492 1.139 . . . . 63.420000000000002 112.889 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.73 3.48 6.41 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.597 1.959 . . . . 73.129999999999995 114.755 170.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -125.96 175.33 7.77 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.458 1.481 . . . . 75.25 112.446 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -103.31 148.07 26.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.568 1.947 . . . . 62.450000000000003 107.765 165.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG23 HD11 ' A' ' 24' ' ' ILE . 2.4 m -127.08 138.87 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.107 -1.442 . . . . 64.400000000000006 107.107 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.14 16.36 2.62 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 114.679 1.362 . . . . 73.239999999999995 114.679 -162.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -169.0 51.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.978 1.311 . . . . 71.510000000000005 107.54 -172.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.523 HD11 HG23 ' A' ' 21' ' ' VAL . 2.7 mp -87.59 115.54 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 107.29 -1.374 . . . . 71.310000000000002 107.29 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -98.5 108.94 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.793 -2.299 . . . . 63.399999999999999 104.793 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 t -104.27 131.92 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 117.24 -1.362 . . . . 74.310000000000002 109.512 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.9 m -123.99 150.3 44.99 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.427 1.079 . . . . 53.439999999999998 109.657 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.408 ' CZ2' ' HE3' ' A' ' 32' ' ' LYS . 31.0 p90 -141.3 25.48 2.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.515 1.126 . . . . 75.329999999999998 113.154 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.54 -153.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 128.158 2.583 . . . . 74.230000000000004 110.556 -170.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.46 18.45 19.14 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.286 1.835 . . . . 64.420000000000002 112.184 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.63 -2.68 0.03 OUTLIER Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.615 1.406 . . . . 73.299999999999997 116.615 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE3' ' CZ2' ' A' ' 28' ' ' TRP . 0.0 OUTLIER -88.85 107.93 19.25 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 119.541 -2.153 . . . . 73.099999999999994 109.902 164.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.566 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 7.0 pm0 -142.2 167.63 21.65 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.169 0.988 . . . . 74.219999999999999 109.309 170.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.49 -175.44 5.01 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.849 2.06 . . . . 74.219999999999999 108.986 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -140.28 147.13 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.864 -1.148 . . . . 64.209999999999994 109.765 167.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.3 t -77.93 168.68 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.783 -1.191 . . . . 64.5 107.783 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.23 -84.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.976 -0.75 . . . . 74.319999999999993 108.976 166.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.0 m -147.49 153.93 40.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.828 1.651 . . . . 42.420000000000002 106.968 176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 39' ' ' LEU . 2.7 tp -125.25 113.0 17.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.922 1.689 . . . . 64.329999999999998 106.984 173.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.79 179.29 6.64 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 124.628 1.205 . . . . 61.130000000000003 110.712 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.88 130.5 47.05 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.631 -0.877 . . . . 73.439999999999998 108.631 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 54.68 21.9 3.75 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.244 1.418 . . . . 72.439999999999998 112.992 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -81.32 174.89 11.06 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.662 -0.866 . . . . 63.5 108.662 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 p -152.3 157.44 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.71 -1.132 . . . . 74.310000000000002 112.747 176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 tt -150.65 140.08 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 N-CA-C 109.089 -0.708 . . . . 75.420000000000002 109.089 172.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -114.73 147.69 39.36 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.196 1.398 . . . . 73.430000000000007 108.932 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -146.95 143.22 28.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.881 -1.054 . . . . 73.409999999999997 110.838 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 t -68.66 124.35 23.38 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.081 1.352 . . . . 55.119999999999997 107.404 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.85 165.52 15.23 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.338 1.855 . . . . 74.409999999999997 108.341 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 32' ' ' LYS . 22.8 m-20 -127.82 58.04 1.51 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.66 0.784 . . . . 74.230000000000004 110.061 -167.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.54 -8.76 0.32 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.133 1.16 . . . . 72.230000000000004 114.133 -172.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.18 -64.13 2.68 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 110.309 -1.116 . . . . 73.0 110.309 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.5 p -115.71 -171.49 1.98 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.49 1.116 . . . . 72.329999999999998 109.398 174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -146.43 153.68 12.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 104.439 -2.43 . . . . 64.450000000000003 104.439 159.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.21 8.64 1.22 Allowed 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.71 1.004 . . . . 75.430000000000007 113.71 165.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -154.8 162.71 41.01 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.983 1.313 . . . . 75.129999999999995 108.862 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.5 ttm -148.26 143.54 27.04 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.383 -1.34 . . . . 74.040000000000006 107.383 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -144.25 70.63 1.29 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.755 1.264 . . . . 55.509999999999998 108.102 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG12 ' HA3' ' A' ' 71' ' ' GLY . 12.3 p -74.84 159.35 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 CA-C-N 115.496 -0.774 . . . . 74.25 109.093 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.711 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.6 OUTLIER -153.25 128.74 9.96 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 104.999 -2.223 . . . . 75.349999999999994 104.999 167.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.32 171.03 36.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.222 -1.551 . . . . 74.519999999999996 109.222 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -138.64 135.06 34.51 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.07 -0.715 . . . . 74.150000000000006 109.07 -167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 93' ' ' VAL . 19.8 p -82.24 167.2 18.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.001 1.721 . . . . 73.230000000000004 110.419 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.62 -32.25 73.67 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.767 -0.583 . . . . 74.549999999999997 110.594 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -6.51 15.73 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.062 0.945 . . . . 74.530000000000001 111.603 171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.53 26.75 56.25 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.322 -1.486 . . . . 74.409999999999997 112.965 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -103.85 146.03 29.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.209 1.004 . . . . 73.319999999999993 108.795 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -118.52 126.59 52.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.165 1.386 . . . . 73.420000000000002 108.742 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -119.23 151.94 37.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.873 -1.529 . . . . 74.239999999999995 106.873 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.711 HG22 ' HB ' ' A' ' 60' ' ' THR . 80.9 p -132.8 148.18 52.31 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 122.873 1.32 . . . . 74.420000000000002 108.448 168.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA2' HG11 ' A' ' 95' ' ' VAL . . . -123.0 84.04 0.37 Allowed Glycine 0 CA--C 1.482 -2.014 0 N-CA-C 105.96 -2.856 . . . . 73.519999999999996 105.96 -168.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -90.1 113.03 24.69 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 128.109 2.887 . . . . 75.409999999999997 105.626 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -142.59 141.62 32.01 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.747 0.819 . . . . 72.310000000000002 109.545 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -138.36 -178.63 5.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.38 -0.97 . . . . 63.240000000000002 108.38 172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.35 50.96 62.14 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.116 0.885 . . . . 74.510000000000005 111.373 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -103.64 136.09 44.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.037 -1.097 . . . . 74.209999999999994 108.037 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -124.73 165.18 22.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 123.735 0.814 . . . . 54.420000000000002 111.506 -173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.9 -179.8 52.9 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 122.212 0.896 . . . . 52.25 111.833 -177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.89 21.78 12.11 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.239 1.416 . . . . 60.340000000000003 112.476 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -149.07 157.58 43.51 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.272 1.429 . . . . 73.409999999999997 109.947 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.7 m -150.1 164.29 35.97 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.496 1.918 . . . . 71.430000000000007 106.699 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.84 179.59 8.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.505 1.122 . . . . 72.540000000000006 108.857 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.2 t -136.04 123.2 33.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 125.654 1.582 . . . . 52.020000000000003 108.028 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.8 m-30 -97.21 104.39 16.4 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 106.351 -1.722 . . . . 75.120000000000005 106.351 167.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.512 HG22 ' CG2' ' A' ' 17' ' ' THR . 61.1 mt -71.86 134.8 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 104.811 -2.292 . . . . 73.120000000000005 104.811 158.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -145.44 -176.01 4.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.463 1.505 . . . . 72.319999999999993 108.125 164.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 mt -106.44 156.76 18.21 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.894 -1.15 . . . . 61.420000000000002 107.894 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -157.61 -166.79 2.1 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.765 -0.828 . . . . 74.530000000000001 108.765 168.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 63.91 -80.65 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 130.267 3.427 . . . . 72.109999999999999 110.515 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -140.44 49.88 1.71 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.399 1.88 . . . . 63.43 108.981 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 56.9 39.97 29.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.713 1.205 . . . . 71.530000000000001 110.112 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -101.32 158.44 16.05 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 127.433 2.293 . . . . 73.230000000000004 107.872 -177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.532 HG21 HG21 ' A' ' 63' ' ' THR . 22.1 t -79.35 124.13 37.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 121.54 -0.725 . . . . 62.420000000000002 109.803 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -122.22 176.1 6.02 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.483 1.135 . . . . 64.409999999999997 111.63 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.772 HG11 ' HA2' ' A' ' 71' ' ' GLY . 1.5 p -125.98 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.913 1.685 . . . . 75.409999999999997 110.037 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -131.23 168.24 17.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 127.671 2.388 . . . . 74.239999999999995 109.017 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.4 pt -152.51 145.05 17.06 Favored Pre-proline 0 N--CA 1.451 -0.389 0 O-C-N 121.386 -0.821 . . . . 64.420000000000002 110.098 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.12 94.0 1.02 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.086 1.191 . . . . 62.310000000000002 110.376 170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -107.75 -172.59 2.1 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.462 1.505 . . . . 64.530000000000001 108.537 166.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.52 -68.75 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.455 -2.258 . . . . 62.549999999999997 107.455 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.3 74.83 0.24 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.154 2.182 . . . . 73.120000000000005 109.541 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.5 tt -135.93 91.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.231 1.812 . . . . 54.32 107.926 168.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 124.227 1.011 . . . . 64.549999999999997 108.334 174.525 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.539 0 N-CA-C 112.033 -0.427 . . . . 72.340000000000003 112.033 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 125.97 29.19 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.392 -1.336 . . . . 75.230000000000004 107.392 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -84.28 -6.71 59.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.205 0.446 . . . . 64.0 112.205 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -139.25 77.06 1.6 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.669 -1.974 . . . . 75.420000000000002 105.669 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.29 -2.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.206 1.384 . . . . 51.530000000000001 114.291 -165.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -152.45 114.59 4.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.6 -1.63 . . . . 74.299999999999997 106.6 152.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -108.25 24.68 12.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.096 0.95 . . . . 73.299999999999997 112.151 -166.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.9 p -135.93 171.88 13.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.737 2.015 . . . . 75.200000000000003 109.947 -168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 164.66 11.78 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.665 0.786 . . . . 72.129999999999995 112.057 -173.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.662 HG22 ' OD1' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -128.39 136.06 50.39 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.916 0.886 . . . . 71.099999999999994 109.724 177.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -134.18 119.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 107.667 -1.234 . . . . 71.140000000000001 107.667 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.444 HH11 ' CB ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -127.15 132.92 50.43 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.493 0.717 . . . . 72.0 111.329 -175.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.24 139.1 42.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.604 0.762 . . . . 73.129999999999995 109.339 -177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.407 HD11 ' HD2' ' A' ' 12' ' ' ARG . 2.8 mp -133.68 115.8 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 125.942 1.697 . . . . 72.109999999999999 107.765 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 21' ' ' VAL . 60.6 t30 -90.92 68.8 6.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.452 1.101 . . . . 75.400000000000006 111.205 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -77.76 55.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.516 1.526 . . . . 73.239999999999995 111.647 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.6 p -131.51 170.8 14.2 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.864 1.266 . . . . 75.439999999999998 111.486 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.41 -15.7 60.42 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 114.182 1.179 . . . . 74.129999999999995 114.182 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -108.7 168.65 9.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.448 1.022 . . . . 52.100000000000001 111.546 -169.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.94 158.15 15.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 60.219999999999999 109.136 167.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 HD21 ' A' ' 15' ' ' ASN . 97.7 t -140.96 146.09 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 C-N-CA 130.244 3.418 . . . . 75.239999999999995 107.212 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -148.13 29.6 0.88 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.106 1.362 . . . . 62.439999999999998 114.675 -163.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 177.81 60.18 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.436 -0.579 . . . . 64.209999999999994 109.436 -160.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.62 127.01 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 120.776 -1.203 . . . . 74.120000000000005 108.118 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' HG3' HG22 ' A' ' 35' ' ' THR . 5.9 mtpt -97.42 151.16 20.24 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.996 0.918 . . . . 55.020000000000003 108.858 159.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 p -140.28 146.65 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.926 -1.509 . . . . 71.129999999999995 106.926 157.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.9 m -128.71 144.92 51.27 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.952 -1.499 . . . . 75.140000000000001 106.952 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.411 ' HB2' HG21 ' A' ' 54' ' ' VAL . 38.5 p90 -142.61 17.99 2.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.195 0.998 . . . . 63.439999999999998 111.416 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 170.55 5.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 126.881 2.073 . . . . 75.420000000000002 108.659 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.35 11.92 0.87 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.925 1.083 . . . . 74.230000000000004 113.925 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -176.51 33.05 0.08 OUTLIER Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.021 -1.674 . . . . 62.200000000000003 112.923 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.24 105.77 7.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.174 -2.158 . . . . 75.219999999999999 105.174 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.19 175.33 7.86 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.238 1.415 . . . . 71.299999999999997 108.542 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -154.77 168.46 26.78 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.844 1.257 . . . . 75.010000000000005 108.644 162.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 25' ' ' LYS . 30.6 p -124.3 161.89 24.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.839 0.352 . . . . 71.239999999999995 111.465 173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.6 t -113.54 146.13 18.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.102 -1.444 . . . . 71.439999999999998 107.102 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -56.54 -76.64 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.543 1.537 . . . . 45.130000000000003 110.61 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 97.6 m -148.69 143.55 26.54 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.327 1.051 . . . . 74.099999999999994 109.741 -173.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 39' ' ' LEU . 1.4 tp -134.11 105.23 6.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.771 2.428 . . . . 64.099999999999994 105.213 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.34 172.16 3.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.256 -1.338 . . . . 54.130000000000003 111.192 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.6 p -53.02 124.36 14.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.283 -1.377 . . . . 73.120000000000005 107.283 163.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 66.82 14.52 9.84 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.571 1.949 . . . . 74.140000000000001 114.372 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -81.44 173.04 12.81 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 120.245 1.384 . . . . 75.109999999999999 109.966 -174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 53.0 p -160.59 160.86 32.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 113.614 0.968 . . . . 75.439999999999998 113.614 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -164.97 143.14 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.014 -1.106 . . . . 73.430000000000007 108.014 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.662 ' OD1' HG22 ' A' ' 10' ' ' THR . 25.3 t70 -116.58 149.87 38.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.95 -1.13 . . . . 72.120000000000005 107.95 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -141.58 142.87 33.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.756 0.789 . . . . 60.299999999999997 110.318 174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -65.45 144.46 57.03 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.342 1.457 . . . . 55.520000000000003 109.31 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -71.46 -173.42 0.91 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.838 0.855 . . . . 35.329999999999998 109.661 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -141.99 43.64 1.69 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.055 -1.028 . . . . 54.530000000000001 109.323 156.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -137.72 -15.42 1.38 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 114.508 1.299 . . . . 74.219999999999999 114.508 -162.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.63 -58.31 4.72 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 119.653 1.115 . . . . 72.140000000000001 111.687 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 p -143.88 169.54 17.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.996 0.903 . . . . 72.310000000000002 110.168 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' A' ' 28' ' ' TRP . 1.5 p -156.98 163.52 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.539 2.736 . . . . 62.340000000000003 107.741 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -148.08 9.74 0.88 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.533 2.333 . . . . 75.040000000000006 111.713 172.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -152.35 163.73 38.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 120.319 -1.488 . . . . 51.229999999999997 110.769 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.1 ttm -157.93 132.55 8.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.837 0.744 . . . . 74.400000000000006 110.676 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -122.81 100.21 6.78 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.058 -1.46 . . . . 75.519999999999996 107.058 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.82 148.48 5.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 125.386 1.475 . . . . 53.140000000000001 109.161 -173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -163.93 140.65 6.77 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.394 -1.336 . . . . 74.400000000000006 107.394 175.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.0 -175.52 40.24 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 109.436 -1.465 . . . . 75.230000000000004 109.436 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.6 m -145.54 134.45 22.5 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.231 1.015 . . . . 64.319999999999993 110.446 -163.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 p -75.11 174.2 9.73 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.848 1.659 . . . . 64.5 111.219 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -61.34 -40.35 93.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.054 2.142 . . . . 71.420000000000002 108.996 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -18.64 64.78 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.077 1.751 . . . . 73.439999999999998 112.925 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.99 23.06 39.57 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 118.157 -1.357 . . . . 51.219999999999999 112.651 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -88.02 144.58 26.44 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 120.275 2.038 . . . . 55.32 107.002 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -106.64 117.66 34.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 119.001 0.819 . . . . 75.530000000000001 110.321 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -90.16 142.6 27.56 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 105.975 -1.861 . . . . 63.229999999999997 105.975 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.6 p -139.54 147.95 41.93 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.687 0.676 . . . . 63.100000000000001 111.679 171.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.23 -86.34 1.51 Allowed Glycine 0 N--CA 1.453 -0.212 0 CA-C-N 115.718 -0.674 . . . . 72.209999999999994 111.827 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 67.1 105.04 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.414 2.286 . . . . 72.340000000000003 110.687 -170.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -139.98 153.01 46.75 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.93 1.292 . . . . 75.540000000000006 110.119 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -142.54 177.84 8.01 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.007 1.723 . . . . 63.119999999999997 109.068 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.02 33.84 88.35 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 123.5 0.571 . . . . 42.210000000000001 111.862 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.81 158.86 22.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.041 -0.725 . . . . 54.43 109.041 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 m -145.43 163.93 11.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 126.984 2.114 . . . . 63.229999999999997 108.067 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.21 152.95 25.34 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.437 1.017 . . . . 43.200000000000003 111.499 173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -82.1 3.73 25.82 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.59 0.959 . . . . 72.200000000000003 113.59 -167.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -145.44 160.87 40.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 120.904 -1.123 . . . . 62.299999999999997 110.661 170.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.65 145.23 30.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.863 2.065 . . . . 75.310000000000002 107.045 -160.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -137.0 -178.01 5.01 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.404 -0.81 . . . . 71.129999999999995 110.523 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.3 t -147.7 110.68 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.786 2.034 . . . . 71.219999999999999 106.75 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -99.66 91.97 5.12 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.661 1.585 . . . . 74.219999999999999 109.016 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.8 mt -76.61 132.46 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.246 -1.761 . . . . 73.430000000000007 106.246 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -148.87 177.46 9.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.556 -0.905 . . . . 75.239999999999995 108.556 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mt -109.4 149.26 29.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.168 -1.419 . . . . 73.530000000000001 107.168 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -153.85 -172.27 4.17 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.438 -0.949 . . . . 73.5 108.438 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 66.37 -70.89 0.1 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.971 2.908 . . . . 74.120000000000005 112.059 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -136.62 16.26 3.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 127.206 2.202 . . . . 61.140000000000001 111.133 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.4 30.87 1.09 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.621 2.768 . . . . 52.219999999999999 111.627 -162.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -84.32 156.12 22.06 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 125.11 1.364 . . . . 62.229999999999997 107.902 169.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.5 t -90.11 116.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 118.094 -1.443 . . . . 62.5 110.796 -164.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -103.82 177.53 4.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.32 1.057 . . . . 54.439999999999998 109.784 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.57 110.76 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 103.915 -2.624 . . . . 74.5 103.915 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -107.09 169.56 8.48 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.465 1.506 . . . . 75.140000000000001 110.162 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.1 pt -150.63 147.07 20.47 Favored Pre-proline 0 N--CA 1.457 -0.106 0 O-C-N 121.122 -0.986 . . . . 75.230000000000004 111.33 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.76 117.0 4.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.925 1.75 . . . . 71.299999999999997 110.008 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -124.05 -173.92 2.87 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.672 1.989 . . . . 71.439999999999998 107.639 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.13 -156.37 24.4 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 107.876 -2.09 . . . . 64.319999999999993 107.876 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -83.37 66.32 8.77 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.405 1.098 . . . . 64.030000000000001 109.475 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.1 pt -113.72 45.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.839 1.655 . . . . 63.0 110.08 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.269 1.427 . . . . 75.340000000000003 110.587 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.643 0 N-CA-C 108.404 -1.878 . . . . 43.439999999999998 108.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 143.99 46.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 61.030000000000001 107.886 163.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.37 7.69 2.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.375 1.07 . . . . 74.239999999999995 113.27 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -149.8 100.69 2.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.321 -2.474 . . . . 74.430000000000007 104.321 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.17 -152.37 8.99 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.436 -0.666 . . . . 54.409999999999997 111.436 -167.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -74.27 73.97 1.82 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.581 -1.266 . . . . 75.140000000000001 107.581 167.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.2 26.02 6.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 129.068 2.947 . . . . 74.439999999999998 108.16 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.2 p -74.19 176.66 6.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.545 1.538 . . . . 65.299999999999997 109.942 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 155.68 18.64 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.326 -0.62 . . . . 72.099999999999994 109.326 162.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -123.74 155.12 38.47 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.247 -2.131 . . . . 62.399999999999999 105.247 164.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.1 mt -125.28 143.19 39.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 104.344 -2.465 . . . . 72.019999999999996 104.344 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 117.12 10.9 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.896 -0.409 . . . . 75.400000000000006 109.896 -172.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 83' ' ' VAL . 2.4 mm? -99.36 138.47 36.41 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.416 1.086 . . . . 74.219999999999999 109.476 -175.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.3 mp -131.5 133.63 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.269 1.428 . . . . 50.210000000000001 108.263 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.807 ' HB2' HD12 ' A' ' 39' ' ' LEU . 50.4 t30 -106.87 66.49 0.68 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.925 1.29 . . . . 44.420000000000002 110.835 -171.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -80.68 24.5 0.47 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.448 1.099 . . . . 74.319999999999993 113.128 -166.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.3 -179.36 3.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.015 1.726 . . . . 70.099999999999994 111.679 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.82 18.13 20.28 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.078 1.51 . . . . 73.319999999999993 115.078 -176.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -127.48 179.03 5.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.332 1.053 . . . . 73.040000000000006 109.557 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -101.15 148.15 25.42 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.691 -1.256 . . . . 75.340000000000003 108.461 169.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 HD11 ' A' ' 24' ' ' ILE . 35.4 m -125.87 134.55 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 119.28 0.945 . . . . 72.439999999999998 110.592 174.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -132.72 32.52 3.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.326 1.05 . . . . 71.040000000000006 112.752 -165.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 174.15 76.67 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 104.57 -2.382 . . . . 73.099999999999994 104.57 -174.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' VAL . 11.6 mm -87.51 139.44 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.948 -1.501 . . . . 74.109999999999999 106.948 159.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CE ' ' HB3' ' A' ' 33' ' ' GLU . 13.3 tptm -109.34 144.92 36.86 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 105.984 -1.858 . . . . 72.319999999999993 105.984 158.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 47' ' ' PHE . 1.2 p -124.88 151.23 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.521 -1.289 . . . . 65.010000000000005 107.521 169.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 33' ' ' GLU . 10.9 m -138.94 140.77 38.39 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.267 1.827 . . . . 51.520000000000003 106.498 171.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -138.62 5.77 2.45 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.948 0.721 . . . . 73.319999999999993 112.948 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.49 -176.49 6.0 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 119.97 -1.706 . . . . 72.420000000000002 107.124 177.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.77 26.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.761 1.023 . . . . 71.439999999999998 113.761 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.59 -13.65 0.1 OUTLIER Glycine 0 CA--C 1.535 1.302 0 C-N-CA 126.355 1.931 . . . . 43.310000000000002 113.006 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 112.07 12.59 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.516 1.658 . . . . 61.329999999999998 108.392 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG2' HG23 ' A' ' 27' ' ' THR . 31.6 mt-10 -136.72 169.86 17.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.856 1.262 . . . . 43.509999999999998 110.841 -174.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.72 178.0 10.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.271 1.828 . . . . 63.340000000000003 110.552 163.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.6 p -138.39 159.99 40.65 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.084 0.856 . . . . 73.040000000000006 111.905 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG22 ' HB ' ' A' ' 24' ' ' ILE . 3.0 m -114.11 165.12 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.211 1.404 . . . . 74.319999999999993 110.757 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -70.24 -86.24 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.778 0.831 . . . . 62.310000000000002 110.177 172.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.0 m -148.23 148.05 30.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.393 1.477 . . . . 74.319999999999993 107.547 -165.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -138.51 117.91 12.86 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.218 1.807 . . . . 71.010000000000005 106.598 -175.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.14 179.41 39.19 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 113.063 -1.881 . . . . 73.239999999999995 111.344 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.4 m -72.43 121.13 19.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.844 -0.798 . . . . 72.409999999999997 109.236 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 60.52 17.93 7.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.77 1.628 . . . . 64.129999999999995 113.056 -170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.643 ' CB ' HD13 ' A' ' 39' ' ' LEU . 3.1 m-20 -69.8 170.31 11.29 Favored 'General case' 0 C--O 1.238 0.497 0 O-C-N 121.479 -0.763 . . . . 74.329999999999998 110.506 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 39' ' ' LEU . 6.1 p -152.64 163.24 40.02 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.732 -0.667 . . . . 64.129999999999995 112.449 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 tt -144.48 152.28 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.906 1.683 . . . . 74.140000000000001 107.483 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -134.73 133.97 40.5 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 126.354 1.862 . . . . 60.229999999999997 106.154 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 26' ' ' VAL . 26.7 p90 -151.02 146.83 26.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.634 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.6 139.41 58.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.587 1.155 . . . . 64.340000000000003 110.122 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 t -81.77 144.06 31.35 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.977 -1.86 . . . . 70.400000000000006 105.977 161.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 29.88 0.4 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.18 0.992 . . . . 72.040000000000006 112.27 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.29 167.3 23.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.79 0.836 . . . . 65.0 110.666 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.07 -32.48 39.44 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 124.905 1.241 . . . . 71.439999999999998 112.538 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.46 157.19 43.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.061 1.344 . . . . 71.340000000000003 107.896 -163.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 p -164.82 158.59 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 64.129999999999995 109.224 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.09 2.44 1.32 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.583 1.553 . . . . 65.129999999999995 113.88 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -146.04 157.02 43.86 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.368 1.44 . . . . 74.329999999999998 109.911 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.7 ttm -157.93 140.52 14.65 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.027 -1.101 . . . . 74.439999999999998 108.027 -173.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.38 92.49 2.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.835 1.198 . . . . 73.340000000000003 108.474 -170.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.31 161.63 2.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.392 -1.336 . . . . 73.010000000000005 107.392 -165.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 96.36 1.02 Allowed 'General case' 0 C--O 1.233 0.223 0 O-C-N 120.833 -1.167 . . . . 64.329999999999998 108.526 169.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -111.36 175.34 17.52 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.503 -0.639 . . . . 74.400000000000006 111.503 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 m -141.46 141.43 33.68 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 118.89 1.345 . . . . 64.439999999999998 111.709 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.1 p -82.91 171.45 13.86 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.164 2.586 . . . . 74.319999999999993 112.788 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 7.5 tt0 -53.99 -42.57 69.17 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.983 1.313 . . . . 73.239999999999995 111.775 169.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -79.0 1.34 24.21 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 123.245 0.34 . . . . 73.099999999999994 111.361 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.14 19.01 68.0 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.809 -1.182 . . . . 73.340000000000003 112.398 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.39 136.06 37.58 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 118.93 1.365 . . . . 73.129999999999995 108.008 168.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -87.03 148.48 25.27 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.792 -1.188 . . . . 72.340000000000003 107.792 164.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -128.24 138.91 52.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.726 -1.212 . . . . 74.219999999999999 107.726 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -122.17 155.87 34.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.623 0.769 . . . . 52.43 109.37 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -150.09 85.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 106.403 -2.679 . . . . 33.009999999999998 106.403 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -84.51 123.2 30.01 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.977 -1.49 . . . . 74.200000000000003 106.977 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -136.82 142.54 42.9 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.473 1.509 . . . . 65.030000000000001 110.14 -173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.71 170.9 14.9 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.257 2.623 . . . . 70.310000000000002 105.508 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 54.93 70.73 0.87 Allowed Glycine 0 CA--C 1.519 0.324 0 N-CA-C 110.909 -0.876 . . . . 74.430000000000007 110.909 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.7 mt -118.48 151.87 37.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.238 1.815 . . . . 64.120000000000005 108.677 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.7 m -130.54 -177.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.967 1.307 . . . . 65.430000000000007 111.146 -168.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.77 -163.41 54.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 123.581 0.61 . . . . 72.109999999999999 112.276 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -131.57 36.86 3.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.213 1.005 . . . . 62.130000000000003 110.271 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -152.66 166.48 31.99 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.427 1.491 . . . . 74.030000000000001 107.883 160.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -143.78 118.2 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.038 -1.097 . . . . 73.010000000000005 108.038 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -87.24 172.44 9.89 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 110.278 -0.268 . . . . 73.239999999999995 110.278 167.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' A' ' 13' ' ' LEU . 61.7 t -141.96 119.62 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 105.647 -1.983 . . . . 65.010000000000005 105.647 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -99.8 105.8 17.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.716 -1.587 . . . . 63.229999999999997 106.716 171.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.5 mt -82.54 122.15 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.298 -2.482 . . . . 44.329999999999998 104.298 167.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.43 159.45 10.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 127.066 2.146 . . . . 63.229999999999997 106.902 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.32 155.74 20.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.203 0.601 . . . . 72.340000000000003 109.799 -172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -154.63 -161.24 1.18 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.289 1.036 . . . . 62.310000000000002 108.996 163.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 55.43 -85.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 129.421 3.089 . . . . 73.129999999999995 109.848 -173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -144.84 49.43 1.29 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 127.062 2.145 . . . . 71.239999999999995 108.295 -166.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.58 39.95 29.07 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.586 1.954 . . . . 33.409999999999997 111.509 -165.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -88.44 150.03 23.36 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.367 -1.346 . . . . 72.0 107.367 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 t -82.5 95.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.148 -0.686 . . . . 61.439999999999998 109.148 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -88.41 -173.79 4.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.346 1.058 . . . . 72.040000000000006 109.766 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.9 t -137.68 138.09 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 105.689 -1.967 . . . . 71.230000000000004 105.689 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.51 168.59 15.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.091 1.756 . . . . 73.040000000000006 108.137 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.3 pt -148.45 144.12 18.19 Favored Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.037 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.93 113.3 3.52 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.918 1.745 . . . . 74.400000000000006 108.365 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -132.46 -176.46 4.09 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.462 1.905 . . . . 74.200000000000003 109.407 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -171.87 -72.16 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 108.787 -1.725 . . . . 44.140000000000001 108.787 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.97 66.27 0.37 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.37 2.268 . . . . 62.340000000000003 110.363 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.2 pt -135.32 39.74 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 127.612 2.365 . . . . 72.230000000000004 108.631 178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 117.117 -1.421 . . . . 72.030000000000001 108.18 -178.232 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.555 0 N-CA-C 108.692 -1.763 . . . . 65.420000000000002 108.692 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.14 168.38 19.84 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.366 -0.976 . . . . 73.010000000000005 108.366 167.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.56 -35.5 81.03 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 118.549 -0.739 . . . . 74.219999999999999 111.4 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.79 26.49 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 122.499 1.143 . . . . 72.010000000000005 110.685 170.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.28 -5.87 88.42 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.251 -1.531 . . . . 70.150000000000006 114.255 -174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -134.79 93.24 3.0 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 119.835 1.817 . . . . 74.25 107.892 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -95.85 26.2 4.22 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.585 0.707 . . . . 71.420000000000002 111.635 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.46 172.45 10.18 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 127.467 2.307 . . . . 24.399999999999999 108.301 177.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.83 -176.49 3.19 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.33 1.052 . . . . 73.129999999999995 110.309 173.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 m -144.65 155.61 43.69 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.765 -1.568 . . . . 72.150000000000006 106.765 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.78 144.8 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.027 -1.842 . . . . 65.329999999999998 106.027 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -141.51 112.13 7.09 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.226 0.466 . . . . 63.240000000000002 110.989 -172.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.469 ' O ' HD21 ' A' ' 39' ' ' LEU . 1.2 mm? -100.47 110.44 22.62 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 117.68 -1.152 . . . . 64.209999999999994 108.891 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.516 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.5 mp -107.38 147.36 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.905 1.229 . . . . 70.310000000000002 108.179 174.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.487 ' HB2' HD23 ' A' ' 39' ' ' LEU . 58.7 t30 -114.99 66.41 0.69 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.542 1.137 . . . . 72.209999999999994 111.788 -174.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -84.38 54.13 2.88 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.067 -1.021 . . . . 61.5 110.754 -163.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 87' ' ' LEU . 4.2 p -134.62 -165.38 1.65 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 126.165 1.786 . . . . 73.510000000000005 111.755 -161.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.78 17.42 19.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.206 1.402 . . . . 74.430000000000007 113.569 178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -141.8 172.66 12.38 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.675 1.19 . . . . 74.040000000000006 111.761 -176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -97.65 154.94 17.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.921 1.289 . . . . 64.040000000000006 109.465 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' CG2' HD11 ' A' ' 24' ' ' ILE . 4.0 m -133.48 138.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.721 1.609 . . . . 72.019999999999996 107.011 172.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -142.12 18.95 2.1 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.899 -1.126 . . . . 71.140000000000001 113.227 -163.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -170.19 43.8 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.824 1.249 . . . . 73.319999999999993 107.864 -169.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' CG2' ' A' ' 21' ' ' VAL . 3.2 mt -82.17 136.31 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.538 -1.653 . . . . 71.439999999999998 106.538 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.0 110.03 10.94 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.174 1.389 . . . . 72.439999999999998 107.404 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.13 143.98 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.512 -0.921 . . . . 74.030000000000001 108.512 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -118.78 146.88 44.45 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.044 -1.836 . . . . 71.230000000000004 106.044 163.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -143.11 15.45 1.89 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.697 1.135 . . . . 71.319999999999993 113.473 -174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.29 -166.83 1.47 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.709 2.404 . . . . 74.439999999999998 105.044 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.42 23.42 3.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.813 -1.179 . . . . 63.219999999999999 110.948 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.6 -22.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.891 1.234 . . . . 62.140000000000001 112.577 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.36 110.5 4.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.095 1.448 . . . . 74.439999999999998 109.169 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -136.26 165.32 26.04 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.954 0.901 . . . . 53.32 111.884 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.47 173.2 17.01 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.617 1.567 . . . . 63.0 109.545 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.9 p -130.58 137.35 49.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.811 0.845 . . . . 63.109999999999999 110.286 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.37 163.57 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.23 -1.026 . . . . 64.400000000000006 108.23 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -64.29 -85.86 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.583 1.083 . . . . 70.099999999999994 110.299 172.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 88.5 m -154.84 160.87 41.53 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.224 -1.398 . . . . 71.120000000000005 107.224 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' A' ' 15' ' ' ASN . 2.9 tp -146.3 107.44 4.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.923 1.689 . . . . 71.409999999999997 107.672 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.02 -172.08 4.16 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.737 1.637 . . . . 21.52 111.93 173.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.6 p -61.26 128.61 37.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.793 -0.827 . . . . 53.310000000000002 110.412 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.45 12.02 0.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.858 1.263 . . . . 74.530000000000001 114.064 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.11 174.27 7.37 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.13 0.967 . . . . 72.340000000000003 111.077 -176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 p -160.35 152.36 20.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.494 -1.23 . . . . 63.43 114.088 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.27 146.53 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.181 2.192 . . . . 74.209999999999994 108.628 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -122.63 136.65 54.94 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.892 2.477 . . . . 74.230000000000004 105.015 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -136.86 152.65 50.49 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.529 0.732 . . . . 64.239999999999995 111.203 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.9 t -62.37 141.64 58.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.042 -0.981 . . . . 72.140000000000001 108.551 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.0 t -99.75 126.95 45.89 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 104.634 -2.358 . . . . 65.129999999999995 104.634 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.51 43.42 0.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.53 1.132 . . . . 71.439999999999998 111.118 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.03 150.81 32.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.237 -0.915 . . . . 41.420000000000002 108.959 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.4 -42.65 81.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.608 -0.997 . . . . 71.150000000000006 110.608 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.82 155.85 45.56 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.867 0.867 . . . . 73.420000000000002 111.365 -167.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.6 t -146.28 138.28 19.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 125.582 1.553 . . . . 72.349999999999994 108.225 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.62 6.37 3.22 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.84 1.256 . . . . 74.120000000000005 113.243 174.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -150.84 153.56 35.61 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.914 1.286 . . . . 71.030000000000001 107.96 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 42.4 ttm -154.02 127.58 8.66 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.674 -0.861 . . . . 52.210000000000001 108.674 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -124.18 105.35 9.45 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 107.577 -1.268 . . . . 71.150000000000006 107.577 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 95' ' ' VAL . 2.5 m -75.39 159.4 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.075 -1.454 . . . . 70.319999999999993 107.075 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.0 OUTLIER -160.19 119.96 2.85 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 103.68 -2.711 . . . . 54.299999999999997 103.68 151.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -135.7 175.8 20.56 Favored Glycine 0 C--O 1.229 -0.166 0 N-CA-C 110.467 -1.053 . . . . 74.310000000000002 110.467 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 2.6 m -137.11 133.27 35.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.142 0.977 . . . . 51.130000000000003 108.492 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.563 HG21 HG21 ' A' ' 93' ' ' VAL . 9.9 p -71.99 173.14 8.8 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.246 1.819 . . . . 64.400000000000006 111.637 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.12 -40.1 80.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.214 1.406 . . . . 74.040000000000006 110.545 171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -62.32 -38.76 90.68 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.57 -0.9 . . . . 74.420000000000002 108.57 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.13 15.42 7.8 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.04 -1.422 . . . . 74.420000000000002 110.95 -174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.61 132.99 37.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 N-CA-C 106.176 -1.787 . . . . 65.329999999999998 106.176 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -88.3 149.33 23.84 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.247 -1.76 . . . . 71.230000000000004 106.247 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -131.07 138.95 49.81 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.036 -1.468 . . . . 72.239999999999995 107.036 166.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 HG22 ' HB ' ' A' ' 60' ' ' THR . 51.2 p -121.77 148.06 45.14 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.971 -1.492 . . . . 74.420000000000002 106.971 163.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.764 ' HA3' HG11 ' A' ' 95' ' ' VAL . . . -113.76 -76.27 0.72 Allowed Glycine 0 CA--C 1.505 -0.56 0 CA-C-O 122.765 1.203 . . . . 61.009999999999998 110.322 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 75.75 112.31 0.07 Allowed 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 129.382 3.073 . . . . 64.329999999999998 110.142 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -134.53 149.37 50.66 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.896 0.878 . . . . 64.109999999999999 109.635 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -145.67 176.32 9.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 127.215 2.206 . . . . 73.219999999999999 106.974 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.68 18.75 79.6 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-O 119.864 -0.409 . . . . 61.32 112.276 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.0 mt -79.08 158.13 27.88 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.846 0.832 . . . . 72.25 109.164 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.43 -179.38 3.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.804 1.242 . . . . 71.219999999999999 109.695 -165.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 59.9 -152.82 35.16 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 123.628 0.632 . . . . 71.010000000000005 112.897 172.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -137.56 20.45 2.91 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.33 1.452 . . . . 63.130000000000003 113.419 -164.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.1 -178.6 6.03 Favored 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 121.299 -0.875 . . . . 64.219999999999999 109.751 155.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.34 164.96 30.73 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.499 -0.926 . . . . 73.209999999999994 108.499 169.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -135.32 -177.95 4.89 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.172 0.989 . . . . 73.310000000000002 108.965 170.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.2 t -139.51 117.24 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 104.385 -2.45 . . . . 74.129999999999995 104.385 167.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -94.43 98.96 11.24 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 105.333 -2.099 . . . . 71.120000000000005 105.333 164.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG21 ' A' ' 17' ' ' THR . 18.3 mt -80.46 129.08 38.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 103.8 -2.667 . . . . 74.299999999999997 103.8 164.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -143.59 157.88 44.08 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.122 1.769 . . . . 70.030000000000001 106.323 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.676 HD12 HG22 ' A' ' 17' ' ' THR . 5.4 mp -75.5 159.25 31.51 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 122.163 0.982 . . . . 73.540000000000006 108.696 175.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.87 177.1 9.18 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.708 -2.042 . . . . 73.0 110.425 169.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.281 4.0 pt-20 46.52 -82.22 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 130.695 3.598 . . . . 62.140000000000001 112.459 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -137.15 42.68 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.813 1.645 . . . . 70.430000000000007 112.085 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 74.82 49.79 0.09 Allowed 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 128.181 2.592 . . . . 43.43 110.107 -177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -96.6 -176.92 3.75 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.09 1.356 . . . . 74.310000000000002 107.989 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 63' ' ' THR . 38.4 t -121.66 81.66 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 118.911 0.778 . . . . 65.239999999999995 110.784 -163.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.95 157.86 15.91 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 122.632 1.206 . . . . 65.239999999999995 112.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.764 HG11 ' HA3' ' A' ' 71' ' ' GLY 0.256 1.5 p -110.07 124.96 67.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 128.141 2.576 . . . . 70.040000000000006 107.466 173.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -121.91 167.96 12.44 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.363 1.865 . . . . 64.430000000000007 107.775 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.94 147.37 26.58 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 121.296 -0.878 . . . . 70.230000000000004 109.216 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.41 118.17 5.15 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 107.521 -1.761 . . . . 64.450000000000003 107.521 169.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -136.49 -169.66 2.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.121 1.768 . . . . 73.329999999999998 107.455 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.41 -14.05 0.05 OUTLIER Glycine 0 C--O 1.226 -0.373 0 O-C-N 121.438 -0.789 . . . . 63.109999999999999 113.449 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.52 67.44 0.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 106.291 -1.744 . . . . 74.109999999999999 106.291 170.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.4 pt -140.85 68.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 126.612 1.965 . . . . 71.049999999999997 110.162 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.243 0.752 0 CA-C-N 112.65 -2.068 . . . . 72.25 113.226 166.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.304 -1.119 . . . . 62.439999999999998 110.304 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.17 5.13 2.08 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.818 1.247 . . . . 62.43 111.935 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 58.11 -169.26 0.12 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.677 0.791 . . . . 72.329999999999998 108.902 -149.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -129.34 -8.5 4.72 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.586 1.554 . . . . 63.109999999999999 111.985 -169.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.66 46.76 3.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.966 0.793 . . . . 41.219999999999999 114.974 -156.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -153.17 107.17 3.07 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.723 1.261 . . . . 74.349999999999994 110.38 -177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -85.63 32.78 0.57 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 128.685 2.794 . . . . 73.219999999999999 112.068 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 139.22 44.44 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.569 -1.271 . . . . 75.409999999999997 107.569 177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.95 173.88 11.24 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.669 0.788 . . . . 75.549999999999997 109.112 166.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 m -136.4 145.3 45.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.673 -0.862 . . . . 75.329999999999998 108.673 173.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.5 mt -121.38 165.77 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 106.9 -1.519 . . . . 52.229999999999997 106.9 -173.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HD2' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -156.29 115.5 3.49 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 119.986 -1.697 . . . . 74.129999999999995 109.789 -177.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.3 102.83 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.815 1.246 . . . . 74.209999999999994 110.949 -171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.414 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -104.45 133.56 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 120.365 1.439 . . . . 74.510000000000005 109.811 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -103.06 65.9 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.364 1.466 . . . . 74.409999999999997 112.257 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -78.86 7.11 7.65 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 120.208 -1.557 . . . . 74.200000000000003 113.826 -169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.481 HG23 HG22 ' A' ' 85' ' ' ILE . 33.8 p -81.3 -174.58 4.99 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.278 1.431 . . . . 71.310000000000002 112.492 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.55 14.57 18.41 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.286 1.587 . . . . 75.299999999999997 115.286 177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -128.9 171.08 12.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.909 0.777 . . . . 74.129999999999995 111.182 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -98.97 152.87 19.32 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.152 -1.425 . . . . 75.219999999999999 107.152 167.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 63' ' ' THR . 2.9 m -133.63 155.71 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.498 1.119 . . . . 74.099999999999994 108.494 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.7 OUTLIER -150.59 16.92 0.8 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.298 0.851 . . . . 55.210000000000001 113.298 -160.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.72 43.01 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.069 0.948 . . . . 61.439999999999998 110.391 -169.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.0 mp -86.63 119.89 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.006 -1.684 . . . . 73.420000000000002 107.09 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' GLN . 18.7 tttt -103.69 142.21 34.74 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 117.406 -1.283 . . . . 62.399999999999999 109.517 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 6.1 m -132.57 146.19 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 CA-C-O 117.042 -1.456 . . . . 73.439999999999998 109.729 173.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 105.07 6.34 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.337 -0.839 . . . . 72.109999999999999 108.811 -169.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -112.4 4.82 17.78 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 121.019 1.736 . . . . 74.420000000000002 114.148 -164.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.23 168.45 25.36 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 128.799 2.84 . . . . 73.010000000000005 105.238 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.57 11.69 1.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.194 0.998 . . . . 73.129999999999995 113.522 -165.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -169.39 46.74 0.21 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.731 1.634 . . . . 62.119999999999997 110.873 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -144.05 116.45 8.55 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 117.175 -1.393 . . . . 73.299999999999997 109.261 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 7.3 pt-20 -130.08 163.81 25.75 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.377 1.071 . . . . 72.129999999999995 110.765 171.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 25' ' ' LYS . 2.8 mm100 -144.94 133.01 21.42 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 127.73 2.412 . . . . 74.329999999999998 106.36 -174.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . 0.298 28.7 p -114.78 142.04 47.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 124.429 1.08 . . . . 30.43 110.171 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.92 134.99 30.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 170.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -55.78 -72.18 0.08 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 117.877 -1.059 . . . . 63.130000000000003 110.597 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 1.5 m -144.8 160.76 40.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.661 1.119 . . . . 73.299999999999997 109.546 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tp -144.81 114.42 7.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.155 -2.165 . . . . 72.409999999999997 105.155 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.53 177.63 25.53 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 124.361 1.038 . . . . 44.340000000000003 110.593 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.6 m -61.48 126.26 26.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.136 -1.061 . . . . 64.230000000000004 108.136 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 57.05 17.65 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.17 1.388 . . . . 54.219999999999999 114.309 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -67.79 165.35 17.61 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.817 -1.177 . . . . 74.5 111.792 176.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 p -149.81 147.33 27.85 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.967 -1.469 . . . . 72.239999999999995 111.326 -178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -155.57 143.04 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 127.268 2.227 . . . . 74.340000000000003 108.012 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -121.84 140.2 52.67 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 127.377 2.271 . . . . 73.340000000000003 106.591 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -142.6 152.66 42.76 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.657 -0.701 . . . . 62.240000000000002 111.771 171.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -65.85 175.44 1.96 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.23 1.412 . . . . 54.32 109.677 169.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 p -127.54 -172.95 2.79 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.915 1.686 . . . . 75.5 108.276 172.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -116.58 15.41 15.56 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.061 1.744 . . . . 74.209999999999994 110.326 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -141.94 130.75 22.91 Favored 'General case' 0 C--N 1.345 0.385 0 O-C-N 120.513 -1.367 . . . . 64.530000000000001 110.046 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.11 -4.87 89.62 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 121.636 -0.665 . . . . 71.349999999999994 113.545 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t -143.72 155.4 44.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.643 1.222 . . . . 72.230000000000004 109.001 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -151.23 144.2 16.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.443 2.297 . . . . 74.540000000000006 106.209 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.97 10.31 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.688 1.595 . . . . 73.430000000000007 110.881 170.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -147.84 153.64 39.42 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.295 -1.503 . . . . 74.010000000000005 108.708 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.2 tpp -153.95 137.29 15.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.675 -0.861 . . . . 62.439999999999998 108.675 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -128.14 106.74 9.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.194 -1.41 . . . . 74.140000000000001 107.194 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 t -79.56 147.12 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.967 -1.124 . . . . 71.209999999999994 107.967 166.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 113.06 3.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.7 -2.334 . . . . 52.5 104.7 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.58 178.13 28.21 Favored Glycine 0 CA--C 1.521 0.444 0 O-C-N 120.414 -1.428 . . . . 61.109999999999999 112.312 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.66 131.9 23.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.157 0.583 . . . . 64.400000000000006 110.312 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.522 ' HA ' HG12 ' A' ' 21' ' ' VAL . 9.8 p -68.85 171.74 7.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.686 1.994 . . . . 70.040000000000006 111.61 175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.56 -34.63 64.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.774 1.229 . . . . 75.140000000000001 112.487 170.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.2 m -70.15 -12.15 61.39 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.06 0.763 . . . . 74.219999999999999 113.06 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.81 16.23 79.42 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.098 -1.39 . . . . 53.43 112.292 -168.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.21 134.47 36.12 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.91 -1.515 . . . . 73.400000000000006 106.91 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -92.24 160.03 15.34 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.07 -0.968 . . . . 65.340000000000003 108.648 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.06 132.61 18.73 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.457 -0.942 . . . . 70.129999999999995 108.457 172.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.1 p -112.0 164.74 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.815 0.817 . . . . 63.030000000000001 109.776 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.64 87.28 0.15 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 108.247 -1.941 . . . . 71.019999999999996 108.247 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -93.37 124.96 37.72 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.001 0.9 . . . . 73.049999999999997 108.755 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -137.76 152.4 49.15 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.11 1.764 . . . . 73.439999999999998 110.745 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -138.44 176.0 9.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.037 1.335 . . . . 63.32 109.92 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 44.68 46.88 9.07 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 128.133 2.778 . . . . 74.530000000000001 113.022 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.71 154.72 39.52 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.848 -0.797 . . . . 65.120000000000005 108.848 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.81 170.79 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.461 1.505 . . . . 51.310000000000002 110.784 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.03 -161.75 18.6 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.58 1.086 . . . . 74.530000000000001 113.777 172.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -125.21 19.93 8.21 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.645 1.578 . . . . 71.209999999999994 113.141 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -136.87 174.75 10.28 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.312 -1.493 . . . . 64.209999999999994 112.136 164.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 148.36 31.06 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.69 1.196 . . . . 75.510000000000005 109.884 176.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -122.57 175.58 6.4 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.511 1.524 . . . . 75.319999999999993 108.764 163.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.26 121.25 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 105.561 -2.014 . . . . 61.520000000000003 105.561 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -101.99 96.42 7.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.574 -1.639 . . . . 64.400000000000006 106.574 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG22 HG23 ' A' ' 17' ' ' THR . 81.2 mt -75.52 119.0 22.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 104.213 -2.514 . . . . 61.420000000000002 104.213 168.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.6 173.04 14.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.532 1.933 . . . . 60.200000000000003 108.186 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.2 mt -114.18 155.52 25.93 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.515 1.126 . . . . 74.540000000000006 109.106 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -159.07 -171.56 3.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.853 1.261 . . . . 72.310000000000002 109.272 173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 64.81 -63.31 0.18 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 129.938 3.295 . . . . 73.019999999999996 113.371 173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -147.28 34.7 0.88 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.659 1.983 . . . . 42.219999999999999 108.58 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 52.86 35.68 19.6 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.265 1.826 . . . . 71.120000000000005 111.81 -163.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -82.32 168.62 17.38 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 123.76 0.824 . . . . 50.329999999999998 108.965 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.72 120.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 119.581 -0.848 . . . . 70.239999999999995 110.915 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.16 177.14 6.87 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.823 1.249 . . . . 54.5 109.062 168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.8 t -125.84 133.46 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.248 -2.13 . . . . 73.140000000000001 105.248 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -120.42 168.02 11.74 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.802 1.241 . . . . 71.420000000000002 109.133 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 97' ' ' ILE . 2.4 pt -148.89 146.36 21.54 Favored Pre-proline 0 N--CA 1.451 -0.401 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.418 175.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.25 118.73 5.64 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 N-CA-C 108.636 -1.332 . . . . 60.310000000000002 108.636 167.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -138.16 -178.09 5.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.771 1.628 . . . . 74.25 109.155 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 164.78 -39.64 0.3 Allowed Glycine 0 C--O 1.226 -0.403 0 C-N-CA 124.757 1.17 . . . . 43.340000000000003 111.65 171.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -78.75 45.62 0.61 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.152 1.781 . . . . 62.450000000000003 110.283 176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.62 105.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 126.362 1.865 . . . . 73.430000000000007 108.121 -171.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.172 1.789 . . . . 73.420000000000002 110.086 162.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 CA-C-O 118.684 -1.065 . . . . 74.299999999999997 111.24 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 -178.29 0.83 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 117.992 0.896 . . . . 75.310000000000002 110.412 170.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -120.42 14.78 12.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.066 0.946 . . . . 70.319999999999993 109.695 168.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.39 23.15 1.31 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.851 1.26 . . . . 74.129999999999995 111.381 176.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.0 78.65 1.38 Allowed Glycine 0 C--N 1.34 0.79 0 O-C-N 120.762 -1.211 . . . . 52.229999999999997 110.509 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -148.65 65.28 1.06 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.301 1.04 . . . . 65.140000000000001 110.846 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -139.05 36.66 2.13 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 121.717 -0.614 . . . . 72.329999999999998 109.904 -170.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 p -83.79 169.94 14.67 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 122.031 0.919 . . . . 61.009999999999998 112.381 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p -78.95 -177.65 5.67 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 121.756 -0.59 . . . . 72.299999999999997 112.06 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -136.32 169.16 18.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.993 -1.003 . . . . 73.010000000000005 108.421 165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.6 mt -134.36 154.12 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.812 1.645 . . . . 74.120000000000005 107.055 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HD2' HD11 ' A' ' 14' ' ' ILE . 9.6 ttm180 -145.54 122.54 11.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.938 -1.101 . . . . 73.430000000000007 108.759 161.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.48 134.08 34.6 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.227 -1.397 . . . . 74.230000000000004 107.227 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.2 mp -124.12 119.5 56.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 125.106 1.362 . . . . 64.450000000000003 107.624 170.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.537 ' HB2' HD12 ' A' ' 39' ' ' LEU . 25.2 t30 -77.71 69.52 3.96 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.447 0.906 . . . . 72.209999999999994 113.447 173.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -78.9 49.74 0.95 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.382 -1.449 . . . . 72.329999999999998 111.954 -173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.25 168.88 18.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.686 1.994 . . . . 74.340000000000003 112.013 -170.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.47 9.44 7.39 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.426 1.891 . . . . 72.109999999999999 114.632 -176.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -130.25 173.79 10.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.853 0.751 . . . . 64.010000000000005 111.899 -173.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -99.05 154.66 17.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.335 1.454 . . . . 55.119999999999997 109.35 166.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 63' ' ' THR . 8.6 m -135.58 143.62 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.021 1.328 . . . . 55.350000000000001 108.747 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.19 18.15 4.07 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.396 -0.815 . . . . 71.349999999999994 113.145 -165.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.532 HD21 ' HB ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -175.12 54.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.923 0.889 . . . . 54.020000000000003 109.893 -170.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.15 104.88 11.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.828 -1.545 . . . . 61.210000000000001 106.828 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -84.19 132.62 34.65 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.335 -1.357 . . . . 71.219999999999999 107.335 163.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -128.21 149.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 124.639 1.175 . . . . 60.450000000000003 108.228 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 m -133.09 153.93 51.05 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 106.844 -1.539 . . . . 72.109999999999999 106.844 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CZ2' ' HE2' ' A' ' 32' ' ' LYS . 45.7 p90 -142.42 19.45 2.05 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 122.672 1.225 . . . . 52.32 110.543 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -170.72 -169.97 0.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.821 1.248 . . . . 75.200000000000003 109.305 -167.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.58 94.49 6.15 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.615 -1.254 . . . . 73.530000000000001 107.615 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.75 26.86 33.7 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.533 0.587 . . . . 72.5 113.672 174.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -127.72 104.15 7.69 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.478 -2.045 . . . . 71.209999999999994 105.478 166.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.56 162.17 27.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.946 2.098 . . . . 55.43 109.156 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.6 174.18 12.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.262 1.025 . . . . 74.450000000000003 109.729 168.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -134.41 147.49 50.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.57 0.7 . . . . 75.129999999999995 110.634 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.52 164.18 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.897 -1.52 . . . . 75.010000000000005 106.897 168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -69.57 -84.99 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.984 1.314 . . . . 61.450000000000003 109.414 164.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.9 m -133.53 160.17 38.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.506 1.523 . . . . 63.43 107.642 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -134.29 118.27 17.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.678 1.591 . . . . 73.25 108.643 176.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.52 170.16 10.14 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.939 1.733 . . . . 71.019999999999996 113.576 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -72.79 134.14 44.8 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 120.397 2.098 . . . . 65.430000000000007 109.884 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.79 2.63 0.76 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 126.973 2.109 . . . . 72.049999999999997 115.076 -171.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' C ' HD11 ' A' ' 39' ' ' LEU . 1.1 m-20 -71.31 175.18 5.59 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.806 0.812 . . . . 71.409999999999997 110.711 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 p -155.97 153.89 30.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 122.966 0.507 . . . . 71.420000000000002 112.158 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -148.51 141.99 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 108.661 -0.866 . . . . 62.340000000000003 108.661 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -109.23 149.76 28.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 126.44 1.896 . . . . 44.43 108.533 174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -146.6 159.46 43.42 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.773 -1.103 . . . . 73.049999999999997 109.103 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -68.37 169.46 10.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.307 -0.861 . . . . 63.399999999999999 109.217 170.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.9 145.92 44.9 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.67 -1.233 . . . . 74.0 107.67 168.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -93.82 34.03 1.25 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.94 1.296 . . . . 73.409999999999997 110.784 -169.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.07 155.81 46.86 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.976 1.31 . . . . 73.140000000000001 108.767 -174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.3 -14.12 59.21 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.203 0.906 . . . . 72.230000000000004 113.814 -173.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 p -163.89 167.08 21.12 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.163 1.385 . . . . 53.399999999999999 108.053 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.18 139.72 41.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 107.257 -1.386 . . . . 52.539999999999999 107.257 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -135.03 -0.69 2.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.021 0.928 . . . . 71.219999999999999 112.936 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -147.25 160.6 42.29 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 121.165 -0.96 . . . . 73.420000000000002 108.822 174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.3 ttm -144.46 144.97 31.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 63.210000000000001 107.16 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.18 98.29 3.82 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.676 -1.972 . . . . 75.439999999999998 105.676 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.39 153.56 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 O-C-N 120.865 -1.147 . . . . 63.539999999999999 110.348 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.0 96.93 1.13 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 104.855 -2.276 . . . . 63.130000000000003 104.855 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -127.15 166.87 19.76 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 121.476 -0.765 . . . . 75.519999999999996 111.499 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.532 ' HB ' HD21 ' A' ' 23' ' ' ASN . 1.2 m -139.19 134.5 32.84 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.51 0.655 . . . . 75.219999999999999 110.047 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.524 ' HA ' HG12 ' A' ' 21' ' ' VAL . 8.7 p -77.66 169.91 17.49 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.537 1.935 . . . . 60.32 112.511 -177.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -51.86 -42.29 62.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.289 1.836 . . . . 72.319999999999993 110.351 169.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -68.64 -0.25 5.0 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.208 1.403 . . . . 23.23 113.975 175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.8 18.37 77.42 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 119.722 1.147 . . . . 41.229999999999997 111.933 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -87.99 141.96 28.16 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 119.027 1.414 . . . . 74.319999999999993 107.899 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -108.36 147.99 30.74 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -137.47 150.66 47.75 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.647 1.179 . . . . 75.409999999999997 108.972 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.3 p -139.69 160.72 39.23 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.844 1.257 . . . . 75.420000000000002 108.875 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -141.51 100.27 0.26 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 105.328 -3.109 . . . . 75.209999999999994 105.328 174.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -101.07 96.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.575 -2.009 . . . . 75.519999999999996 105.575 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -116.85 142.95 46.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.701 1.2 . . . . 75.439999999999998 109.57 -167.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -133.57 171.25 14.36 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.317 1.447 . . . . 51.240000000000002 108.635 172.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.41 41.74 76.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-O 119.494 -0.614 . . . . 60.329999999999998 112.089 173.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.6 mt -96.42 151.19 19.78 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.386 0.612 . . . . 75.109999999999999 109.776 -177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 166.47 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 124.787 1.235 . . . . 71.409999999999997 109.293 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.48 157.21 30.52 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.79 1.186 . . . . 55.439999999999998 111.078 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -83.17 5.22 23.49 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.624 1.17 . . . . 74.200000000000003 112.977 -174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -144.42 159.94 41.89 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.966 1.306 . . . . 73.400000000000006 108.387 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.35 97.78 3.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.182 0.992 . . . . 61.039999999999999 108.519 -171.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -91.48 152.21 20.45 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 109.171 -0.677 . . . . 65.120000000000005 109.171 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.4 t -137.05 117.32 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 106.563 -1.644 . . . . 55.509999999999998 106.563 -170.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -103.83 100.81 10.61 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.801 -1.555 . . . . 70.299999999999997 106.801 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 60.2 mt -78.5 110.63 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 103.379 -2.823 . . . . 62.340000000000003 103.379 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.63 173.52 10.81 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.436 1.895 . . . . 74.409999999999997 106.332 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 35.1 mt -92.41 173.82 7.61 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.026 -1.102 . . . . 73.400000000000006 108.026 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -149.46 -170.82 3.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.401 -0.52 . . . . 73.420000000000002 110.056 146.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.344 0.1 OUTLIER 48.57 -74.28 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 129.155 2.982 . . . . 75.310000000000002 116.646 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.52 36.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.791 1.636 . . . . 63.130000000000003 109.787 -160.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.98 49.79 18.15 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.204 1.802 . . . . 73.329999999999998 111.399 -166.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.62 146.1 26.18 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.43 -1.693 . . . . 75.150000000000006 106.43 160.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 t -88.35 113.27 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 123.499 0.499 . . . . 62.409999999999997 109.826 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.9 -173.21 2.64 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.095 0.958 . . . . 61.399999999999999 108.795 172.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.4 t -138.18 129.84 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.903 -1.518 . . . . 53.109999999999999 106.903 167.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -117.66 168.03 10.8 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.121 1.368 . . . . 73.340000000000003 109.684 178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 97' ' ' ILE . 5.2 pt -152.37 143.91 16.16 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 107.538 -1.282 . . . . 74.340000000000003 107.538 178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.05 78.54 3.55 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.077 1.851 . . . . 74.0 109.763 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -94.21 175.23 6.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.275 1.43 . . . . 74.439999999999998 108.501 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.91 -11.53 0.03 OUTLIER Glycine 0 N--CA 1.466 0.69 0 O-C-N 121.583 -0.698 . . . . 75.329999999999998 113.261 -168.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -135.32 63.92 1.6 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 104.246 -2.502 . . . . 63.229999999999997 104.246 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.7 tt -136.49 77.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 125.758 1.623 . . . . 63.409999999999997 108.255 -167.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.5 t0 . . . . . 0 C--O 1.249 1.029 0 C-N-CA 127.147 2.179 . . . . 63.439999999999998 111.707 -178.201 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.246 -1.142 . . . . 65.239999999999995 110.246 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.46 27.3 2.3 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.779 2.431 . . . . 65.030000000000001 110.423 -175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 64.04 -2.66 0.54 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.472 2.309 . . . . 74.099999999999994 114.861 -170.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.87 29.61 1.5 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.251 1.387 . . . . 70.430000000000007 111.576 -172.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 -140.04 0.48 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 125.684 1.611 . . . . 31.129999999999999 112.092 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -128.17 42.46 3.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.672 0.789 . . . . 73.030000000000001 110.933 -173.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -122.35 24.69 9.25 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.488 1.115 . . . . 63.0 112.32 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -72.61 165.69 24.22 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.938 1.695 . . . . 74.040000000000006 111.563 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 p -90.29 -179.04 5.53 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.335 1.854 . . . . 64.430000000000007 112.867 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.5 m -142.52 160.37 40.42 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.844 0.857 . . . . 61.229999999999997 109.868 169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mt -133.08 148.63 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.455 -1.313 . . . . 71.0 107.455 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 120.01 14.93 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.526 0.73 . . . . 74.209999999999994 110.119 -177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.8 125.93 51.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.223 -1.028 . . . . 74.219999999999999 108.223 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.45 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.2 mp -125.8 114.1 37.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.15 0.98 . . . . 74.129999999999995 110.094 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB2' HD12 ' A' ' 39' ' ' LEU . 15.0 t30 -80.04 60.86 3.72 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.499 1.296 . . . . 45.009999999999998 114.499 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' HG22 ' A' ' 14' ' ' ILE . 9.4 mt-30 -72.66 41.7 0.09 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.379 2.272 . . . . 74.349999999999994 114.562 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.47 -168.1 1.72 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.826 2.45 . . . . 51.109999999999999 109.573 -171.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.92 5.66 40.98 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.458 1.503 . . . . 63.549999999999997 113.814 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.28 -163.5 0.93 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.652 1.581 . . . . 73.140000000000001 109.562 -161.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -135.12 153.39 52.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.052 -1.833 . . . . 24.510000000000002 106.052 166.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG23 HD11 ' A' ' 24' ' ' ILE . 28.0 m -133.22 144.51 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 119.926 1.239 . . . . 73.439999999999998 111.21 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.45 15.94 2.56 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.276 1.213 . . . . 72.450000000000003 114.276 -165.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.07 59.84 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.443 -0.947 . . . . 62.340000000000003 108.443 -163.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 21' ' ' VAL . 3.1 mp -102.74 104.0 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.541 1.136 . . . . 71.409999999999997 108.32 -174.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.422 ' HG2' HG22 ' A' ' 35' ' ' THR . 1.6 mtpp -83.91 136.45 34.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.896 -1.15 . . . . 70.140000000000001 107.896 165.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.64 144.55 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 107.198 -1.408 . . . . 70.200000000000003 107.198 171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.0 m -142.28 115.51 8.9 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.042 1.292 . . . . 71.040000000000006 108.542 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -107.12 15.61 25.01 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.773 1.629 . . . . 70.140000000000001 112.188 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 -176.18 2.6 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.809 -1.182 . . . . 73.400000000000006 110.78 -173.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -89.48 61.63 5.65 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.419 0.688 . . . . 75.120000000000005 109.404 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.13 -9.18 9.64 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.573 -1.126 . . . . 43.130000000000003 114.131 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.1 117.74 27.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.958 1.879 . . . . 73.010000000000005 108.709 176.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.39 176.58 9.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.776 0.83 . . . . 74.219999999999999 112.093 -177.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -159.11 173.76 15.92 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 126.911 2.084 . . . . 74.310000000000002 108.311 162.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 25' ' ' LYS . 49.3 p -126.18 144.11 50.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.129 0.972 . . . . 70.430000000000007 109.564 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.98 130.7 49.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.061 -1.459 . . . . 65.340000000000003 107.061 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.01 -61.86 2.32 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.636 0.255 . . . . 71.200000000000003 111.583 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 m -149.53 154.78 39.27 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 106.764 -1.569 . . . . 65.540000000000006 106.764 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -128.57 128.27 43.94 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 104.59 -2.374 . . . . 63.219999999999999 104.59 168.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 39' ' ' LEU . . . -66.65 -151.77 0.17 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 125.191 1.557 . . . . 30.43 114.591 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.46 124.05 47.32 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.093 -1.24 . . . . 51.229999999999997 108.863 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 59.15 9.81 1.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.654 1.582 . . . . 70.209999999999994 114.421 -173.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -87.02 -178.53 6.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.283 1.433 . . . . 74.230000000000004 109.566 -157.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.5 p -142.91 156.57 44.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.35 0.66 . . . . 74.239999999999995 110.945 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.498 HG22 HD23 ' A' ' 39' ' ' LEU . 18.3 tt -147.59 159.26 8.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.236 2.215 . . . . 61.100000000000001 106.621 166.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.6 147.16 40.71 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.011 -1.107 . . . . 63.039999999999999 108.011 173.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.15 161.56 39.94 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.271 1.428 . . . . 73.109999999999999 109.405 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -96.87 125.29 41.2 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.255 1.022 . . . . 54.32 109.22 -173.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.69 172.38 4.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.57 1.148 . . . . 72.340000000000003 110.77 162.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.58 20.35 11.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.896 1.678 . . . . 62.200000000000003 109.053 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.77 52.78 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.563 1.945 . . . . 70.230000000000004 109.519 -169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.01 -8.35 58.03 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.841 1.21 . . . . 72.409999999999997 115.204 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 p -173.15 158.97 3.78 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.597 1.559 . . . . 73.439999999999998 109.899 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.3 t -136.26 105.36 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 126.547 1.939 . . . . 71.400000000000006 107.127 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.75 7.75 37.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.452 0.701 . . . . 64.040000000000006 112.797 174.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.08 153.83 30.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.026 1.285 . . . . 73.200000000000003 110.265 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.1 tpp -148.87 125.12 10.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.673 -1.232 . . . . 65.430000000000007 107.673 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -121.53 111.93 17.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.013 1.725 . . . . 74.040000000000006 106.821 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.64 145.29 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.071 1.748 . . . . 72.420000000000002 109.509 -174.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -168.02 103.43 0.47 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.116 -1.068 . . . . 45.200000000000003 108.116 -173.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -149.2 177.95 27.06 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.507 -0.745 . . . . 70.420000000000002 111.354 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -130.36 143.28 50.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.626 1.17 . . . . 71.409999999999997 112.28 -168.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -78.55 171.23 15.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.024 2.13 . . . . 64.209999999999994 111.103 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.8 -47.28 67.72 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.105 0.962 . . . . 51.140000000000001 109.349 165.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -67.6 2.18 1.98 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.867 1.667 . . . . 32.310000000000002 114.09 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.17 13.02 84.07 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 119.588 1.085 . . . . 62.420000000000002 112.576 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 62' ' ' THR . 4.6 mt-10 -83.79 154.6 23.44 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.211 -1.403 . . . . 72.150000000000006 107.211 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.08 115.53 21.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.038 0.923 . . . . 71.209999999999994 109.635 -172.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HB3' HG22 ' A' ' 93' ' ' VAL . 5.9 p90 -83.14 145.32 29.27 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 112.483 -2.144 . . . . 73.120000000000005 106.636 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.9 p -137.02 158.91 43.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 119.577 1.08 . . . . 71.439999999999998 109.87 162.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -145.35 89.34 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.581 -1.008 . . . . 74.109999999999999 110.581 -177.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -101.64 83.72 2.46 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.758 0.823 . . . . 73.230000000000004 112.106 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.15 152.69 26.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.128 1.371 . . . . 44.539999999999999 113.334 -168.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.33 176.11 9.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.241 1.417 . . . . 75.340000000000003 109.863 175.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.36 22.65 75.42 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.253 0.454 . . . . 64.409999999999997 113.985 170.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -78.68 166.51 22.43 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.594 1.188 . . . . 72.430000000000007 110.655 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 m -147.36 164.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 129.397 3.079 . . . . 64.310000000000002 107.879 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.57 155.58 27.19 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.851 0.695 . . . . 64.329999999999998 111.738 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -92.38 2.27 56.75 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.967 1.099 . . . . 71.340000000000003 113.967 -167.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.56 162.93 20.89 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.264 1.425 . . . . 74.140000000000001 108.507 173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -139.43 97.6 3.32 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.706 173.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.62 162.69 29.15 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.264 -0.897 . . . . 70.200000000000003 109.796 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.79 109.77 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.711 -2.329 . . . . 71.109999999999999 104.711 169.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -84.65 136.21 33.85 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 106.188 -1.782 . . . . 74.310000000000002 106.188 164.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.0 mt -119.26 121.48 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 105.591 -2.003 . . . . 71.319999999999993 105.591 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -154.87 173.14 16.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.551 1.14 . . . . 74.230000000000004 111.924 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.1 mt -101.89 141.07 35.3 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.459 1.504 . . . . 70.150000000000006 108.93 -175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -138.06 -178.62 5.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.913 -1.143 . . . . 60.109999999999999 107.913 172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 71.77 -77.02 0.06 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 127.252 2.221 . . . . 74.540000000000006 111.431 163.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.41 39.52 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 127.28 2.232 . . . . 74.319999999999993 110.467 -167.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 53.09 41.11 32.14 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.295 1.438 . . . . 72.450000000000003 110.126 -166.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -91.13 135.11 33.99 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 104.248 -2.501 . . . . 74.519999999999996 104.248 166.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 69' ' ' PHE 0.266 1.6 p -71.56 133.02 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 C-N-CA 117.468 -1.693 . . . . 64.219999999999999 110.041 164.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -107.17 -164.49 0.99 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.753 2.821 . . . . 74.349999999999994 108.142 168.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.4 t -134.18 147.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 105.63 -1.989 . . . . 52.039999999999999 105.63 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.36 172.69 11.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.364 1.866 . . . . 74.540000000000006 109.586 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 pt -156.49 145.38 14.85 Favored Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 124.677 1.191 . . . . 63.140000000000001 108.77 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.65 115.24 3.99 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 N-CA-C 107.987 -1.582 . . . . 73.239999999999995 107.987 165.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -134.28 154.28 51.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.218 1.407 . . . . 71.120000000000005 107.874 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.8 -93.89 0.15 Allowed Glycine 0 CA--C 1.522 0.47 0 N-CA-C 108.008 -2.037 . . . . 73.430000000000007 108.008 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -105.49 75.63 1.16 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.707 1.603 . . . . 74.439999999999998 110.919 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 21.42 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.383 1.073 . . . . 73.019999999999996 112.749 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.707 -1.14 . . . . 72.409999999999997 109.011 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.57 -1.412 . . . . 73.420000000000002 109.57 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.43 175.13 5.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.516 -1.29 . . . . 73.219999999999999 107.516 166.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -72.93 -34.58 66.65 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 120.562 -0.455 . . . . 75.340000000000003 111.008 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -132.72 18.46 4.25 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 122.187 0.994 . . . . 75.450000000000003 110.068 -158.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.71 20.81 1.32 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.949 1.261 . . . . 75.340000000000003 115.316 -164.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -158.92 106.62 1.84 Allowed 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 105.635 -1.987 . . . . 62.340000000000003 105.635 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.73 32.09 5.15 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.566 1.146 . . . . 55.130000000000003 111.085 -177.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.68 135.38 38.06 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.341 1.856 . . . . 73.310000000000002 109.95 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.13 166.36 20.05 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.23 1.412 . . . . 74.109999999999999 110.612 166.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.3 m -132.1 158.7 40.93 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.636 -1.616 . . . . 72.019999999999996 106.636 168.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.0 mt -122.77 153.74 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.384 -1.339 . . . . 72.019999999999996 107.384 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' HD11 ' A' ' 14' ' ' ILE . 18.4 ttm-85 -136.73 138.39 40.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 108.383 -0.969 . . . . 55.240000000000002 108.383 166.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.37 137.28 49.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.772 -1.936 . . . . 64.310000000000002 105.772 168.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 12' ' ' ARG . 4.4 mp -121.86 161.58 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.53 1.932 . . . . 75.230000000000004 106.751 174.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -130.07 61.76 1.58 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.969 1.47 . . . . 71.310000000000002 114.969 -176.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -82.0 54.07 2.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.574 -1.328 . . . . 75.150000000000006 113.491 -169.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 p -118.53 -164.16 1.01 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.035 0.934 . . . . 72.519999999999996 112.311 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.15 3.25 19.99 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.312 1.227 . . . . 61.43 114.312 168.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.52 -163.59 0.97 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.531 1.532 . . . . 74.420000000000002 110.776 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -124.41 155.78 38.25 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.318 -1.489 . . . . 53.25 109.114 170.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.57 131.61 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.152 1.381 . . . . 44.039999999999999 108.256 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER -133.37 20.52 3.99 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.185 0.994 . . . . 65.349999999999994 113.154 -162.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -174.49 54.59 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.396 -0.815 . . . . 71.450000000000003 108.997 -164.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.51 105.14 16.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -71.49 150.9 44.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.382 -0.97 . . . . 52.030000000000001 108.382 164.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.27 143.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.935 -1.876 . . . . 52.119999999999997 105.935 164.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -131.9 110.09 10.54 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.981 -1.859 . . . . 72.510000000000005 105.981 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.1 p90 -103.85 15.35 28.89 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.355 1.062 . . . . 73.030000000000001 111.634 -169.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.17 -176.88 2.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.974 1.31 . . . . 71.030000000000001 109.062 -172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.74 6.56 20.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.933 1.086 . . . . 74.319999999999993 113.933 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.92 37.65 0.09 OUTLIER Glycine 0 C--N 1.335 0.512 0 CA-C-O 119.236 -0.758 . . . . 42.450000000000003 112.483 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -133.47 118.31 18.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 105.729 -1.952 . . . . 71.129999999999995 105.729 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.14 174.29 12.1 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 124.194 0.934 . . . . 72.349999999999994 110.027 177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.08 166.15 21.64 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 127.251 2.22 . . . . 71.540000000000006 107.827 169.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.13 143.28 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.985 -0.746 . . . . 74.25 108.985 170.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -80.67 166.94 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 124.405 1.082 . . . . 64.340000000000003 110.271 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.15 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.483 -0.932 . . . . 64.549999999999997 108.483 161.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 61.0 m -149.82 160.84 43.24 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.777 1.231 . . . . 65.129999999999995 107.958 -168.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 39' ' ' LEU . 4.4 tp -137.81 108.49 6.61 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 106.055 -1.832 . . . . 75.219999999999999 106.055 173.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.75 178.01 9.29 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 124.224 0.953 . . . . 62.310000000000002 111.267 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 125.71 24.88 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.398 -1.06 . . . . 63.530000000000001 110.124 -175.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 57.28 14.16 2.0 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.366 1.467 . . . . 73.310000000000002 113.819 -174.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.35 179.0 2.62 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.401 1.001 . . . . 55.439999999999998 112.037 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.6 p -152.02 158.29 42.86 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.177 -0.92 . . . . 60.409999999999997 110.578 173.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 tt -147.67 142.77 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 125.807 1.643 . . . . 55.119999999999997 106.635 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.29 127.74 44.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.554 1.942 . . . . 74.319999999999993 106.782 -172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -151.53 163.45 38.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.799 0.809 . . . . 75.409999999999997 110.034 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -78.24 166.15 23.06 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.89 0.876 . . . . 54.340000000000003 110.917 -174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.6 p -117.93 127.81 54.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.265 -1.754 . . . . 50.420000000000002 106.265 162.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.01 44.78 0.14 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.294 1.438 . . . . 52.409999999999997 111.316 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.73 164.57 33.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.257 1.823 . . . . 74.310000000000002 109.078 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.89 -7.6 47.11 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 123.593 0.616 . . . . 73.209999999999994 113.276 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.8 p -156.43 159.88 39.1 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 118.897 1.349 . . . . 73.310000000000002 109.076 172.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.8 t -142.45 97.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 107.128 -1.434 . . . . 55.409999999999997 107.128 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -94.05 -3.77 50.65 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.274 0.842 . . . . 72.010000000000005 113.274 171.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -143.81 145.82 32.63 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 120.793 -1.192 . . . . 70.120000000000005 109.653 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.1 ttm -145.36 100.31 3.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.527 -1.657 . . . . 75.409999999999997 106.527 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -86.38 118.88 26.1 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.287 -1.746 . . . . 74.219999999999999 106.287 170.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.494 HG22 ' H ' ' A' ' 71' ' ' GLY . 2.2 m -101.19 148.46 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 103.217 -2.883 . . . . 71.25 103.217 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 116.14 3.36 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.889 -2.263 . . . . 65.25 104.889 168.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.87 177.86 26.82 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.398 -0.681 . . . . 42.340000000000003 111.398 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.4 m -139.96 133.91 30.79 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.435 1.094 . . . . 74.450000000000003 108.826 -172.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.578 HG21 HG21 ' A' ' 93' ' ' VAL . 19.0 p -76.88 172.86 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.982 1.313 . . . . 62.439999999999998 112.138 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -49.16 -48.71 44.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.247 1.819 . . . . 71.420000000000002 109.815 167.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.95 9.69 2.77 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.302 1.441 . . . . 74.540000000000006 113.706 176.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.16 13.55 83.52 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-O 118.458 -1.19 . . . . 62.229999999999997 112.668 167.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.18 138.73 31.16 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.241 -1.392 . . . . 51.439999999999998 107.241 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -112.11 129.28 56.28 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 124.101 0.96 . . . . 73.140000000000001 108.973 -166.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -117.17 140.92 48.93 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.366 -1.346 . . . . 72.120000000000005 107.366 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -135.65 135.52 40.23 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.826 -1.176 . . . . 72.439999999999998 107.826 169.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.599 ' CA ' HG11 ' A' ' 95' ' ' VAL . . . -102.65 -77.34 1.22 Allowed Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 108.385 -1.886 . . . . 43.030000000000001 108.385 -174.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 58' ' ' ASP . 30.0 m-70 74.45 68.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 110.727 -2.736 . . . . 74.530000000000001 110.377 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -80.93 148.52 29.8 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.771 0.828 . . . . 74.349999999999994 109.085 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -148.98 162.3 40.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.1 1.36 . . . . 74.439999999999998 108.01 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.17 32.41 80.42 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.802 -0.999 . . . . 75.430000000000007 112.653 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.8 mt -64.86 167.53 7.49 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.71 0.804 . . . . 44.43 109.612 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 102' ' ' ILE . 3.2 t -129.83 159.78 41.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.503 -1.665 . . . . 74.430000000000007 106.503 173.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.52 153.89 28.71 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 125.182 1.372 . . . . 53.119999999999997 112.434 170.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.1 19.59 4.88 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.148 0.979 . . . . 62.43 110.638 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -139.16 162.27 35.38 Favored 'General case' 0 CA--C 1.512 -0.488 0 O-C-N 121.042 -1.036 . . . . 74.010000000000005 108.829 164.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.15 141.08 44.06 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 109.103 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -127.35 172.37 10.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.267 1.027 . . . . 61.229999999999997 108.311 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 94.5 t -142.25 122.84 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 104.979 -2.23 . . . . 72.450000000000003 104.979 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -100.51 142.14 32.4 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.198 -1.408 . . . . 72.510000000000005 107.198 169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.5 mt -124.5 115.98 46.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 101.999 -3.334 . . . . 64.349999999999994 101.999 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -152.71 164.91 36.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.709 1.603 . . . . 75.439999999999998 107.514 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.27 168.28 12.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.386 0.612 . . . . 74.319999999999993 112.075 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -87.13 178.21 6.97 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.708 1.603 . . . . 72.209999999999994 108.95 162.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.64 -44.8 47.81 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.603 1.561 . . . . 73.129999999999995 111.826 174.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -79.32 4.09 16.26 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.671 0.788 . . . . 61.439999999999998 112.836 -172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 63.59 29.35 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.87 1.268 . . . . 63.119999999999997 111.283 -160.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -76.81 175.3 9.57 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.412 -0.959 . . . . 73.230000000000004 108.412 167.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.578 HG21 HG21 ' A' ' 63' ' ' THR . 41.6 t -113.51 105.51 18.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 O-C-N 121.358 -0.838 . . . . 74.230000000000004 110.934 -161.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -111.92 179.45 4.01 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.36 1.076 . . . . 75.209999999999994 111.97 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' CA ' ' A' ' 71' ' ' GLY . 1.5 p -127.96 138.05 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 130.189 3.395 . . . . 61.520000000000003 109.103 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -133.75 171.38 14.22 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.128 2.171 . . . . 75.209999999999994 108.715 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.53 147.51 23.31 Favored Pre-proline 0 C--O 1.237 0.422 0 O-C-N 120.833 -1.167 . . . . 61.549999999999997 111.43 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.63 116.88 4.75 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.102 2.535 . . . . 63.149999999999999 108.447 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.69 -170.73 3.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.174 2.19 . . . . 52.009999999999998 107.364 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.6 -70.03 0.33 Allowed Glycine 0 CA--C 1.502 -0.719 0 N-CA-C 106.466 -2.654 . . . . 31.039999999999999 106.466 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -119.9 83.36 2.03 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 107.291 -1.374 . . . . 64.239999999999995 107.291 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.514 HG23 ' HB ' ' A' ' 77' ' ' VAL . 7.8 tt -127.54 27.28 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 126.42 1.888 . . . . 74.150000000000006 108.913 168.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.595 1.558 . . . . 51.340000000000003 110.238 176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.49 0 N-CA-C 109.059 -1.617 . . . . 72.549999999999997 109.059 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 66.3 0.66 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.576 -1.268 . . . . 71.510000000000005 107.576 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -51.19 -53.26 36.62 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.05 0.94 . . . . 64.230000000000004 108.995 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -157.86 82.6 0.87 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 104.43 -2.433 . . . . 72.239999999999995 104.43 170.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.84 -169.17 25.3 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 109.511 -1.436 . . . . 40.240000000000002 109.511 -174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -123.25 67.02 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.432 -1.322 . . . . 75.129999999999995 107.432 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -147.7 53.33 1.05 Allowed 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.936 2.094 . . . . 75.129999999999995 106.042 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 p -103.99 167.11 9.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.458 1.103 . . . . 73.430000000000007 111.456 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -126.32 160.02 31.53 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.198 2.199 . . . . 62.130000000000003 108.907 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -132.96 145.47 50.92 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 123.696 0.623 . . . . 75.129999999999995 109.551 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -101.33 159.37 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.806 -1.553 . . . . 75.420000000000002 106.806 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -145.96 113.97 6.54 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.575 -1.639 . . . . 74.530000000000001 106.575 161.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.48 139.75 35.0 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.604 -1.258 . . . . 61.450000000000003 107.604 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG22 ' HG3' ' A' ' 16' ' ' GLN . 4.2 mp -122.76 145.78 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.109 -1.812 . . . . 75.420000000000002 106.109 168.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.457 ' CB ' HD12 ' A' ' 39' ' ' LEU . 14.3 t30 -118.82 53.71 0.98 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.861 1.664 . . . . 61.520000000000003 110.328 -176.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' HG3' HG22 ' A' ' 14' ' ' ILE . 15.9 mt-30 -70.81 61.79 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.205 2.202 . . . . 60.020000000000003 110.658 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 p -141.73 161.18 38.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 128.292 2.637 . . . . 75.109999999999999 108.949 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -73.56 -22.2 60.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.124 -0.943 . . . . 74.200000000000003 113.276 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -95.75 169.11 10.24 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.086 -1.009 . . . . 75.329999999999998 111.503 -175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.57 147.44 22.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.9 1.68 . . . . 73.329999999999998 107.173 164.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.93 154.58 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 121.248 -0.907 . . . . 73.010000000000005 110.448 174.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 63' ' ' THR . 1.1 pmtp? -138.42 28.74 2.46 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 113.509 0.929 . . . . 75.239999999999995 113.509 -163.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.24 60.48 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.36 -0.237 . . . . 74.109999999999999 110.36 -166.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.73 93.32 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 120.375 -1.453 . . . . 75.310000000000002 109.069 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 119.99 19.1 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 117.221 -1.371 . . . . 44.43 107.841 168.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 34' ' ' GLN . 9.9 p -113.9 153.45 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 121.024 1.738 . . . . 73.450000000000003 107.081 173.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.1 m -140.79 144.03 35.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 117.309 -1.329 . . . . 63.350000000000001 107.438 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -144.11 10.46 1.52 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.182 1.355 . . . . 70.140000000000001 113.202 -175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -178.89 7.31 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 125.995 1.718 . . . . 73.349999999999994 108.473 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -84.28 66.69 9.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.111 0.957 . . . . 73.510000000000005 110.773 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.91 -22.21 5.17 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.838 1.208 . . . . 42.119999999999997 112.745 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -83.7 113.27 20.76 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 118.917 1.359 . . . . 74.349999999999994 107.708 -179.606 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.56 176.75 8.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.705 1.602 . . . . 63.25 110.886 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.42 ' HB2' HG12 ' A' ' 26' ' ' VAL . 17.3 mm100 -138.2 168.17 20.3 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 126.946 2.098 . . . . 64.239999999999995 109.075 173.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -135.51 160.21 39.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.012 0.91 . . . . 62.130000000000003 108.547 148.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.0 m -108.99 175.16 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 126.19 1.796 . . . . 64.109999999999999 109.323 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -77.17 -85.16 0.06 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.961 1.705 . . . . 64.230000000000004 109.475 168.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.8 m -146.5 152.8 39.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.758 1.617 . . . . 74.439999999999998 110.813 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.457 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -133.63 132.73 41.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.087 2.155 . . . . 73.510000000000005 109.609 -178.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.3 177.27 46.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.213 1.387 . . . . 53.509999999999998 113.353 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 p -72.22 129.79 39.28 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.193 -1.18 . . . . 74.329999999999998 109.164 171.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 59.16 11.41 2.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.448 1.899 . . . . 74.5 114.182 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.7 177.12 7.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.018 0.927 . . . . 73.120000000000005 110.754 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 p -150.17 171.32 17.11 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.791 0.836 . . . . 63.109999999999999 110.764 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 tt -155.67 143.84 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 125.481 1.513 . . . . 74.219999999999999 108.636 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.35 147.82 45.81 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 126.073 1.749 . . . . 71.5 109.036 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -158.26 156.95 31.6 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.701 0.626 . . . . 75.349999999999994 110.772 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.9 t -62.49 163.09 9.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.021 1.728 . . . . 64.519999999999996 110.184 172.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.69 166.37 19.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.795 1.638 . . . . 75.109999999999999 107.416 174.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -112.13 60.4 0.63 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.9 1.28 . . . . 64.140000000000001 108.678 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.52 113.97 3.47 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.386 -0.821 . . . . 54.350000000000001 109.758 -162.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.56 -38.53 43.56 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.886 -0.885 . . . . 62.350000000000001 110.886 164.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 p -155.58 165.64 35.96 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.06 1.43 . . . . 72.109999999999999 110.831 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -133.85 146.93 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.321 -1.363 . . . . 73.310000000000002 107.321 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.14 1.27 0.96 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.327 1.051 . . . . 72.519999999999996 112.762 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.52 157.75 43.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 125.509 1.524 . . . . 54.149999999999999 107.39 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 ttm -144.43 145.55 31.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.767 -1.568 . . . . 45.439999999999998 106.767 169.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.95 73.87 1.43 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.925 1.345 . . . . 73.329999999999998 107.729 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.25 153.77 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 115.041 -0.981 . . . . 63.119999999999997 109.712 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.427 ' HB ' HG22 ' A' ' 70' ' ' THR . 1.4 t -160.28 116.9 2.43 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.874 -1.898 . . . . 72.319999999999993 105.874 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.74 -176.9 17.27 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 124.828 1.204 . . . . 43.520000000000003 110.551 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.09 139.77 29.08 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 117.3 0.55 . . . . 73.099999999999994 110.908 -170.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.442 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 29.7 p -70.94 172.27 9.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.451 1.5 . . . . 74.219999999999999 112.199 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -18.39 1.51 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 116.012 1.856 . . . . 74.209999999999994 116.012 166.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 t -115.49 4.06 14.18 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.643 1.977 . . . . 73.030000000000001 111.48 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.1 73.25 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-O 118.534 -1.148 . . . . 52.439999999999998 113.689 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -75.26 124.8 27.72 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 119.689 1.745 . . . . 62.109999999999999 108.848 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -76.04 147.93 38.36 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.861 -1.162 . . . . 74.049999999999997 107.861 173.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -137.62 149.42 46.61 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.729 -1.582 . . . . 63.350000000000001 106.729 168.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 HG22 ' HB ' ' A' ' 60' ' ' THR . 71.7 p -147.55 164.62 32.86 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.971 -1.492 . . . . 74.049999999999997 106.971 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -139.57 93.87 0.2 Allowed Glycine 0 CA--C 1.506 -0.528 0 N-CA-C 106.43 -2.668 . . . . 64.25 106.43 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -84.83 115.17 22.59 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.786 -1.931 . . . . 74.450000000000003 105.786 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.0 160.39 40.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.831 0.824 . . . . 70.230000000000004 109.948 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -154.88 172.99 17.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.578 1.551 . . . . 70.219999999999999 108.651 -170.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.33 29.32 63.02 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.627 0.632 . . . . 72.420000000000002 112.952 177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.6 mt -77.31 153.87 33.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.68 0.752 . . . . 64.239999999999995 109.357 -174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -140.87 157.32 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 124.416 1.086 . . . . 73.230000000000004 109.704 -178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.36 160.68 29.17 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.92 1.248 . . . . 65.510000000000005 112.771 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -85.26 21.38 1.72 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.538 1.535 . . . . 71.549999999999997 112.962 -173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -150.04 166.59 29.25 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.915 1.286 . . . . 70.140000000000001 110.594 167.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -139.88 98.98 3.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.093 0.957 . . . . 72.549999999999997 108.95 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 32.9 mtm-85 -91.27 160.99 15.23 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.627 -1.296 . . . . 74.430000000000007 109.435 173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.6 t -142.81 114.43 2.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.608 -1.256 . . . . 52.229999999999997 107.608 -173.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -98.42 94.15 6.57 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 108.225 -1.028 . . . . 70.439999999999998 108.225 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.65 112.39 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 105.177 -2.157 . . . . 51.439999999999998 105.177 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.88 175.5 13.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.711 -1.588 . . . . 73.329999999999998 106.711 168.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.431 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -109.55 154.12 23.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.708 -1.219 . . . . 72.129999999999995 107.708 -174.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -142.37 162.61 35.03 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.349 -1.722 . . . . 74.420000000000002 106.349 176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 69.04 -75.61 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.515 1.926 . . . . 70.150000000000006 111.981 174.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -137.39 36.49 2.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.069 1.348 . . . . 73.349999999999994 110.577 -167.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 59.66 26.56 15.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.118 0.967 . . . . 44.25 110.992 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -75.98 126.89 31.85 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.646 -1.242 . . . . 73.420000000000002 107.646 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 63' ' ' THR . 2.7 t -75.39 97.99 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-O 121.202 0.525 . . . . 54.340000000000003 109.752 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -113.02 -174.89 2.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.007 -1.451 . . . . 74.120000000000005 107.823 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.9 t -134.43 144.7 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 106.298 -1.741 . . . . 70.209999999999994 106.298 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -134.38 169.58 17.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 126.828 2.051 . . . . 63.539999999999999 108.347 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 pt -148.23 144.32 18.62 Favored Pre-proline 0 N--CA 1.449 -0.523 0 O-C-N 121.567 -0.708 . . . . 61.350000000000001 109.213 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.78 116.33 4.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.806 -1.652 . . . . 50.149999999999999 107.806 164.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -137.72 -167.03 2.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.768 2.827 . . . . 65.129999999999995 107.406 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.78 -76.53 0.02 OUTLIER Glycine 0 C--N 1.331 0.298 0 N-CA-C 108.322 -1.911 . . . . 71.519999999999996 108.322 174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.38 61.42 0.14 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.732 2.813 . . . . 73.310000000000002 111.45 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.54 78.03 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.776 1.23 . . . . 72.150000000000006 109.487 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 C--O 1.252 1.206 0 C-N-CA 128.064 2.546 . . . . 71.25 113.415 155.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.377 0 N-CA-C 110.898 -0.881 . . . . 51.149999999999999 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.46 170.33 8.32 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.335 0.654 . . . . 64.439999999999998 110.725 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.65 -57.57 12.15 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.498 -0.927 . . . . 71.129999999999995 108.498 162.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -156.76 62.4 0.52 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.4 1.095 . . . . 74.120000000000005 110.836 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.59 58.81 5.01 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.969 0.795 . . . . 54.409999999999997 111.582 -169.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -71.05 30.91 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.448 2.299 . . . . 70.439999999999998 113.914 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -155.71 42.39 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.028 -1.045 . . . . 74.129999999999995 111.675 -163.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 142.73 34.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.035 -1.098 . . . . 72.219999999999999 108.035 167.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.65 167.65 14.74 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.592 -0.892 . . . . 71.439999999999998 108.592 163.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.5 m -130.96 137.78 49.42 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.914 -1.513 . . . . 73.219999999999999 106.914 168.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.2 mt -104.6 151.0 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.809 -1.923 . . . . 73.239999999999995 105.809 171.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 14' ' ' ILE . 14.7 ttm-85 -136.28 131.58 34.62 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.323 -1.362 . . . . 72.439999999999998 107.323 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.07 137.23 38.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.361 -1.348 . . . . 75.329999999999998 107.361 172.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.57 HD11 ' HD2' ' A' ' 12' ' ' ARG . 3.7 mp -128.84 140.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.045 1.738 . . . . 71.319999999999993 108.002 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -106.73 57.98 0.64 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.332 1.453 . . . . 65.519999999999996 113.627 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -74.29 57.96 0.7 Allowed 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.032 -1.667 . . . . 74.450000000000003 112.597 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.76 HG22 HD12 ' A' ' 87' ' ' LEU . 17.6 p -136.36 170.98 15.15 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.007 1.723 . . . . 75.439999999999998 111.511 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 5.81 16.04 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.855 1.662 . . . . 72.420000000000002 114.401 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -122.74 -169.83 1.99 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.032 0.833 . . . . 71.129999999999995 111.758 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -121.7 150.12 42.25 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.521 3.128 . . . . 51.020000000000003 107.642 172.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 63' ' ' THR . 3.6 m -133.43 144.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.593 1.157 . . . . 65.120000000000005 108.717 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 64' ' ' GLN . 0.4 OUTLIER -139.17 23.74 2.55 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.203 1.186 . . . . 71.439999999999998 114.203 -166.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.73 73.47 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.978 -1.489 . . . . 70.120000000000005 106.978 -170.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.03 96.59 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.897 -1.149 . . . . 74.310000000000002 107.897 -174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HE2' ' HG3' ' A' ' 33' ' ' GLU . 6.5 mtpp -70.03 147.75 49.68 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 119.366 -0.934 . . . . 72.109999999999999 110.068 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.8 t -136.86 135.71 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 116.99 -1.481 . . . . 74.430000000000007 107.463 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.8 m -133.76 152.27 51.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.812 1.645 . . . . 74.239999999999995 109.505 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -156.24 18.17 0.35 Allowed 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 120.144 1.338 . . . . 74.329999999999998 113.66 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.35 -170.91 3.4 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.791 -1.929 . . . . 61.039999999999999 105.791 171.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.05 92.48 8.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.276 -1.379 . . . . 63.049999999999997 107.276 175.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.2 51.56 2.75 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.209 1.385 . . . . 71.109999999999999 110.056 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' CE ' ' HA ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -148.59 97.68 2.77 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 106.199 -1.778 . . . . 71.420000000000002 106.199 179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 1.4 pm0 -147.57 156.97 43.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.709 1.256 . . . . 73.120000000000005 109.461 -173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.69 -169.14 2.55 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.262 2.225 . . . . 75.439999999999998 107.748 171.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 25' ' ' LYS . 1.2 t -144.82 153.08 41.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 119.805 1.184 . . . . 73.510000000000005 109.101 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.36 141.72 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 106.186 -1.783 . . . . 64.109999999999999 106.186 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -49.07 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 126.854 2.062 . . . . 71.340000000000003 110.7 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 85.7 m -148.25 139.95 23.75 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.331 -1.729 . . . . 65.549999999999997 106.331 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 39' ' ' LEU . 5.4 tp -124.09 103.2 8.15 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.017 -1.846 . . . . 72.109999999999999 106.017 176.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.67 -178.33 9.36 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.767 1.175 . . . . 72.219999999999999 111.613 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 p -55.56 117.52 3.68 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.233 -1.157 . . . . 74.150000000000006 111.152 -177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 56.7 20.19 4.89 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.191 1.396 . . . . 74.530000000000001 113.63 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.0 175.65 9.38 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.269 -0.894 . . . . 74.530000000000001 111.897 178.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.3 p -160.88 165.98 29.21 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.246 0.832 . . . . 64.530000000000001 113.246 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 tt -153.89 144.47 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.171 1.388 . . . . 74.340000000000003 108.487 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.55 145.98 31.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.701 0.682 . . . . 74.239999999999995 109.331 167.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -152.89 159.16 42.98 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.729 0.812 . . . . 70.109999999999999 110.662 172.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 t -76.64 143.5 40.1 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.032 -1.043 . . . . 64.319999999999993 108.616 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.9 161.64 26.57 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.882 -1.155 . . . . 71.150000000000006 107.882 157.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.79 64.6 3.49 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.952 1.301 . . . . 60.439999999999998 107.632 171.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.59 129.67 1.92 Allowed 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 122.018 -0.426 . . . . 42.549999999999997 110.331 -171.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -78.77 -20.88 69.97 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.767 -0.533 . . . . 63.329999999999998 111.767 170.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -145.21 144.7 30.97 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 118.303 1.051 . . . . 75.310000000000002 109.978 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.7 t -147.2 145.16 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.333 0.653 . . . . 74.329999999999998 109.718 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.98 0.22 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.516 1.926 . . . . 74.239999999999995 113.338 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.55 161.11 40.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.987 1.315 . . . . 73.120000000000005 109.988 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 ttm -148.46 143.69 26.91 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.09 0.956 . . . . 73.450000000000003 109.539 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -134.77 108.31 7.9 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.651 1.18 . . . . 61.240000000000002 108.168 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -98.34 147.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 105.413 -2.069 . . . . 74.219999999999999 105.413 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.67 101.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.051 -2.203 . . . . 75.310000000000002 105.051 178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.48 177.02 21.47 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.946 -0.919 . . . . 72.230000000000004 111.8 -170.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.2 m -139.76 140.79 36.81 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.485 1.143 . . . . 74.409999999999997 111.744 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' HG12 ' A' ' 21' ' ' VAL . 6.8 p -79.53 178.25 8.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.512 1.925 . . . . 61.539999999999999 112.294 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.423 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . 3.8 tt0 -51.85 -48.62 63.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.972 1.309 . . . . 70.120000000000005 109.788 167.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -70.19 -1.76 11.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.784 1.634 . . . . 75.25 113.418 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.43 6.86 89.05 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 119.36 0.982 . . . . 71.120000000000005 111.536 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -71.29 108.92 5.0 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.816 -1.179 . . . . 75.209999999999994 107.816 176.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -90.47 123.6 34.3 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.986 1.314 . . . . 75.230000000000004 107.711 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -116.12 155.14 28.72 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.671 1.588 . . . . 72.430000000000007 108.269 -176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.6 p -137.0 154.94 50.28 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.28 1.432 . . . . 60.219999999999999 108.821 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.32 -77.24 1.08 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 108.269 -1.932 . . . . 62.509999999999998 108.269 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 59.79 106.47 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 129.069 2.948 . . . . 73.540000000000006 110.513 -170.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -131.93 137.86 48.12 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 125.135 1.374 . . . . 71.230000000000004 108.945 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -112.74 170.54 8.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.898 2.079 . . . . 72.420000000000002 108.41 171.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 46.52 52.91 10.33 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 126.0 1.762 . . . . 64.430000000000007 113.399 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 137.69 46.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.683 -1.599 . . . . 71.349999999999994 106.683 173.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.91 162.3 13.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.633 -0.506 . . . . 64.140000000000001 109.633 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.92 140.84 8.34 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.472 -1.051 . . . . 64.450000000000003 110.472 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -79.9 19.02 0.72 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.998 1.719 . . . . 55.229999999999997 111.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.55 163.74 29.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.274 1.43 . . . . 60.240000000000002 108.841 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -141.4 144.16 34.33 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 123.88 0.872 . . . . 74.140000000000001 108.685 -170.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -139.92 -178.35 5.4 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.2 -0.938 . . . . 73.530000000000001 110.12 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 86.0 t -140.71 110.95 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.132 -2.544 . . . . 61.310000000000002 104.132 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -94.56 90.6 6.23 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.93 -1.508 . . . . 72.549999999999997 106.93 170.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.1 mt -67.98 127.26 29.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 105.648 -1.982 . . . . 64.409999999999997 105.648 164.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -148.78 167.83 24.57 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.427 0.691 . . . . 75.209999999999994 109.674 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD12 HG22 ' A' ' 17' ' ' THR . 5.6 mp -76.76 165.83 24.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.239 1.018 . . . . 55.109999999999999 109.055 174.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -158.52 -178.87 7.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.308 -1.769 . . . . 74.150000000000006 109.082 166.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 58.58 -69.51 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 129.352 3.061 . . . . 71.340000000000003 114.099 168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -146.44 31.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.256 1.822 . . . . 72.450000000000003 110.782 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 65.46 56.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.426 1.49 . . . . 22.539999999999999 108.813 -163.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.01 -168.17 2.05 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.303 2.241 . . . . 74.519999999999996 108.228 173.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.77 96.7 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 121.285 -0.884 . . . . 71.340000000000003 108.953 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.78 169.43 8.45 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 122.258 1.028 . . . . 44.149999999999999 110.933 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.0 t -124.03 123.78 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 105.592 -2.003 . . . . 75.310000000000002 105.592 176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -121.47 168.98 11.1 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.779 1.632 . . . . 75.310000000000002 107.45 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 pt -150.27 144.69 17.75 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-O 118.271 -0.871 . . . . 74.140000000000001 109.878 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.76 89.38 0.29 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.024 2.483 . . . . 73.239999999999995 112.737 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -115.68 169.6 9.08 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.953 1.301 . . . . 74.510000000000005 111.303 -175.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -125.48 -59.53 0.16 Allowed Glycine 0 C--N 1.333 0.414 0 N-CA-C 109.467 -1.453 . . . . 42.43 109.467 -157.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -85.62 52.98 2.61 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.898 0.856 . . . . 73.209999999999994 110.494 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 8.9 pt -115.43 57.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.616 1.167 . . . . 42.450000000000003 107.923 170.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.245 0.85 0 C-N-CA 124.177 0.991 . . . . 73.530000000000001 109.385 165.641 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.499 0 N-CA-C 109.269 -1.532 . . . . 42.340000000000003 109.269 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.04 16.28 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.721 0.808 . . . . 51.409999999999997 110.361 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.73 -5.32 19.83 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.755 0.822 . . . . 74.409999999999997 112.796 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -144.64 107.86 4.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 102.276 -3.231 . . . . 60.439999999999998 102.276 169.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.97 67.43 0.13 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 108.033 -2.027 . . . . 55.32 108.033 -169.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -148.43 44.48 1.04 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.574 1.95 . . . . 74.549999999999997 107.679 -169.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -137.48 97.71 3.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 103.828 -2.656 . . . . 52.43 103.828 164.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . 6.0 t -74.28 -166.79 0.45 Allowed 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.726 0.81 . . . . 63.25 109.651 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.52 161.57 13.51 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.028 -0.42 . . . . 63.5 110.553 170.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.4 m -120.29 160.39 23.08 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 124.112 0.965 . . . . 72.340000000000003 108.745 177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.1 mp -138.45 149.05 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.013 -1.847 . . . . 53.119999999999997 106.013 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -139.8 121.48 15.31 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 124.392 1.077 . . . . 71.099999999999994 108.819 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -103.41 131.23 50.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.453 1.501 . . . . 62.439999999999998 108.036 -177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' HG2' ' A' ' 16' ' ' GLN . 3.3 mp -129.53 115.5 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.996 -1.113 . . . . 61.109999999999999 107.996 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' HB2' HD12 ' A' ' 39' ' ' LEU . 43.4 t30 -75.59 114.07 13.75 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 107.86 -1.163 . . . . 64.239999999999995 107.86 168.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 14' ' ' ILE . 5.3 mt-30 -117.91 25.96 10.0 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.037 1.29 . . . . 74.420000000000002 110.545 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.1 p -111.07 172.77 6.68 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.114 1.766 . . . . 74.400000000000006 111.788 -175.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 20.15 1.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.873 1.669 . . . . 72.219999999999999 113.505 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -134.3 -173.12 3.18 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 120.401 -1.437 . . . . 72.099999999999994 111.022 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -119.81 154.18 34.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.252 1.421 . . . . 75.019999999999996 107.557 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 63' ' ' THR . 5.4 m -133.25 151.7 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 119.064 0.847 . . . . 75.109999999999999 109.806 174.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 0.0 OUTLIER -139.96 12.79 2.45 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.501 1.667 . . . . 72.120000000000005 115.501 -163.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.44 ' ND2' ' H ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -167.21 40.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.263 -0.898 . . . . 75.239999999999995 110.848 -165.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 24' ' ' ILE . 3.4 mp -88.3 103.28 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.459 0 N-CA-C 106.691 -1.596 . . . . 72.409999999999997 106.691 -165.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 35' ' ' THR . 7.8 mtpt -72.38 146.92 46.71 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 107.043 -1.466 . . . . 52.340000000000003 107.043 170.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.51 143.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 106.724 -1.584 . . . . 64.209999999999994 106.724 160.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.73 143.6 47.7 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.615 -2.365 . . . . 74.409999999999997 104.615 170.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 47.0 p90 -138.65 11.58 2.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.989 0.813 . . . . 75.209999999999994 112.012 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.19 179.39 2.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.162 -1.421 . . . . 73.219999999999999 107.162 -170.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -87.79 85.27 7.02 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.689 1.195 . . . . 52.240000000000002 108.141 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.76 33.19 4.49 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.647 -0.658 . . . . 62.240000000000002 113.315 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -135.08 112.33 10.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.886 1.274 . . . . 74.519999999999996 108.813 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.49 141.24 35.4 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.998 1.319 . . . . 75.430000000000007 109.571 -171.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.39 171.37 15.58 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.721 1.208 . . . . 73.430000000000007 108.146 168.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 25' ' ' LYS . 43.6 p -131.1 144.42 51.4 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.089 -1.078 . . . . 75.310000000000002 108.089 -175.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -80.25 138.24 20.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.355 -1.72 . . . . 63.210000000000001 106.355 168.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.32 -76.01 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.321 1.848 . . . . 73.310000000000002 108.346 173.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 21.0 m -143.77 150.63 38.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.227 -2.138 . . . . 74.040000000000006 105.227 171.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -127.05 110.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.859 -1.904 . . . . 63.219999999999999 105.859 176.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.58 -179.93 3.48 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.739 2.114 . . . . 73.040000000000006 114.825 -175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.67 117.76 8.59 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.954 1.301 . . . . 73.319999999999993 108.862 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . 0.252 1.7 m170 54.84 29.13 11.4 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.386 0.674 . . . . 61.009999999999998 112.815 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.73 -176.85 5.38 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.213 1.006 . . . . 75.409999999999997 109.057 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.7 p -147.56 172.84 13.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.289 1.035 . . . . 51.340000000000003 110.161 168.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -155.28 153.22 8.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.669 -1.234 . . . . 71.510000000000005 107.669 161.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -121.01 149.05 43.26 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 123.864 0.865 . . . . 74.5 108.819 163.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -144.04 146.44 32.86 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.235 1.014 . . . . 75.120000000000005 109.014 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.04 147.73 51.98 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.515 -0.92 . . . . 71.329999999999998 108.515 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -174.86 2.64 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.158 0.983 . . . . 44.409999999999997 108.824 167.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -140.86 67.95 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 104.554 -2.387 . . . . 73.299999999999997 104.554 163.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.94 -16.76 0.08 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.83 1.048 . . . . 74.200000000000003 113.83 -168.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 8' ' ' THR . . . 77.51 -36.7 1.59 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 120.766 -1.209 . . . . 60.210000000000001 113.819 177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -146.97 160.51 42.26 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.06 1.744 . . . . 75.400000000000006 109.267 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.23 150.9 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.27 2.228 . . . . 75.200000000000003 109.427 168.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.43 13.87 1.23 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.218 1.807 . . . . 72.530000000000001 111.746 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -152.86 158.6 42.42 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.067 -1.646 . . . . 73.099999999999994 109.184 -177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.8 ttm -156.98 100.84 1.9 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.888 0.767 . . . . 54.030000000000001 110.947 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -93.07 88.16 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.016 -1.105 . . . . 51.140000000000001 108.016 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.1 t -77.38 143.68 12.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.789 1.236 . . . . 64.5 109.144 171.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 70' ' ' THR . 0.1 OUTLIER -158.5 126.82 5.31 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.05 -1.833 . . . . 71.439999999999998 106.05 173.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.8 -173.02 22.45 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.63 -0.669 . . . . 55.409999999999997 111.446 173.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.44 ' H ' ' ND2' ' A' ' 23' ' ' ASN . 0.9 OUTLIER -138.67 136.91 36.35 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.466 1.907 . . . . 63.100000000000001 108.702 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.654 ' HA ' HG12 ' A' ' 21' ' ' VAL . 10.8 p -76.45 173.07 11.94 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.503 1.121 . . . . 71.340000000000003 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -44.99 -51.17 10.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.433 1.493 . . . . 73.129999999999995 108.886 167.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.89 35.76 0.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.404 1.082 . . . . 75.310000000000002 111.956 -177.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.73 5.85 40.39 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 115.413 0.925 . . . . 22.34 115.413 164.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -83.67 134.07 34.79 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 119.425 1.613 . . . . 64.430000000000007 109.119 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.97 136.94 52.09 Favored 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 121.182 -0.949 . . . . 63.200000000000003 108.637 -169.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -125.65 147.92 49.16 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 126.534 1.933 . . . . 75.340000000000003 107.991 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 60' ' ' THR . 28.3 p -145.35 147.62 32.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.273 0.472 . . . . 71.430000000000007 112.273 173.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.79 -83.12 1.71 Allowed Glycine 0 C--O 1.223 -0.572 0 N-CA-C 111.398 -0.681 . . . . 54.310000000000002 111.398 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 72.17 67.25 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.27 2.228 . . . . 72.5 111.948 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -96.03 153.23 17.89 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.486 -0.779 . . . . 71.430000000000007 110.348 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 166.44 25.11 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.603 1.961 . . . . 65.439999999999998 108.643 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.25 22.91 74.79 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.608 -0.551 . . . . 53.399999999999999 113.827 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.0 mt -74.04 175.08 7.76 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.69 1.196 . . . . 72.439999999999998 109.852 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.6 t -135.38 176.15 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.8 1.24 . . . . 72.340000000000003 108.386 -168.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.4 -173.95 54.9 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 120.844 -1.16 . . . . 74.140000000000001 112.49 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.63 30.53 6.19 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.366 1.466 . . . . 75.340000000000003 110.68 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -157.97 158.96 35.91 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 125.953 1.701 . . . . 75.109999999999999 107.579 174.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.2 155.62 46.76 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.835 0.854 . . . . 64.319999999999993 110.487 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -133.54 169.32 17.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.147 -1.057 . . . . 60.130000000000003 108.147 173.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 64.4 t -148.96 105.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 105.043 -2.206 . . . . 73.340000000000003 105.043 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -91.53 105.35 17.69 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.301 1.44 . . . . 71.329999999999998 107.367 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 15' ' ' ASN . 50.9 mt -86.6 114.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.259 -1.756 . . . . 75.219999999999999 106.259 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -154.61 -179.94 8.46 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 108.927 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.3 mt -101.91 160.5 14.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.006 0.923 . . . . 71.129999999999995 111.066 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -150.83 -173.05 4.36 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.562 1.945 . . . . 74.099999999999994 107.862 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 69.78 -71.91 0.12 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 129.379 3.072 . . . . 73.299999999999997 112.136 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -142.97 17.67 1.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.903 1.281 . . . . 64.430000000000007 110.491 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . 75.26 35.62 0.56 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.899 2.08 . . . . 64.140000000000001 110.208 -156.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.89 153.95 26.08 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.277 -1.379 . . . . 71.010000000000005 107.277 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 t -81.53 113.71 21.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 121.624 -0.673 . . . . 64.0 109.445 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -117.47 -168.46 1.49 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.736 1.214 . . . . 74.0 109.801 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.95 141.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.555 -2.017 . . . . 71.0 105.555 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -139.93 170.34 16.04 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.727 0.775 . . . . 73.519999999999996 110.196 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.8 pt -151.95 152.07 29.21 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 125.013 1.325 . . . . 61.329999999999998 111.229 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -73.07 114.58 4.08 Favored 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.747 2.298 . . . . 70.299999999999997 108.585 163.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -136.95 171.84 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.442 1.497 . . . . 51.030000000000001 107.47 166.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 138.61 -73.96 0.4 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 108.785 -1.726 . . . . 54.219999999999999 108.785 168.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -147.94 71.57 1.19 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 106.351 -1.722 . . . . 73.319999999999993 106.351 -175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -129.13 19.18 2.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.504 1.122 . . . . 72.239999999999995 110.671 175.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.874 -1.06 . . . . 72.510000000000005 109.478 171.67 . . . . . . . . 0 0 . 1 stop_ save_